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Abstract 
Impa i red and aberrant w o u n d heal ing imposes a huge f inanc ia l burden i n the 
developed w o r l d and is an insurmountable p rob lem i n the undeveloped one. M a n y 
new approaches, such as gene therapy and tissue engineered sk in have met w i t h 
l im i t ed success. 
The appl icat ion o f plant-based medic ines provides, in p r inc ip le , a cost e f fect ive 
therapy; a ma jo r c r i t i c i sm o f herbal medic ines, however , is that they are not subjected 
to the rigours o f thei r pharmaceut ical соип ІефаПз. Th is w o r k sc ient i f ica l ly 
investigates the effects o f four A f r i c a n herbal medic ines used general ly i n the 
treatment o f wounds; the behaviour o f normal human dermal fibroblasts ( N H D F ) is 
k n o w n to be cruc ia l to the onset o f w o u n d heal ing disorders and cul ture o f this ce l l 
type was the means by w h i c h effects were gauged. 
The herbs are Cissus rotundifolia lea f extract (C. rotundifoliaQu)), Cassia abbreviata 
bark extract (C. abbreviata(B)), Zanthoxylum chalybeum bark extract (z 
chalybeนm(E)) and Zanthoxylem chalybeum lea f extract (Z chalybeum{L)). 
Aqueous extract ions o f herbal medicines were used i n a l l exper iments. 
Single and pai red combinat ions o f the herbal medic ines were assessed. The effects o f 
combinat ions were compared to a theoret ical addi t ive (obta ined by the summat ion o f 
ind iv idua l herbal extract ef fects) ; thus, combina t ion behaviour was def ined in terms o f 
be ing addi t ive, greater than addi t ive or less than addi t ive 
The effects o f single and comb ined herbal extracts on cu l tured N H D F were assessed 
w i t h respect to the f o l l o w i n g w o u n d heal ing parameters: 
1. G r o w t h o f N H D F i n basal med ia (to unequivoca l ly establ ish the extent o f ef fects) 
і і і 
and basal media / 2%FBS ( to s imulate impa i red heal ing). 
2. G r o w t h o f N H D F i n basal med ia 110% FBS + 70 μΒ / m l o f insu l in - l i ke g row th 
factor ( to simulate fíbrotic heal ing) 
3. N H D F exposed to H2O21 FeSOa ox idant env i ronment ( to s imulate impa i red heal­
ing) . N H D F were either pre- incubated w i t h herbal extracts for 12 һ ( to assess 
protect ive effects) or exposed to oxidants and extracts s imul taneously ( to assess 
the ab i l i t y o f extracts to neutral ise oxidants) 
4. N H D F product ion o f pro-col lagen type I carboxypept ide (PICP) and kerat inocyte 
g rowth factor ( K G F ) 
For g rowth related effects and the extent to w h i c h N H D F were damaged by exposure 
to ox idants, the M T S assay was used as an indi rect determinat ion o f v iab le ce l l 
number. 
The product ion o f b iomolecu les (PICP and K G F ) , was measured by enzyme l i nked 
immunosorbent assay (EL ISA) . 
С. rotundifolia{L) and c. abbreviata{B) enhanced the g row th o f N H D F i n basal 
med ia and basal media / 2 % FBS. 
Combinat ions o f these herbal extracts, when appl ied i n basal media , produced l e s s 
than addi t ive effects w h e n the c. rotundifoliaQJ) p ropor t ion exceeded 1:1 but greater 
than addi t ive effects at c. rotundifolia{L) proport ions o f 1:1 or less. 
I n the case o f c. rotundifoliaÇL) I c. abbreviata(B) combinat ions appl ied i n basal 
med ia / 2 % FBS, the effects were greater than addi t ive at a l l proport ions. 
Ζ chalybeum{B) had ant ipro l i ferat ive effects on the N H D F f ib ro t i c mode l . W h e n 
comb ined w i t h ζ chalybeum{B) i n proport ions greater than 1:1, c. rotmdifolia(L) 
IV 
reduced the extent to w h i c h z chalybeum{B) was able to inh ib i t g row th ; when present 
i n proport ions o f 1:1 or less, c. rotundifolia(h) was not able to in f luence the effects o f 
Z chalybeum(B). 
Nei ther single nor combined herbal extracts had any ef fect on the product ion o f 
b iomolecu les such as PICP and K G F . The apparent changes corresponding to the 
appl icat ion o f с rotundifoliaÇL), с. abbreviata(B) and z chalybeum(B) were due 
ent i re ly to thei r growth-re lated effects. 
I n terms o f ant iox idant ef fects, none o f the herbal extracts (single or combined) , when 
incubated w i t h N H D F pr ior to ox idant add i t ion , were able to protect cel ls f r o m 
damage. 
c. rotundifol։a{L), z. chalybeum{L) and z chalybeum(B), i n descending order o f 
potency, demonstrated an ab i l i t y to neutral ise the effects o f oxidants w h e n ox idant 
and herbal extracts were added simultaneously. 
Combinat ions o f c. rotundifoliaÇL) and z chalybeum{B) produced effects w h i c h were 
addi t ive at a l l proport ions. 
Combinat ions o f c. rotundifoliaÇL) and z chalybeum{L) produced effects w h i c h 
were addi t ive at z chalybeum(L) proport ions greater than 1:1 but super-addit ive at X . 
chalybeum(L) proport ions o f 1:1 or less. 
Combinat ions o f z chalybeum(B) and z chalybeum{L) were less than addi t ive at a l l 
proport ions. 
The w o r k has prov ided an appropr iate p la t fo rm for the broader study o f the fou r 
herbal medic ines and i t is reasonable to conclude that there is a sc ient i f ic basis fo r the 
appl icat ion o f these herbal extracts to the treatment o f wounds and w o u n d heal ing 
disorders. 
A l l o f the herbal extracts have in f luenced at least one o f the selected w o u n d heal ing 
aspects, whether s ingly or i n combina t ion ; i n part icular , c. rotundifolia(L) and z. 
chalybeum{L) have demonstrated g row th related and ant iox idant propert ies. 
The further invest igat ion o f e f fect ive herbs, i n terms o f other sk in ce l l types 
(kerat inocytes or endothel ia l cel ls) or more invo lved study (organ cul ture, human 
tr ia ls) w o u l d be o f mer i t . 
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Chapter 1 一 Introduction 
1.1 T h e s k i n : an o v e r v i e w o f s t r u c t u r e and f u n c t i o n 
The skin is the largest and most complex organ o f the body and its funct ions are bo th 
protect ive and regulatory. Together w i t h its der ivat ive structures, i t is also k n o w n as 
in tegument and fo rms a barr ier against physical , chemica l and in fect ious insul t ; 
structural and chemica l adaptat ion o f this integumentary system exert cont ro l over 
fluctuations in temperature and water content, together w i t h responding to external 
physical s t imu l i such as pressure. ' 
Sk in has a surface area o f one po in t five to t w o square metres, represents up to f i f teen 
percent o f to ta l bodywe igh t and is the organ most a f fected by d i rect env i ronmenta l 
in f luence. ' 
The integumentary system is composed o f three d is t inct funct iona l layers, w h i c h are 
themselves mul t i layered. A n outer epidermis provides the ma in protect ive func t ion , 
the dermis contains the capi l la ry ne twork responsible fo r nutr ient p rov is ion and tox i c 
waste remova l , and a basement membrane serves as an adhesive and communica t i ve 
j u n c t i o n between the two. 2*^ 
A l t h o u g h dist inct , these layers never func t ion independent ly and their respective 
physical and b iochemica l characterist ics result i n the func t ion o f the sk in as a 
complete organ.^ 
1.1.1 Ep idermis 
Th is tissue layer is f o rmed f r o m squamous strat i f ied ep i the l ium and, i n c o m m o n w i t h 
other examples o f epi thel ia, is avascular. I t is the first l ine o f defence against physical 
and chemica l insul t and is responsible for the prevent ion o f excess water loss or gain 
I n cel lu lar terms, epidermis consists predominant ly o f kerat inocytes (up to n inety five 
percent) bu t also inc luded are melanocytes (p igmenta t ion) , Langerhans cel ls ( immune 
response) and M e r k e l cel ls (nerve conduct ion).^ 
1.1.2 Dermis 
Responsible for most o f the structural strength o f the sk in , the dermis is largely 
connect ive tissue w i t h fibroblasts, a f e w adipose cel ls and macrophages. Co l lagen is 
the m a i n connect ive tissue fibre but elast in is also present.^ 
The dermis is subdiv ided in to the papi l la ry layer (adjacent to the ep idermis) and a 
deeper ret icular layer . ' 
A l t hough lack ing the st rat i f icat ion o f ep idenna l t issue, the dermis is structural ly 
comp lex and able to interact phys ica l ly w i t h the epidermis. 
1.1.3 Basement membrane 
The cutaneous basement membrane zone is located between the epidermis and the 
dermis and is also k n o w n as the dermal -ep idermal j unc t i on . The j m c t i o n separates 
these t w o ce l lu lar ly d ist inct compartments and provides adhesion and a dynamic 
interface between them, thus govern ing the overa l l structural in tegr i ty o f the sk i n . ' 
The basement membrane restricts the transit o f molecules between the epidermis and 
the dermis on the basis o f size and charge, thereby ma in ta in ing correct dermal and 
epidermal compos i t ion * 
1.2 T h e n o r m a l response o f the sk in to i n j u r y 
1.2.1 Acu te w o u n d heal ing 
I n terms o f the sk in , wound ing is def ined as be ing a d israpt ion o f the structure and 
func t ion o f the epidermis, dermis and basement membrane; cutaneous w o u n d heal ing 
is the process by w h i c h cont inu i ty o f these tissues is restored, together w i t h 
phys io log ica l f unc t i on . ' 
Hea l ing proceeds v ia un impai red progression through four over lapp ing phases: 
haemostasis, i n f l ammat ion , p ro l i fe ra t ion and remode l l i ng ; each phase is characterised 
by the in f i l t ra t i on in to the w o u n d site o f speci f ic ce l l t y p e s / " a l l o f w h i c h interact and 
communica te , by chemica l signals, to opt imise repair. 
1.2.1.1 Haemostasis 
The immedia te purpose o f this phase is the prevent ion o f fur ther tissue loss f r o m 
damaged b l ood vessels. Th is is achieved, upon platelet adhesion and aggregat ion, by 
the synthesis o f insoluble fibrin; adhesive molecules such as fibronectin and 
v i t ronec t in are deposited onto the fibrin mesh. The fo rma t ion o f the fibrin based c lo t 
w i t h i n damaged b l ood vessels faci l i tates cessation o f hemorrhage whereas discharge 
f r o m b l ood vessels in to surrounding tissue provides a prov is ional ma t r i x over w h i c h 
cel ls responsible fo r repair can migrate. 
I n the final stages o f haemostasis, fibrin degradat ion products, together w i t h platelet 
der ived g row th factors, are attractants fo r i n f l ammato ry cells. 
1.2.1.2 In f l ammat ion 
I n th is phase, a var iety o f leukocytes are rełeased from b l o o d vessels i n response to 
cel lu lar signals, taflammation is t rad i t iona l ly separated in to an early and late stage, 
each o f w h i c h is characterised by the predominance o f par t icu lar leukocytes. The 
early stage features พ օ տ ժ debr idement, fac i l i ta ted by the phagocytosis and eventual 
destruct ion o f bacter ia and ce l l debris by пеиЇгорШІ8 whereas the late stage consists o f 
macrophage predominance and the eventual i n f i l t ra t i on into the w o u n d site o f 
lymphocytes. 
Macrophages in i t i a l l y assist and u l t imate ly supercede neutrophi ls , i n add i t ion to 
releasing several potent g row th factors and chemoattractants whereas lymphocytes 
appear to represent a regulatory func t ion o f the immune system on w o u n d heal ing, 
albei t a poor ly understood one. 
1.2.1.3 Pro l i fe ra t ion 
St imulated g row th and m ig ra t ion o f ne ighbour ing dermal and ep idermal cel ls to the 
site o f in ju ry is the ha l lmark o f th is phase. Ce l lu la r p roduct ion o f b io log ica l molecules 
fur ther contr ibutes to restorat ion o f lost t issue components. Pro l i fe ra t ion and 
mig ra t ion occurs by means o f autocr ine and paracrine s ignal l ing cascades. 
Fibroblasts and endothel ia l cel ls construct connect ive tissue r i ch i n co l lagen, 
abmdan t l y populated by f ibroblasts and h igh ly vascular ised, due to the fo rma t ion o f 
new b lood vessels; co l lec t ive ly , this is k n o w n as granulat ion tissue. 
Format ion o f new epidermis is due to kerat inocyte m ig ra t ion from the w o u n d 
margins, f o l l o w e d by s t imulated pro l i fe ra t ion and d i f fe rent ia t ion i n a process k n o w n 
as re-epi thel ia l isat ion. 
1.2.1.4 Remode l l i ng 
Remode l l i ng occurs i n tandem w i t h pro l i fe ra t ion i.e as soon as new tissue is produced 
it is remodel led. T rad i t iona l l y , i t has been treated as a separate phase, p r imar i l y 
because i t continues fo r up to t w o years after in ju ry , long after the p ro l i fe ra t ion phase 
has ceased. 
Th is aspect o f cutaneous heal ing denotes an al terat ion o f the compos i t ion and hence 
structure o f granulat ion t issue, to the end o f approx imat ing the pr ior , undamaged state 
by the fo rmat ion o f scar t issue; however , despite the length o f t ime a f fo rded to 
remode l l ing , the extracel lu lar ma t r i x o f a maณre scar never attains the physical 
propert ies o f un in ju red s t í n . 
Further tissue reorganisat ion is brought about by the real ignment o f co l lagen f ibres by 
in ternal ly generated ce l lu lar forces and direct cel lu lar degradat ion and synthesis o f 
b iomoleculeร. 
1.3 W o u n d hea l i ng ะ a 2 1 " c e n t u r y perspect ive 
1.3.1 Chron ic wounds 
M u l t i p l e local disturbances and systemic disease can result i n impa i red w o u n d 
h e a l i n g ; " the resul t ing pro longed i n f l ammat i on and tox ic m ic roenv i ronment are the 
m a i n reason fo r t ransi t ion f r o m the acute to chronic state. 
Pressure ulcers, d iabet ic foo t ฟcers and venous leg ฟcers are c o m m o n examples o f 
chłonie w o u n d s . " 
1.3.2 F ibrot ic heal ing disorders 
Ex t reme ce l lฟa r act iv i ty results i n the hea l ing process progressing beyond the po in t at 
w h i c h tissue structure and func t ion are restored.*^ Th is results i n excess scar 
fo rmat ion w h i c h , i n add i t ion to be ing cosmet ica l ly undesirable, disturbs the structure 
and fimction o f sk in ; the most c o m m o n examples o f such fíbrotic disorders are 
kelo ids and hyper t rophic scarr ing. ^ ՚՛ 
1.4 P lan ts ะ a n a t u r a l resource i n w o u n d t h e r a p y 
I n deve lop ing countr ies such as A f r i c a , i n ju ry to the sk in is c o m m o n and a general 
lack o f med ica l resources o f ten results i n a chron ic state o f healing.*^ 
Chron ic wounds are also a p rob lem i n the developed w o r l d ; the management o f these 
wounds and the i r associated morb id i t y /mor ta l i t y places an enormous dra in on 
healthcare resources. Est imates o f the financial burden imposed by chronic wounds i n 
the Un i t ed K i n g d o m were rev iewed recent ly and are as fo l lows** ： the overa l l cost o f 
wounds to the Na t iona l Hea l th Service is about one b i l l i o n pounds a year. 
Foot u lcerat ion is the most c o m m o n compl i ca t ion o f diabetes that requires 
hospi ta l isat ion and accounts fo r around twenty four thousand admissions a year, 
cost ing some seventeen m i l l i o n pounds. The annual costs o f t reat ing venous leg 
u lcerat ion and pressure ulcers were est imated at four hundred and three hundred 
m i l l i o n pounds respect ive ly /^ 
K e l o i d and hyper t rophic scars have af fected patients for centuries and remain among 
the most chal lenging problems fo r physicians and surgeons. 
Deve lopment o f tissue си ІШге techniques and an ima l models has revolut ion ised the 
understanding o f w o u n d heal ing i n terms o f the processes i nvo l ved and such scient i f ic 
methodologies have been used i n the development o f novel approaches to c føonic 
w o u n d t rea tmen t . " Prominent examples are g row th factor therapy and tissue 
engineered sk in equivalents. However , a recent report publ ished i n the B r i t i sh 
Journal o f Surgery ind icated that there has been a general ly d isappoint ing c l i n i ca l 
outcome f r o m g rowth factor tr ials;^" tissue engineered sk in has shown promise bu t 
there are st i l l concerns regarding host-graft interactions.^* 
Research into ke lo ids and hypert rophic scars has been less f h i i t f u l and they remain an 
ongo ing c l i n i ca l chal lenge, requ i r ing m u l t i m o d a l therapy to achieve only par t ia l ly 
successful results. U n t i l such t ime as more ef fect ive t reatment becomes avai lable, 
c l in ic ians must ut i l ise ex is t ing regimes wh i l e con t inu ing to exper iment w i t h new 
approaches.^^ 
I n recent years, at tent ion has been turned to the invest igat ion o f cost e f fec t ive, 
accessible alternatives. Trad i t iona l fo rms o f med ic ine pract iced fo r centuries i n A f r i c a 
and As ia are be ing sc ient i f ica l ly invest igated for thei r potent ia l i n the treatment o f 
wounds and related disorderร.^'''^'* 
1.4.1 Trad i t iona l herbal med ic ine and w o u n d heal ing 
The treatment o f in ju ry or disease by plants or p lant mater ia l , either i n the crude or 
processed state, is k n o w n as t rad i t ional herbal medic ine. 
W o u n d care can be traced back to early c iv i l i sa t ions and most treatments were based 
on the use o f indigenous plants or phytomedicines.^'* Today, i n deve lop ing countr ies, 
up to eighty percent o f the popula t ion depend ma in l y on med ic ina l plants for the i r 
p r imary heal th care.^* Consequent ly, largely due to lack o f resources, there remains a 
s igni f icant role i n w o u n d management for plant-based m e d i c i n e ' * ' " and i t has been 
est imated that approx imate ly one- th i rd o f a l l t rad i t iona l herbal medic ines are used fo r 
the treatment o f wounds or sk in disorders.^* 
I n developed countr ies such as the Un i t ed K i n g d o m and Un i t ed States, a convent ional 
medica l system prevai ls and ph j^omedic ines are considered to be al ternat ive, 
unproven forms o f therapy. However , the use o f herbal remedies i n these countr ies to 
treat a w ide var iety o f a i lments has increased exponent ia l ly over the last t w o 
decades;^' this popular i ty af fords a t ime l y oppor tun i ty to sc ient i f ica l ly investigate the 
potent ia l for t rad i t iona l herbal medic ines as a cost e f fect ive t reatment o f w o u n d 
heal ing disorders. 
1.4.2 Bioprospect ing. 
The establ ishment o f t rad i t iona l med ic ine systems has resulted i n comprehensive 
repositories o f i n fo rma t ion regarding the use o f med ic ina l plants i n the treatment o f 
in ju ry and disease. Such indigenous knowledge, together w i t h the vast b iod ivers i ty 
typ ica l o f deve lop ing countr ies, represents a genuine pharmacolog ica l resource for 
those searching for novel drugs and therapies.^" 
B ioprospect ing is the exp lora t ion , ext ract ion and sc ient i f ic assessment o f b io log ica l 
d ivers i ty and indigenous knowledge for commerc ia l l y valuable resources.^^ The 
premise beh ind successful b ioprospect ing is the screening o f p lant mater ia l by v i r tue 
o f low-cost bioassays w h i c h reproduce pharmacolog ica l propert ies in vitro.^^ 
Bioprospect ing methodologies fa l l in to t w o contrast ing categories, each o f w h i c h is 
determined by the search strategy.'^ 
1.4.2.1 H i g h throughput screenings (HTS) . 
Plant extracts are screened fo r pharmacolog ica l ac t iฬ ty w i t h respect to a par t icu lar 
disease as represented by an appropriate bioassay. Large numbers o f compounds are 
screened very qu i ck l y and such a methodo logy is favoured by many d rug companies 
because i t results i n a greater sample d i ve rs i t y . ^ 
A ma jo r disadvantage, however , is that, due to the h igh throughput nature, on ly one 
bioassay can be used to assess the ac t iv i ty o f each p lant ; consequently, plants hav ing 
genuine in vivo ac t iv i ty bu t not exh ib i t i ng the part icu lar in vitro e f fect are l iable to be 
over looked. 
1.4.2.2 Targeted screenings 
Th is approach is dependent on cooperat ion between scientists and t rad i t iona l healers. 
Searches are directed by the app l ica t ion o f obta ined indigenous knowledge and have 
the advantage that the choice o f bioassay is thus determined by t rad i t iona l use o f the 
p lant as opposed to a disease chosen arbi t rar i ly . Sample co l lec t ion , ext ract ion and 
screening general ly takes place over a longer per iod than for H T S and more t ime and 
analysis is devoted to samples selected in this way.^ ' 
A l t hough lack ing the expediency and sample divers i ty o f H T S , a targeted search 
strategy is, at least i n p r inc ip le , more e f f ic ient , due to the invest igated samples already 
hav ing reported effects i n man. ' ^ 
1.5 Screen ing o f w o u n d - h e a l i n g p lan ts 
1.5.1 General ce l l culture-based รณdies o f w o u n d heal ing 
Cul tured cel ls have been used to investigate cel lu lar aspects o f tissue repair such as 
pro l i fe ra t ion and produc t ion o f g row th քսօէօէտ,՝ ՛* damage due to excess tox ins 
produced dur ing i n f l ammat i on , ^ ' and synthesis o f w o u n d heal ing b iomolecu leร . ' * 
These in vitro models permi t the examinat ion o f isolated components o f the w o u n d 
heal ing process, an under tak ing w h i c h is d i f f i cu l t i n the more heterogeneous in vivo 
situat ion. Ce l l cu l ture techniques also enable the p re l im inary assessment o f mater ia ls 
fo r their potent ia l to promote w o u n d repair.^ ' 
Pharmacologica l agents, d issolved i n g rowth med ia , are appl ied to monolayer сฬtures 
o f cells w h i c h have been der ived f r o m skin. The cel ls are incubated fo r a speci f ied 
per iod pr ior to the measurement o f a pharmacolog ica l response synonymous w i t h 
w o u n d heal ing. D e r m a l fibroblasts, epidermal kerat inocytes and dermal endothel ia l 
cells are the most studied wound healing 6քք60է0քտ.՛*" 
1.5.2 Ce l l culture-based studies o f w o u n d heal ing herbal medic ines 
1.5.2.1 General procedures 
E x t r a c t i o n o f p l a n t m a t e r i a l 
Plant mater ia l is macerated and extracted in to hot water. Subsequent extract ions o f 
pharmacolog ica l ly act ive herbs are carr ied out using organic solvents but aqueous 
extract ions can be most easi ly reconst i tuted i n g rowth media. The resul t ing herbal 
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extract solut ions are l yoph i l i sed and stored i n the dark at 4 c . Solut ions for ce l l 
сฟture-app l ica t ion are d i lu ted f r o m stock on the day at w h i c h exper iments begin. 
Assessment o f P r o l i f e r a t i o n 
The w o u n d heal ing process requires the pro l i fe ra t ion o f a var iety o f reparative cel ls 
such as fibroblasts, kerat inocytes and endothel ia l cells. 
The extent to w h i c h herbal extracts in f luence the g row th o f these cel ls is an ind ica t ion 
o f the i r potent ia l fo r w o u n d heal ing. I n studies o f th is nature, ce l l g row th med ia is 
supplemented w i t h a var iety o f factors w h i c h fac i l i ta te o p t i m u m ce l l cu l ture; to 
s imulate the d i f f e r i ng w o u n d microenv i ronments characterist ic o f par t icu lar heal ing 
disorders, cel ls are cu l tured i n med ia conta in ing d i f f e r i ng propor t ions o f supplements 
p r io r to the add i t ion o f herbal extracts. 
I n add i t ion to a p re l im inary assessment o f w o u n d heal ing act iv i ty , p ro l i fe ra t ion assays 
can also prov ide in fo rmat ion as to the l i m i t i n g cy to tox ic concentrat ion. 
Assessment o f a n t i o x i d a n t ef fects 
Prolonged i n f l ammat i on is c o m m o n to chronic wounds such as presswe ulcers, 
d iabet ic ulcers and venous leg ulcers. Part o f the func t ion o f i n f l ammat i on is the 
preparat ion o f the w o u n d env i ronment fo r i n f i l t ra t i on by reparat ive cel ls such as 
f ibroblasts. D u r i n g the in f l ammato ry phase, bacteria are destroyed b y the release o f 
oxygen free r ad i ca l s / " Pro longed i n f l ammat ion results i n a tox i c excess o f these 
species and impai rs the heal ing process. The add i t ion to ce l l cultures o f oxygen 
free radicals provides an approx imat ion o f such a w o u n d mic roenv i ronment and 
enables the ant iox idant ab i l i t y o f herbal extracts effects to be gauged. 
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Assessment o f co l l agen -p roduc ing ef fects 
Fundamenta l ly , a w o u n d represents a loss tissue w h i c h must be replaced by the 
heal ing process. The extent to w h i c h cu l f t i red fibroblasts produce b iomolecules such 
as col lagen is a factor c m c i a l to bo th impa i red and excessive heal ing. The ab i l i t y to 
in f luence col lagen product ion by cu l tured cel ls is therefore another ind ica t ion o f the 
w o u n d heal ing-potent ia l o f t rad i t iona l herbal medic ine extracts. 
1.5.2.2 Examples o f ce l l culture-based invest igat ion o f w o u n d heal ing t rad i t iona l 
medic ines 
Centella asiatica is a p lant g row ing abundant ly around the Ind ian Ocean and has been 
used t rad i t iona l ly fo r several centuries i n Ind ia and Or ienta l countr ies as a treatment 
fo r wounds. A drug der ived from the plant has been developed i n Europe, under the 
name o f "T i t ra ted Ext rac t f r o m Centella asiatica" ( T E C A ) . The extract is a 
reconst iณted m i x ณ r e o f asiatic ac id , madecassic ac id and asiaticoside'*^ and has been 
invest igated in terms o f its effects upon fibroblast p ro l i fe ra t ion and col lagen 
production, where it was found to enhance the latter. 42 
E u p o l i n , an o in tment used i n V i e t n a m to treat bums, consists o f an aqueous extract 
f r o m the leaves o f Chromolaena odorata suspended i n pet ro la tum. D u e to the lack o f 
resources i n V i e t n a m , considerable interest has been expressed i n the c l in ica l 
app l ica t ion o f th is t rad i t iona l remedy.^ ' Aqueous and organic extracts o f th is herb 
have exh ib i ted effects upon f ibroblast , endothel ia ! ce l l and kerat inocyte 
^էօճւԽտճօէւ՛^՝*^ i n add i t ion to protect ion o f fibroblasts and kerat inocytes f r o m oxygen 
free radicals.'*'* 
Scophularia nodosa, an I r ish f o l k medic ine , is s t i l l used today i n the treatment o f 
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wounds. Me thano l i c extracts o f the p lant have recent ly shown the ab i l i t y to enhance 
f ibroblast p ro l i fe ra t ion and fur ther study is ongoing.՚ ՛* S imi la r effects were evident i n 
studies o f extracts from the leaves o f Buddleja globosa, used i n Ch i le and A r g e n t i m 
fo r top ica l w o u n d t rea tment / ^ 
I t is c o m m o n i n Trad i t iona l Chinese med ic ine to apply aqueous extract ions o f several 
herbs i n combina t ion . Aqueous solut ions o f B u m heal ing l i qu id ( B H L ) have been 
used for centuries i n Ch ina as a top ica l t reatment o f bums. B H L is compr ised o f four 
components ： Radix sanguisorbae, Rhizoma Bletilae, Caul is lonicerae and Rhizoma 
Polygoni Cuspidati. The pro l i fera t ive ef fects o f b u m heal ing l i qu i d on fibroblasts and 
kerat inocytes have been demonstrated. ՚*՛ 
The t rad i t iona l history o f ณrmer ic i n Ind ia and other As ian countr ies is fo r its use i n 
f ood flavouring and medic ine , w o u n d heal ing i n part icular. Th is y e l l o w powder is 
obta ined from the t rop ica l p lant Curcuma longa. A n act ive w o u n d heal ing ingredient 
o f curcuma longa, cu rcumin , was iden t i f i ed by v i r tue o f its demonstrated protect ion 
o f fibroblasts f r o m oxidants.'** 
1.6 Reasons f o r u n d e r t a k i n g the s tudy 
"There is no alternative medicine. There is scientifically proven, evidence-based 
medicine supported by solid data, or unproven medicine for which scientific evidence 
is lacking"*^ 
Th is statement underl ines the essential d i f ference between ai teraat ive medic ines, such 
as herbal drags, and thei r m o d e m pharmaceut ical counterparts. A l t hough a s igni f icant 
number o f the latter trace the i r o r ig in to plants, they must meet o f f i c i a l l y decreed, 
str ingent requirements fo r pur i ty , safety and ef f icacy pr io r to pub l i c d is t r ibu t ion or 
c l i n i ca l appl icat ion. Th is discrepancy has resฟted i n plant-based medic ines be ing 
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v iewed as u n k n o w n quant i t ies, to be denied acceptance as bona f ide medic ines un t i l 
subjected to the same r igours as m o d e m drugs. 
These observations p r o j d e a general impeณร fo r the current wo rk : a desire to 
determine i f the t rad i t iona l use o f herbal medic ines can be rat ional ised scient i f ica l ly . 
I n more speci f ic terms, i t is intended to investigate the potent ia l o f certain w o u n d 
heal ing herbal medic ines as a cost e f fect ive therapy i n bo th the developed and the 
develop ing wor lds . 
1.7 A i m o f t he s tudy 
N a m e o f H e r b O r i g i n T r a d i t i o n a l use 
Cissus rotundifolia leaves Kenya The leaves are appl ied d i rect ly to 
burned and scalded sk in 
Zanthoxylum chalybeum bark. Kenya Used t rad i t iona l ly on sk in diseases and 
as an ant i - in f lammatory . 
Zanthoxylum chalybeum bark. Kenya Used t rad i t iona l ly on sk in diseases and 
as an ant i - in f lammatory . 
Cassia abbreviata bark M a l a w i Powdered bark is used for dressing 
ulcers. 
T a b l e 1.1 N a m e , o r i g in and t rad i t iona l use o f the herbal medic ines examined in the 
current study. 
The current รณdy involves the assessment o f the w o u n d heal ing ac t iv i ty o f four herbs, 
used t rad i t iona l ly i n A f r i c a for the treatment o f wounds and / or sk in disorders, w h i c h 
are described b r ie f l y i n Table 1.1 
Nu t ra l i f e U K , a nut r i t iona l supplement company, are sponsors o f the c iurent w o r k 
who have entered in to a partnership w i t h t rad i t iona l healers i n M a l a w i and Kenya. 
General ly, such an arrangement involves the targeted screening o f p lant extracts used 
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i n A f r i c a n t rad i t ional med ic ine ; there is anecdotal evidence o f their e f f icacy but they 
have not been invest igated sc ient i f ica l ly and the rat ionale fo r the i r use is based upon 
generations o f indigenous knowledge w h i c h i n tu rn is u l t imate ly der ived f r o m t r ia l 
and error. 
Cu l tu red cel l monolayers w i l l be employed to determine the effects o f aqueous herbal 
extracts on ce l l p ro l i fe ra t ion , ce l lu lar response to oxidants, co l lagen produc t ion and 
wound-re lated g rowth factor product ion. 
There are no publ ished studies o n the w o u n d heal ing ac t iv i ty o f any o f the A f r i c a n 
herbal medic ines and, more general ly, there is h i ther to no documented w o r k on the 
effects o f any herbal extracts on g row th factor product ion. 
The use o f mu l t i p le herbs is c o m m o n i n t rad i t iona l Chinese medic ine and the 
combinator ia l nature o f b u m heal ing l iquiď*^ suggested the idea o f invest igat ing the 
A f r i c a n herbs i n such a manner. Th i s approach af fords an oppor tun i ty to determine 
the pharmacolog ica l p ro f i l e o f herbal extracts i n combina t ion , as compared w i t h thei r 
i nd iv idua l p ro f i le . 
W h e n drugs are studied i n this way , the possib i l i ty arises that the measured effects o f 
comb ined drags may be greater or less than the sum o f ef fects der ived ind iv idua l ly . 
Such d e l a t i o n s o f comb ined drugs f r o m pure ly addi t ive behaviour ref lect changes i n 
d rug potency; thus, an al ternat ive descr ip t ion o f the phenomenon is that a greater or 
lesser amount o f a drug is requi red to produce a part icu lar e f fect i n comb ina t ion than 
is requi red i n d i ฬ d u a l l y ; ' " when used w i t h appropriate stat ist ical too ls , compar ison 
between theoret ical addi t ive and combina t ion behaviour have been described as the 
' go ld standard' o f such pharmacolog ica l investigations^^ 
The overa l l a i m o f th is study is the in vitro examinat ion o f the w o u n d heal ing effects 
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o f four A f r i c a n herbs, used t rad i t iona l ly for t reatment o f พ o m d s , w h i c h have not been 
previously studied. Add i t i ona l l y , i t is in tended to examine such effects i n terms o f 
single and comb ined herbs, by the app l ica t ion o f proven statist ical techniques, as a 
means o f de termin ing the extent o f pharmacolog ica l interact ion. 
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C h a p t e r 2 一 C h r o n i c a n d f ì b r o t i c h e a l i n g 
2.1 C h r o n i c w o u n d hea l i ng 
I n the absence o f compl ica t ions, most wounds tend to heal w i t h i n a f e w weeks. 
Chronic wounds, i n contrast, either require a pro longed t ime to heal , do not heal , or 
recur f requent ly. These wounds tend to occur when the norma l w o u n d heal ing process 
has been compromised , fo r example, by in fec t ion , metabol ic disturbances, or an 
under ly ing disease.^^ 
Chron ic wounds in f l i c t a huge cost upon society, impa i r i ng the qual i ty o f l i fe fo r 
m i l l i ons w o r l d w i d e and, irrespective o f the under ly ing disease, are invar iab ly 
characterised by a re lat ive inab i l i t y to generate new էւտտս6.*՛՛՛^՛՛ 
2.1.1 Pressure ulcers 
Pressure ulcers are one o f the ma jo r causes o f morb id i t y i n o lder people and the most 
impor tant p rob lem i n nurs ing home residents, dramat ica l ly increasing the cost o f 
medica l and nurs ing care. I n part icular , pressure ulcers o f the foo t are very c o m m o n 
and d i f f i cu l t to heal among elder ly immob i l i sed patients. 
C o m m o n l y referred to as pressure sores, bedsores, decubitus ulcers, or s imp ly 
decubitus, pressure ulcers can develop when a sustained load , friction, or shear is 
appl ied to local ised areas o f the body, leading to degenerat ion o f the sk in and 
under ly ing soft tissues.^*" 
There are var ious expiat ions regarding the e t io logy o f pressure ulcers, w i t h most 
experts adher ing to the theory that they result f r o m chronic occ lus ion o f capi l lary 
b lood flow, leading to a l ternat ing periods o f ischemia and reperfusion. Th is process is 
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associated w i t h repet i t ive fo rmat ion o f react ive oxygen species and concomi tant tissue 
necrosis.^^ 
A l t hough ischaemia has long been studied i n the chronic pressure ulcer, comb ined 
ischaemia I reper fus ion events have on ly recent ly been d i rect ly considered i n its 
pathogenesis.^^ 
Excessive p roduc t ion o f proteases and fur ther p roduc t ion o f reactive oxygen species 
by the newly- recru i ted neutrophi ls exacerbates the cond i t ion .^ ' 
2.1.2 Venous ulcers 
Venous leg u lcerat ion is a d i f f i cu l t c l i n i ca l p rob lem to treat. I t occurs in around one 
percent o f the adul t popu la t ion , and its incidence is five t imes higher among people 
over sixty. The treatment o f these ulcers, i nvo l v i ng regular appl icat ion o f dressings, is 
lengthy and costly.^" 
Venous ulcers const iณte the major i t y o f a l l leg ulcers, account ing for up to e ighty 
percent and, i n Europe, account for up to t w o percent o f the healthcare budget.** 
The suggested pathomechanics invo lve the development o f venous hypertension or 
chronic venous insu f f i c iency by the dysfunct ion o f valves o f the super f ic ia l , deep, and 
commun ica t ing veins due to congeni ta l or acquired incompetence, deep venous 
ou t f l ow obst ruct ion / muscle dysfunct ion and c a l f muscle pump f a i l u r e . " ' " ' * ' * 
The resul t ing forces generated are suf f ic ient to cause in termi t tent capi l lary closure 
and subsequent ischaemia I reperfusion injury,*^ leading to a sequence o f events 
resul t ing i n venous leg u lcerat ion; speci f ica l ly , these generate tox ic amounts o f 
proteoly t ic enzymes such as collagenase and elastase, together vsdth in f lammatory 
cytokines and free r a d i c a l s . " ' " ' * ' * ' * * 
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Al ternat ive ly , recent invest igat ions have focused at tent ion on the invo lvement o f 
i n f l ammato ry cel ls i n the deve lopment o f venous ulcers; large numbers o f act ivated 
leukocytes have been shown to occlude capi l lary loops in a f fected legs and the release 
f r o m these cel ls o f tox ic and degradative species is thought to be a ma jo r factor i n 
pro longed tissue necrosis.* ' 
2.1.3 D iabet ic ulcers 
A reduced capacity to carry out general tissue repair processes is a c o m m o n 
compl i ca t ion o f diabetes me l l i tus and diabet ic heal ing is characterised by reduced 
tensi le strength o f wounds due to defect ive ma t r i x product ion.** 
F i f teen percent o f people w i t h diabetes develop a foot ulcer du r ing thei r l i f e t ime ; such 
chronic wounds remain the most c o m m o n reason for diabetes-related hospi ta l isat ion 
and recurrence rates i n patients vsath previous foo t ulcers are i n excess o f fifty percent. 
Diabet ics are ten to fifteen t imes more l i ke ly to have a lower l i m b amputat ion than 
ind iv idua ls w i thou t the disease, and the rate o f ma jo r amputøt ion cont inues to r ise.^ ' 
Foot problems i n part icular develop i n diabet ic patients for the f o l l o w i n g reasons ： 
1. Hyperg lycaemia- induced ox idat ive stress results i n decreased nerve 
conduct ion ve loc i ty and decreased endoneural b lood flow, bo th o f w h i c h are 
neuropathic precursors.* ' 
2. Neuropathy, leading to al tered sensation and vu lnerab i l i t y to t rauma and 
atrophy o f the skeletal muscles in the feet is o f ten associated w i t h a 
subsequent derangement o f the bony anatomy o f the foot . ' " '^^ '^^ 
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Ischaemic compl icat ions may also arise from per ipheral arter ial disease. These 
under ly ing problems are not mu tua l l y exclusive and have been k n o w n to 
coexist.™' '^ ' '^ 
A s is the case fo r pressure ulcers and venous leg ulcers, ox idant stress results f r o m 
ischaemia I reperfusion and the generat ion o f react ive oxygen species. 73 
2.1.4 Factors w h i c h рефеШа Їе chron ic wounds 
2.1.4.1 Generat ion o f free radicals 
A free radical is any species capable o f independent existence w h i c h contains one or 
more unpaired electrons 7՛* The unpaired electron alters the chemica l react iv i ty o f the 
molecu le / a tom, mak ing i t more react ive than the corresponding non-radical f o r m . 
Oxygen der ived free radicals are co l lec t ive ly te rmed 'reactive oxygen species' and the 
t w o ma jo r examples o f b io log ica l impor tance are the superoxide and hyd roxy l 
radical ' '* and are generated by neutrophi ls as part o f the in f l ammato ry response to 
in jury . 
Neu t roph i l ac t iv i ty such as phagocytosis o f bacter ia, secretion o f proteo ly t ic enzymes 
and immunomodu la to ry agents are accompanied by a 'respiratory burst' caused by 
act ivat ion o f the plasma membrane-bound N A D P H 04ւժսՏ6.՛՛ ՛*՛^^ ： 
NADP+ + 20շ -> NADP+ + 2๐2՜ + н+ 
Օ շ . ՜ undergoes rap id d ismutat ion to f o r m hydrogen peroxide ( H2O2 ) i n a react ion 
catalysed by superoxide dismutase. '* Hydrogen perox ide alone is not reactive enough 
to cause damage to macromoleculeร; i t can, however , f o r m the h igh ly reactive 
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hydroxy l radical v ia two interdependent react ions. '* '^ ' ： 
Fe 2 + + H2O2 — O H + O H — + Fe 3 + ( Fen ton reac t i on ) 
The resul t ing fer r ic i ron can be reduced to ferrous i ron as fo l l ows ： 
F e ^ + Օ շ ՜ 4 ( H a b e r - W e i s s reac t ion ). 
The ferrous i ron produced f r o m the Haber-Weiss react ion provides fur ther reactant fo r 
the Fenton react ion; thus, in the presence o f i r on , phys io log ica l generat ion o f 
superoxide dur ing the respiratory burst culminates i n hyd roxy l radical generat ion. 
A m o n g react ive oxygen species, the hyd roxy l radical is the most potent damaging 
species, able to react w i t h proteins, nuc le ic acids, carbohydrates and l ip ids. The h igh 
react iv i ty o f the radical results i n the d is rupt ion o f the D N A molecu le v ia fo rma t ion o f 
prote in cross- l inks, single and double strand breaks and damage to const i tuent bases; 
general ce l l damage is a consequence o f l i p i d perox ida t ion and pro te in 
fragmentation.^*''^' 
Ischaemia / reper fus ion in ju ry is a c o m m o n pathophysio logica l factor i n the three 
types o f chronic u lcer and the phenomenon is wo r thy o f fur ther explanat ion. W h e n 
depleted o f the i r b l ood supply for a s ign i f icant amount o f t i m e , tissues may reduce 
thei r metabo l ism to preserve funct ion.* " 
Reper fus ion and the accompanying oxygenat ion result i n elevated amounts o f oxygen 
free radicals; inherent mechanisms w h i c h enable tissues to neutral ise these species are 
compromised due to the reduced metabol ic rate and they are elevated to tox ic levels.*^ 
Ischaemia-reperf t is ion events are usual ly repet i t ive and the deleterious effects are 
potent iated, eventual ly becomong suf f ic ient to cause ulcerat ion.*^ 
I n venous ulcers, the ischemic event occurs when the norma l arter ial-venous pressure 
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gradient is no longer present. There is b lood stasis and ef fect ive loss o f c i rcu la t ion. 
W h e n the leg is elevated, c i rcu la t ion is restored, and the in f lammatory changes that 
occur w i t h reperfusion exacerbate the in jury . For pressure ulcers, the ischaemic event 
is the result o f a pro longed appl icat ion o f force suf f ic ient to prevent tissue per fus ion 
and, when the force is finally removed, the reperfusion in ju ry occurs.*^ 
I n diabetic ulcers, ox idat ive stress is compounded by the persistent hyperg lycaemia o f 
the under ly ing diabetes, causing increased product ion o f oxygen free radicals է Խ օ ս ց հ 
auto-ox idat ion o f glucose.*^ 
There have been re lat ive ly f e w studies o f the ox idant stress in chronic or acute w o u n d 
fluids. One study determined the a l lanto in ： ur ic ac id percentage rat io o f chron ic 
w o u n d exudates as a marker o f ox idat ive stress in v /vo.^ ' A s igni f icant e levat ion o f 
the rat io was found i n w o u n d f l u i d f r o m chronic leg ulcers compared to acute surgical 
w o u n d fluid.^' Other studies have indicated that ant iox idant characterist ics are 
enhanced i n the chronic w o u n d env i ronment compared w i t h that o f acute wounds.*"***^ 
The h igh ly damaging hydroxy l radical is produced by the reduct ion o f i ron i n the 
Fenton react ion. ' * B io log i ca l systems are no rma l l y protected from this tox ic 
consequence o f free i r on by v i r tue o f pro te in complexes such as haem and t ransferr in , 
w h i c h b ind and transport i ron respect ively; i r on is unreact ive when comb ined w i t h 
these complexes un t i l i t is reduced, mob i l i sed and thereby rendered avai lable fo r 
redox react ions** '*^ 
Elevated amounts o f free i r on in chronic w o u n d exudates have recently been 
demonstrated;**** ' a resul t ing increase i n hydroxy l radicals v ia the Fenton react ion has 
been proposed to exp la in the persistent i n f l ammat ion and r esฟ t ing tissue destruct ion 
fo r w h i c h the host i le m ic roenv i ronment o f chronic leg ulcers is ք շտթ օ ոտ ւ եԽ . * * ՛ * ՛ 
Chron ic w o u n d heal ing is, therefore, t yp i f i ed by a delayed t ransi t ion between the 
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i n f l ammat i on and pro l i fe ra t ion phases; the damage incur red by reparat ive cel ls as a 
consequence means that extracel lu lar ma t r i x mode l l i ng is also compromised and does 
not occur to the same degree o f e f f i c iency as fo r acute wounds . ' " 
2.1.4.2 Excess proteolyt ic act iv i ty . 
M M P ร (mat r i x metal loproteinases) are a f am i l y o f st ructural ly related enzymes w h i c h 
degrade proteins. A b o u t twen ty d i f fe rent members o f the f a m i l y have been ident i f ied 
and are produced by a var ie ty o f cel ls i nc lud ing fibroblasts, endothel ia l cel ls, 
macrophages, neutrophi ls and k e r a t i n o c y t e s . I n general, M M P ร are not no rma l l y 
expressed i n sk in bu t are induced temporar i l y in response to the elevated g row th 
factor levels, ce l l -mat r ix interact ions and altered cel l - to-cel l contacts characterist ic o f 
tissue in jury . ' ^ 
O n l y four inh ib i tors o f metal loproteinases ( T I M P ร ) are current ly k n o w n and the 
act iv i ty is t igh t ly cont ro l led by T I M P - 1 and T IMP-2 . ' ^ ' " * 
M a t r i x degradat ion is an essential component o f the normal w o u n d repair process and 
is evident du r ing i n f l ammat i on , p ro l i fe ra t ion and remode l ing ; however , a combina t ion 
o f excess proteoly t ic act iv i ty by M M P ร and reduced amounts o f the i r corresponding 
inh ib i tors is thought to contr ibute to the inab i l i t y o f chronic wounds to heal . '^ 
Research has shown that chronic wounds conta in an abundance o f neutrophi ls , w h i c h 
secrete M M P ร and ekstases, leading to the inact ivat ion o f wound-hea l ing g row th 
factors and excessive pro te in ժ 6 § ւ ս ժ ս է ւ օ ո . ՛ * ՛ ՛ ՛ ՛ ՛ * ՛ " 
The product ion o f chemica l w o u n d heal ing-factors by platelets, i n f l ammato ry cel ls 
and reparative cells is cont inuous throughout a l l phases o f acute w o u n d hea l ing; the 
w o u n d heal ing-factors o f ma jo r s igni f icance are shown i n Tab le 2.1. '""·^"*'*"^ 
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The stabi l i ty o f peptide g rowth factors exposed to fluids from heal ing surgical wounds 
and f r o m non-heal ing chronic wounds was examined i n v i t r o . ' * T rans fo rming g row th 
factor-beta ( TGF-ß ) or platelet- der ived g rowth factor ( P D G F ) was incubated w i t h 
fluids f r o m heal ing surgical wounds and fluids f r o m venous stasis or pressure ulcers; 
incubat ion w i t h f lu ids f r o m the chronic wounds resul ted i n s igni f icant degradat ion o f 
these g rowth factors and these results o f fer a reasonable explanat ion for the relat ive 
lack o f success f r o m g row th factor therapy. '^ 
W o u n d fluid f r o m chron ic ulcers contained extensively degraded v i t ronec t in and 
fibronectin (adhesive molecules essential for ce l l m ig ra t ion dur ing w o u n d heal ing) , 
w i t h a corresponding reduced capacity fo r ce l l adhesion and i t was hypothesised that 
these observations were due to excessive protease a c t i v i t y . " Subsequent w o r k 
demonstrated elevated amounts o f neutrophi l elastase i n these fluids ( f i ve to ten- fo ld ) 
compared to those o f acute w o u n d fluid.'*'" and examinat ion o f fluid from acute 
surgical wounds and f r o m non-heal ing pressure ulcers revealed levels o f M M P - 2 and 
M M P - 9 elevated to more than ten and twenty five t imes respect ively, i n the chron ic 
w o u n d fluids/"^ 
A more comprehensive considerat ion o f mat r i x metal loproteinase behaviour i nvo lved 
measurement o f the concentrat ions o f M M P - 1 , M M P - 2 , M M P - 8 , M M P - 9 and T I M P - 2 
i n extracts o f the b iopsy homogenates o f d iabet ic ulcers and non-diabet ic t raumat ic 
wounds. '^ The concentrat ion o f M M P - 1 was increased sixty five-fold i n biopsies o f 
diabet ic foot ulcers compared w i t h s imi la r analysis o f t raumat ic w o u n d tissue. 
Fur thermore, M M P - 2 levels were increased s ix - fo ld , M M P - 8 , t w o f o l d and M M P - 9 , 
four teen- fo ld These results were associated w i t h a t w o - f o l d reduct ion i n the 
expression o f T I M P - 2 . " 
Cont inued studies i n th is area demonstrated higher levels o f M M P - 1 , M M P - 8 and 
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correspondingly lower levels o f T I M P - 2 ; addi t ional ly , M M P - 1 and M M P - 8 were 
inact ive dur ing the f ina l phases o f heal ing i n acute wounds whereas, in chronic leg 
ulcers, bo th were present i n their act ive forms. 
Interest ingly, there is some evidence o f un i f i ca t ion between excessive protease 
act iv i ty and ox idat ive stress. The study discussed i n the previous sect ion^ ' established 
a posi t ive corre lat ion (ŕ = 0.72) between elevat ion o f neutrophil-elastase and an 
increased a l lanto in ： ur ic ac id percentage ratio. 
2.1.4.3 M i c r o b i a l in fec t ion 
D u r i n g periods o f chronic wound- ischemia, the ab i l i t y to neutral ise bacter ia is 
d imin ished and bacter ial colonies increase i n number.*^ 
H u m a n studies have established cr i t ica l tissue oxygen levels at w h i c h the r isk o f 
w o u n d in fec t ion increases. Lower mean subcutaneous tissue oxygen tensions were 
documented i n general surgery patients w h o developed w o u n d infect ions compared to 
those remain ing infect ion- f ree. ՚ " ՛ * ՛ * " * 
Th is increased presence o f bacteria is a fur ther st imulant for neutrophi l invasion o f the 
wound site and the resultant product ion o f degradative proteases and ha rmfu l 
oxidants. 
Swabs taken f r om chronic leg ulcers revealed the most c ommon microbes to be 
Staphylococcus aureus,  m i x ed coliforms.  Pseudomonas aeruginosa and anaerobes.*"* 
Staphylococcus aureus,  co l i fo rms and anaerobes were associated w i t h delayed heal ing 
and Pseudomonas-colonized ulcers were s ign i f icant ly larger and o f longer dwa t i o n 
than uncolon ized u l ce rs / " * 
I n addi t ion to s t imula t ing in f l ammato ry degradative and tox ic species, there is some 
27 
evidence that some species o f microbes may themselves contr ibute to the product ion 
o f degradative species. Pseudomonas aeruginosa occurs i n about twenty to th i r ty 
percent o f a l l chronic ulcers^" ' and such co lon isat ion apparent ly results i n di f ferences 
in ulcer size and durat ion, p rompt ing research into the possible product ion o f 
proteinases by the spec ies / " * ' * " ' 
The same microbe, by v i r tue o f elastase expression, induced degradat ion o f f ibroblast-
produced proteins and proteoglycans in vitro, thus m i m i c k i n g proteoly t ic ac t iv i ty 
previously ident i f ied i n chronic ulcer f l u i d i n v i v o ; addi t ional ly , elastase-containing 
condi t ioned m e d i u m and pu r i f i ed elastase inh ib i ted fibroblast cel l g r o w t h / * " These 
effects, i n con junc t ion w i t h the f i nd ing that proteinase product ion was detected i n 
w o u n d fluid ex vivo, suggest that bacter ia l proteinases p lay a pathogenic role i n 
c feon ic ulcers. 
2.2 Fibrotic disorders 
Cont inuance o f the reparatory processes o f wound heal ing beyond the po in t at w h i c h 
scar fo rmat ion is opt imised results in the fo rmat ion o f ke lo ids or hypert rophic scars; 
Un ique to humans, these t w o f ib ro t i c heal ing disorders are characterised by 
hypervascular i ty and hypercel lu lar i ty^"* together w i t h excessive scarr ing and an 
overproduct ion o f extracel lu lar mat r i x components such as type I c o l l a g e n / " ' 
The c l in ica l course and physical appearance o f kelo ids and hypert rophic scars def ine 
them as separate en t i t i es . " " 
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2.2.1 Ke lo ids 
These ben ign, ЬурефГ0Іі£егаЇІУе growths o f dermal col lagen result f r o m excessive 
fibroblast response to skin t r a u m a / " 
Several cel l culture-based observations have been made concerning di f ferences 
between f ibroblasts f r o m kelo ids and normal scar tissue. * * ^ ՛ " ՛ ՛ 
Greater fibroblast densities have been demonstrated i n ke lo id tissue compared w i t h 
norma l granulat ion tissue, suggesting a greater level o f p ro l i f e ra t i on " ^ They consist o f 
excessive amounts o f thick, densely packed col lagen bundles i n an i r regular pattern; 
extending beyond the conf ines o f the or ig ina l wound, ke lo ids do not regress 
spontaneously, and tend to recur after excision."^ 
I t has been est imated that fifteen to twenty percent o f Afr icans, Hispànics and 
Orientals suf fer from keloids""* and genetic predisposi t ion coupled w i t h some f o r m o f 
sk in t rauma are factors w h i c h play a ma jo r ro le i n development. A var iety o f d i f fe rent 
types o f sk in in jury can lead to ke lo id g rowth , inc lud ing surgery, ear piercings, 
lacerat ions, abrasions and any process resul t ing i n sk in i n f l a m m a t i o n . " ^ 
2.2.2 Hyper t roph ic scars 
Rap id ly developing in to a genuine concern and c l in ica l chal lenge, hypert rophic scars 
are pa in fu l , imsight ly , and detr imenta l to sk in func t ion and the cond i t ion o f ten 
necessitates reconstruct ive surgery . " * 
I n contrast to kelo ids, this type o f scarr ing is on ly produced by deep, dermal i n j u r y , " ' 
may regress spontaneously and rarely recurs after e x c i s i o n . " * 
Hyper t roph ic scarr ing is a fibroblast-associated dermal disorder, sharply demarcated 
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from the surrounding skin and characterised by raised, red, nodular and inelast ic scars 
that undergo s low and incomplete regression i n compar ison to normal scars. These 
scars f requent ly occur after severe thermal i n ju ry o f the s k i n " ' and, 
pathophysio logica l ly , are characterised by excess fibroblast act iv i ty i n terms o f 
pro l i fe ra t ion , col lagen synthesis and col lagen deposi t ion w i t h i n the w o u n d . " ' 
The events d i f fe rent ia t ing hypertrophic and norma l heal ing actual ly commence dur ing 
the development o f granulat ion tissue and are apparent between three and five weeks 
after injury.*^" 
One o f the most notable di f ferences is the or ientat ion o f col lagen fibres. I n the 
hypertrophic scar granulat ion tissue, there is a tendency for the col lagen f ibres to 
or ient themselves i n a whor l - l i ke pattern as opposed to the basket weave m o t i f typ ica l 
o f normal heal ing.*^" 
2.3 Fibroblasts are pivotal to chronic and fîbrotic healing 
N o r m a l cutaneous wound heal ing has been shown to require the orchestrated 
commun ica t i on and interact ion o f a var iety o f i n f l ammato ry and reparatory cel ls and 
i t is not appropriate to focus on one cel lu lar ent i ty w h i c h complete ly represents the 
process. 
Fibroblasts are one o f the key cells i n w o u n d repair; apart from produc ing ma jo r 
extracel lu lar components such as col lagen, elast in, and proteoglycans, they also 
generate chemotact ic and mi togenic factors for kerat inocytes and endothel ia l cells. 
As a result o f their central role i n the synthesis and remode l l ing o f extracel lu lar mat r i x 
molecules, and the reduced and excessive product ion o f these materials i n chronic and 
fíbrotic hea l ing respect ively, attent ion has been turned to fibroblast behaviour dur ing 
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the onset o f such disorders. 
A key quest ion is whether the deviat ion f r o m norma l heal ing is due to an abnormal 
subpopulat ion o f fibroblasts or whether they are norma l wound-hea l ing cells behav ing 
d i f fe rent ly under some chemica l or physical in f luence/^^ 
2.3.1 Fibroblasts and chronic heal ing 
2.3.1.1 Reduced pro l i fe ra t ion and premature senescence o f c føonic w o u n d fibroblasts 
W h e n determin ing the rate o f pro l i fe ra t ion o f diabet ic u lcer-der ived fibroblasts after 
fo r ty eight, seventy t w o and n inety six hours, a s igni f icant decrease i n the 
pro l i fe ra t ion rate was found i n the chronic w o u n d f ibroblasts compared to those f r o m 
ип і іцшес і βΗγ!.^^·* Th is study was developed fiirther to i l lustrate an association 
between elevated fo rma t ion o f L-lactate and reduced pro l i fe ra t ion by diabet ic ulcer-
der ived քւեքօե13տէտ,*^՛՛ suggesting that specif ic metabol ic by-products o f diabetes 
contr ibute to delayed healing. 
Further attempts have been made to determine the in f luence upon g rowth o f the 
chronic wound mic roenv i ronment ; fibroblasts from the newborn, k nown to g row 
rapidly, were used as a mode l system to explore the inf luence o f chronic wound fluid 
on the g rowth o f regenerative f i b r o b l a s t s / " Results ind icated that wound fluid f r om 
venous leg ulcers dramat ica l ly inh ib i ted g rowth by interference w i t h the cel l cyc le ; 
specifically, entry into the ร-phase ( D N A synthesis-phase) by fibroblasts was 
prevented. '^* 
F l m d samples from non-heal ing venous leg ฟcers were compared w i t h those taken 
f r o m ulcers that had changed f r o m a non-heal ing to a heal ing phase / * " 
There was a s ign i f icant ly reduced pro l i ferat ive response to non-heal ing wound fluid 
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samples compared to hea l ing samples and the p ro - in f lammatory cytokines 
in te r leuk in -1 , in ter leukin-6 and tumor necrosis factor-alpha were found present i n 
s ign i f icant ly higher concentrat ions/^* suggesting that heal ing may be impa i red by 
elevated levels o f i n f l ammato ry mediators. 
Increased pressure upon dermal tissues due to venous hypertension is one aspect o f 
venous leg ulcer pa thophys io logy* ' Fibroblasts f r o m normal sk in were subjected to 
hydrostat ic pressures tw ice and three t imes the magni tude o f atmospher ic pressure.^*^ 
Cel ls cu l tured i n this way demonstrated proport ionately reduced g rowth rates and 
abnormal morphologies s imi la r to cu l tured fibroblasts isolated from venous ulcers. I t 
was proposed that altered f ibroblast func t ion and morpho logy due to pressure 
elevations resul t ing f r o m venous hypertension contr ibute to the delayed wound 
heal ing observed i n this type o f chronic w o u n d . " ' 
The g rowth o f fibroblasts f r o m c feon ic wounds was s ign i f icant ly decreased compared 
w i t h those f r o m acute wounds and norma l dermis and the size and morpho logy o f 
fibroblasts from chronic wounds resembled in vitro aged or senescent fibroblasts.^^* 
I t has been hypothesized that the percentage o f senescent cel ls i n in vitro populat ions 
o f fibroblasts isolated f r o m venous ulcers is d i rect ly related to the c l in ica l heal ing 
t i m e / ^ ' Analys is o f fibroblasts pro l i fe ra t ion f r o m biopsies o f venous ulcers 
established a posi t ive corre la t ion (r^ = 0.81) between percentage o f senescence and 
ulcer heal ing t ime and i t was postulated that a value o f f i f teen percent may be used to 
ident i f y ulcers w h i c h are ' d i f f i c u l t to h e a l / ^ " 
A l t h o u g h senescence has been proposed as an explanat ion o f impa i red tissue 
fo rmat ion and remode l l ing by fibroblasts, recent studies compar ing venous leg ulcer-
der ived and in vitro senesced fibroblasts i l lustrated that tissue fo rmat ion and 
remode l l ing in senescent fibroblasts is actual ly superior to that o f f ibroblasts f r o m 
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chronic wounds, as evidenced by attachment to type I col lagen and product ion o f 
M M P - 2 , ind icat ive that senescence alone is insuf f ic ient to expla in delayed h e a l i n g . " " 
2.3.1.2 A l te red response o f chronic w o u n d fibroblasts to wound-hea l ing factors 
I n addi t ion to the reduced pro l i fe ra t ion and senescent characterist ics previously 
observed/^* the mi togenic response o f chronic wound f ibroblasts to human 
recombinant platelet-der ived growth factor was d imin ished w i t h ulcer age.*^* 
Compar ison o f normal fibroblasts and those der ived f r o m venous ฟcers i l lustrated a 
complete unresponsiveness o f the latter cel ls to t ransforming g rowth factor-beta, i n 
terms o f type I col lagen թ ք օ ժ ա է ւ օ ո ; * ^ ՛ ^ this was associated w i t h a f ou r - f o l d decrease i n 
g rowth factor receptor expression. 
A s imi lar lack o f response to t rans forming g rowth factor-beta i n terms o f venous ulcer 
der ived fibroblasts compared to their acute counterparts has been documented'^^ and 
the pro l i ferat ive response o f diabet ic u lcer-der ived f ibroblasts was d imin ished relat ive 
to normal controls for epidermal g rowth factor, insu l in- l ike g rowth factor, basic 
fibroblast growth- factor and platelet-der ived growth-factor. 
2.3.1.3 Upregu la t ion o f proteolyt ic enzymes 
Operat ing under the premise that excessive degradat ion by mat r i x metal loproteinases 
may contr ibute to impa i red healing, the expression o f these proteins i n dermal and 
epidermal cells from acute and chronic venous ulcers was invest igated/^ '* 
Collagenase-3 ( MMP - 1 3 ) was expressed abundant ly by fibroblasts deep i n the chronic 
ulcer bed but was not detected i n any acute wound tissue, suggesting that this protease 
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is on ly upregulated by f ibroblasts der ived f r o m chronic พ օ ա ժ տ . * ՛ ՛ * 
The hypothesis that the defect ive extracel lu lar ma t r i x remode l l ing characterist ic o f 
chionic wounds is associated w i t h di f ferences i n the act iv i ty o f the ma t r i x 
metal loproteinases and their inhib i tors ( T I M P ร ) was studied i n chronic w o u n d and 
pat ient-matched norma l fibroblasts i n three-dimensional col lagen latt ice systems. 
The c toon ic w o u n d f ibroblasts exh ib i ted s ign i f icant ly reduced levels o f M M P - 2 , a 
finding w h i c h was associated w i t h a corresponding increase i n T I M P - 1 and T I M P - 2 
leve ls . " ^ 
A l t h o u g h diabet ic foot ulcers are characterized by elevated levels o f M M P s , i t was not 
k n o w n whether this was due to the under ly ing diabet ic cond i t ion or a func t ion o f 
diabet ic w o u n d heal ing. I n an attempt to gain ins ight into the d is t inc t ion, cells were 
taken from unwounded diabet ic and non-diabet ic pa t ien ts ; " * when compared w i t h the 
non-diabet ic contro ls, diabet ic fibroblasts produced elevated amounts o f M M P - 2 and 
precursor molecules o f M M P - 3 , w h i c h suggests that diabetes alone is able to disrupt 
the pro l i fe ra t ion and remode l l ing phases/^* 
2.3.2 Fibroblasts and fíbrotic heal ing disorders 
2.3.2.1 Structure o f kelo ids and hypertrophic scars 
The col lagen nodule, absent f r o m norma l scars, is the structural un i t o f a l l 
hypert rophic scars and kelo ids and i t is reasonable to assume that study o f the fine 
structure o f the nodule m igh t ref lect the o r ig in o f the hypertrophic and ke lo id s c a r . " ' 
Nodules were shown to be composed o f a marked increase o f un id i rect ional col lagen 
fibrils a l igned in a h igh ly stressed or ientat ion. There is also a marked increase i n the 
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number o f f ibroblasts and, a l though relat ively avascular, the n o d ฟ e is surrounded by 
microvessels and i t was suggested that the o r ig in o f the hypert rophic scar and ke lo id 
is related to w o u n d revascularisation. 
I n add i t ion to the observat ion that col lagenous nodules are c o m m o n to bo th disorders, 
kelo ids and hyper t ropMc scars exh ib i ted h igh levels o f occ luded microvessels and 
microvascular comparisons suggested kelo ids may be more s imi lar to mature scars 
than to hypert rophic scars/^* W h e n examined by t ransmission electron microscopy 
the col lagen fibrils o f ke lo ids were larger, more i r regular and more densely packed 
than i n hypertrophic scars. The occurrence o f the i rregular f ib r i l s i n kelo ids may 
ref lect a s igni f icant d i f ference i n terms o f col lagen synthesis, fus ion or breakdown. I t 
was also suggested that the essential d i f ference between kelo ids and hypert rophic 
scars may be i n the vo lume o f microvessels in jured, and, hence, the amount 
regenerated. 
М о ф Ь о ю д і с а І examinat ion o f fifty s ix post- in jury granulat ion tissues, taken from 
five cases o f vary ing age post- in jury, indicated that nodules are o f vary ing shape and 
size due to fus ion o f adjacent microvascular col lagen masses between lateral 
b ranches / ^ ' Granulat ion tissue was imp lan ted in to nude mice and a l though several 
proceeded to develop scar, nodules on ly developed when the implants contained 
lateral microvascular branches. I t was proposed that hypert rophic scars and kelo ids 
are a product o f granulat ion tissue elements, the most impor tant o f w h i c h are p r imed 
act ive fibroblasts and excessive microvascular regenerat ion. '^ ' 
2.3.2.2 Pro l i fera t ion o f ke lo id and hypert rophic scar-f ibroblasts 
Biopsies o f tissue f r o m normal sk in, ke lo ids and ЬурефГ0Іі£егаІіуе scars were 
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assessed and compared i n terms o f fibroblast density and բՀօԱԽտէւօո.^*՛^ 
Generally, the mean density o f dermal fibroblasts was s ign i f icant ly higher i n kelo ids 
and hypert rophic scars than i n norma l skin, w i t h ke lo id fibroblasts exh ib i t ing the 
greatest density. The same trend was observed for p ro l i fe ra t ing act iv i ty ' ' ' " and 
con f i rmed in a later study. ^ ՚ * * I t was proposed that the higher fibroblast density and 
pro l i fe ra t ive act iv i ty o f kelo ids may exp la in how they cont inue to increase their 
vo lume and invade the surrounding tissue, wh i l e hypert rophic scars, w i t h lower 
f ibroblast density and pro l i fe ra t ing activity, show a tendency towards spontaneous 
2.3.2.3 Response o f ke lo id and hypert rophic scar f ibroblasts to g row th factors 
The ab i l i t y o f fibroblasts isolated f r om lesions o f hypert rophic scars, keloids, no rma l 
skin, or norma l scars i n contract ing the prov is ional wound mat r i x was compared and 
analysed."^ Hyper t roph ic scar fibroblasts showed a consistently h igher level o f fibrin 
mat r i x gel contract ion than other fibroblasts. Th is heightened level o f cont ract i l i ty 
was at t r ibuted par t ia l ly to the autocr ine ef fect o f t rans forming g row th factor-beta 1. 
No rma l and ke lo id fibroblasts exh ib i ted s imi lar basal rates o f gel contraction, and 
both responded to platelet-der ived g row th factor and t rans forming g row th factor-beta 
by increasing contract ion between two and three-fold. ՚ ՛ ՛ ^ 
However, for ty five percent o f the t rans forming g rowth factor-beta- induced increase 
i n gel contract ion by ke lo id fibroblasts was mediated by the autocr ine product ion o f 
platelet-der ived g rowth factor. ՚ ՛ ՛ ^ The observed di f ferences i n fibrin mat r i x gel 
contract i l i ty and the under ly ing g row th factor-mediated contract ion were proposed to 
contr ibute to the d i f ferent pathologies o f ke lo ids and hypert rophic scars. 
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I n norma l cutaneous w o u n d heal ing, apoptosis is be l ieved to mediate the decrease i n 
ce l lฝa r i t y du r ing the t ransi t ion between granulat ion tissue and scar and disrapt ions to 
apoptot ic pathways may contr ibute to the onset o f fibrotic heal ing (1ւտօքժ6քտ;^՛ ՛ ՛ ՛ hence, 
the resistance o f normal skin-derived, ke lo id-der ived and hypert rophic scar-derived 
fibroblasts to Fas-mediated and staurosporine-induced apoptosis was assessed/"*' 
I n contrast to f ibroblasts f r om normal sk in and hypert rophic scars, ke lo id-der ived 
f ibroblasts were s igmf icant ly resistant to both Fas-mediated and staurosporine-
induced apoptosis. 
Add i t i o n o f t rans fo rming g rowth factor-beta-1 s ign i f icant ly inh ib i ted Fas-mediated 
apoptosis i n hypert rophic scar-derived and normal sk in-der ived f ibroblasts; 
furthermore, neutral isat ion o f autocrine t rans forming g rowth factor-beta 1 w i t h its 
ant ibody abrogated the resistance o f ke lo id-der ived fibroblasts. Ant i -apopto t ic act iv i ty 
was not observed w i t h t rans forming g rowth fac to r -be ta-2 / ՚ * ' 
The s t imula t ing effects o f exogenous t rans forming g rowth factor-beta 2 on cu l tured 
fibroblasts f r om keloids, bum-hyper t roph ic scars and norma l sk in were examined i n 
terms o f contract ion o f a col lagen latt ice and whether such effects can be suppressed 
w i t h the g row th factor antibody. ՚ ՛ * ՛ * K e l o i d fibroblasts were most af fected by the 
add i t ion o f the g rowth factor and, i n contrast w i t h normal fibroblasts, in i t ia l 
contract ion by cel ls f r om bo th disorders was s ign i f icant ly increased; ant ibody add i t ion 
inh ib i ted the func t ion o f ke lo id and b um hypert rophic scar fibroblasts and also 
reversed the increased contract ion o f a l l the treated ց ք օ ս բ տ ; ^ ՛ * ՛ ՛ imp l i ca t ing an altered 
cel lu lar response to t rans forming g rowth factor-betø 2 i n the et io logy o f ke lo id and 
bum-hyper t roph ic scars. " ՚ * 
A s a means o f b iochemica l l y d is t inguishing between b um and non -bum hypertrophic 
scars, pro l i fe ra t ive scar specimens were imp lan ted into athymic, asplenia nude rats; 
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upon successful establishment, scars were in jected w i t h vary ing doses o f t rans forming 
g rowth factor-beta 2 or cont ro l fo r five consecutive days and then again on days ten, 
fifteen, and twenty. '* ' 
The specimens were measured week ly dur ing the treatment per iod and a biopsy was 
acquired on days th i r ty and sixty. Fibroblasts from the explanted biopsies and the 
or ig ina l scars were g r own i n cel l culture, and pro l i fe ra t ion studies were performed. 
F rom the or ig ina l scar specimens, ke lo id scars demonstrated the greatest ce l l 
p ro l i fe ra t ion kinetics. A f t e r treatment w i t h the g rowth factor, bo th kelo ids and b um 
hypertrophic scars showed an increase i n their cel l p ro l i fe ra t ion k inet ics wh i ch was 
not exh ib i ted by non -bum hypertrophic scars/"** 
I n add i t ion to establ ishing a c ommon pathophysio logy between kelo ids and b um 
hypertrophic scars, this study served to demonstrate that the nature o f in ju ry exerts an 
in f luence on the b iochemica l characterist ics o f hyper t rophic scars i n general. 
The ro le o f t rans forming g rowth factor-beta 1 was fur ther invest igated i n terms o f the 
rate o f col lagen synthesis by f ibroblasts f r om normal, ke lo id and hypert rophic 
scars. ՚ ՛ ՛ * 
F ibroblasts were cu lmred i n fibrin-gel matr ices i n the presence or absence o f the 
g rowth factor or g rowth factor ant ibody and col lagen product ion was measured after 
fo r ty eight hours. Ke l o i d fibroblasts increased thei r rate o f col lagen product ion by 
almost threefo ld i n response to t rans forming g rowth factor-beta 1, whereas fibroblasts 
der ived f r om hypert rophic scars and normal sk in were unaf fected; the ant ibody 
reduced the rate o f co l lagen synthesis o f ke lo id fibroblasts by for ty percent but d i d not 
suppress normal co l lagen product ion by the other fibroblast types/ ՚ * * I t was concluded 
that, a l though s imi lar i n that they bo th overproduce collagen, ke lo id and hypert rophic 
scars d i f fe r i n thei r sensi t iv i ty to t rans forming g rowth factor-beta 1, wh i ch is abundant 
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dur ing the pro l i fe ra t ion phase o f w o u n d healing,'"** 
A l t hough the b io log ica l act iv i t ies o f t ransforming g row th factor-beta 1 had been 
extensively studied, its regulat ion remained obscure. A n enzyme- l inked 
immunosorbent assay ( E L I S A ) revealed a greater than t w o f o l d increase i n product ion 
o f the g rowth factor in cond i t ioned m e d i u m obtained from insฟ in - l i ke g rowth factor-
treated cells compared to that f r o m untreated controls. ՚ ՛ * ՛ These results were 
associated w i t h a greater than two f o l d increase in t rans forming g row th factor-beta 1 
m R N A in response to insu l in - l i ke g row th factor-1, an ef fect wh i ch persisted for at 
least fo r ty eight hours after remova l o f the latter f r om the cul ture medium.^ปี 
Furthermore, almost s ixty percent o f the increase i n t rans forming g r o w t h factor-beta 
1, caused by insu l in - l i ke g rowth fac to r -1 , cou ld be b locked by the add i t ion o f 
t rans forming g rowth factor ant ibody to the cul ture m e d i u m , suggesting that auto-
induct ion o f t rans forming g rowth factor-beta 1 may be involved;*"* ' these findings 
suggest a regulatory role fo r insu l in - l i ke g rowth fac tor -1 . 
The ab i l i t y o f ke lo id f ibroblasts to resist apoptosis was found to correlate w i t h over-
expression o f insu l in- l ike g rowth factor-1 recep to r ; " * insu l in - l i ke g row th factor may 
inh ib i t apoptosis by induc t ion o f t rans forming g rowth factor-beta 1， w h i c h is also 
associated w i t h such resistance. ՚ ՛ * ՛ ՛ 
I n add i t ion to its potent ia l ro le i n regulation, insu l in - l i ke g rowth factor-1 induces 
enhanced mRNA expression o f procol lagen I and ш "9 and reduced product ion o f 
collagenase*^" by hyper t rophic scar-derived fibroblasts. 
The in vitro m igra t ion rate o f ke lo id fibroblasts is used to represent the c l in ica l l y -
observed ou tg rowth o f tissue beyond the w o u n d margin.*^* Exper iments using such a 
methodology have demonstrated greatly enhanced m ig ra t i on w h i c h is associated w i t h 
both over-expression o f insu l in - l i ke g rowth factor-1 receptor** ' and measured 
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amounts o f the g rowth factor itself. 152 
2.3.2.4 Product ion o f col lagen by ke lo id and hypert rophic scar f ibroblasts 
Quant i f i ca t ion o f general col lagen product ion after fo r ty eight hours by cul tured 
fibroblasts from normal sk in, ke lo id and hypert rophic scars demonstrated the 
product ion by ke lo id and hypert rophic scar fibroblast o f twe lve and three t imes 
respectively that o f normal cel ls ,** ' support ing the assumpt ion that excessive col lagen 
product ion is one aspect o f the et io logy o f fibrotic disorders. 
There is, however, evidence that the relat ive p ropor t ion o f co l lagen types, as opposed 
to a general overproduct ion o f col lagen, may be more explanatory o f c l in ica l aspects 
o f abnormal scar structure. The ratios o f types I and in col lagen produced by 
f ibroblasts from no rma l , ke lo id and hypert rophic scars were e x a m i n e d / * ' A l t hough 
bo th disorders demonstrated increased type I ： type ш rat ios compared w i t h normal 
scar f ibroblasts, the increase was almost threefo ld fo r ke lo id f ibroblasts whereas 
hypert rophic scar f ibroblasts exh ib i ted an increase o f on ly th i r ty percent. Fur thermore, 
the increase i n type I co l lagen for ke lo id fibroblasts was associated w i t h an increase i n 
the expression o f procol lagen I (a precursor molecu le to type I col lagen) o f s i x fo ld 
that produced by normal scar cel ls; expression o f procol lagen ш was not s imi lar ly 
elevated i n ke lo id fibroblasts. I n hypert rophic scar and normal scar f ibroblasts, 
expression o f procoUagens I and ш was unaffected. '^^ 
S imi lar w o r k compared the synthesis o f procol lagen I and ш by cu l tured fibroblasts 
from normal granulat ion tissue, kelo ids and hypert rophic scars. I t was found that 
type I procol lagen product ion by fibroblasts from kelo ids and hypertrophic scars was 
s ign i f icant ly higher than fo r granulat ion tissue fibroblasts; however, i n contrast to the 
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previous study, hypertrophic scar fibroblast product ion o f procol lagen I was more 
than sixty percent greater than that o f ke lo id fibroblasts. ՚ ^ ՛ * Synthesis o f type ш 
procol lagen by abnormal scar f ibroblasts was s igmf icant ly reduced i n compar ison 
w i t h their granulat ion tissue counterparts ( fo r ty s ix and seventy three percent o f 
granulat ion tissue values fo r kelo ids and hypertrophic scars respectively). 
Interest ingly, the type I ： type ш col lagen ratios for kelo ids and hypert rophic scars 
were comparable ( th i r ty two po in t four and thirty three point four respect ively) 
compared w i t h twe lve po in t t w o fo r granulat ion էւտտսշ/^ ՛ * 
A l t hough some aspects o f the latter รณdy are contradictory o f the former , factors 
c o m m o n to bo th are the elevated product ion o f procol lagen I and increased type I ： 
type Ш col lagen ratios relat ive to fibroblasts f r o m normal tissues. 
4.3.3 Conc lus ion 
The chronic w o u n d env i ronment is d i rect ly associated w i t h some under ly ing disease 
or condi t ion. The venous hypertension and physical occ lus ion o f b l ood vessels, 
aeteological to venous leg ulcers and pressure ulcers respect ively, cause ischaemia 
w h i c h can increase the r isk o f m ic rob ia l in fec t ion and potentiate the in f lammatory 
response; i n add i t ion, due to eventual tissue reperfusion, a tox ic excess o f reactive 
oxygen species are generated พ Ы с һ рефеШаІе8 i n f lammat ion . 
Diabetes can generate reactive oxygen species by glucose ox ida t ion , w h i c h , i n 
add i t ion to tissue tox ic i t y and i n f l ammat ion , is a causative factor i n the neuropathy 
characterist ic o f diabet ic foot ulcers. I n general, these events conspire to render the 
subsequent pro l i fe ra t ion and remode l l ing phases inef f ic ient , resul t ing i n improper 
w o u n d closure and scar fo rmat ion . A l t h o u g h a var iety o f cells are subjected to the 
41 
deleterious effects o f the under ly ing pathology and pro longed in f l ammat ion o f a 
part icular chronic wound , there is considerable evidence that these condi t ions alter the 
behaviour o f dermal fibroblasts i n part icular. 
I n the case o f fíbrotic disorders, there are pronounced behavioural d i f ferences 
between fibroblasts from ke lo ids, hypert rophic scars and normal w o u n d tissue i n 
terms o f structure, p ro l i fe ra t ion rates, p rogrammed cel l death, response to w o u n d -
heal ing factors and synthesis and remode l l ing o f col lagen. 
A l t h o u g h less understood than chronic wounds, there is evidence that bo th kelo ids 
and hypertrophic scars are a consequence o f the genetic pred i lec t ion o f fibroblasts fo r 
an altered phenotype in response to in jury. 
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Chapter 3-MateriaIs and Methods 
Due to their pivotal position in chronic and fíbrotic wound healing, the work 
described here used fibroblasts as the cellular representative o f such disorders. 
It was not possible to obtain tissue from pressure ulcers, venous ulcers, diabetic 
ulcers, keloids or hypertrophic scars. The cell сиІШге environment o f normal human 
dermal fibroblasts w i l l be modified as a means o f simulating the behaviour o f 
fibroblasts from these disorders. 
Normal human dermal fibroblasts w i l l hereafter be referred to simply as NHDF and it 
was decided to assess the effects o f single and combined African herbs on the 
fol lowing wound healing aspects ： 
1. NHDF proliferation 
2. Proliferation o f an NHDF-based model o f fíbrotic disorder. 
3. Exposure o f NHDF to hydroxyl radicals 
4. Production o f procollagen type I carboxy peptide (PICP) by NHDF. 
5. Production o f Keratinocyte Growth Factor (KGF) by NHDF 
3.1 Mater ia ls 
3.1.1 Normal Human Dermal Fibroblasts (NHDF) 
NHDF were purchased from Biowhittaker U K Ltd, Woking, England. 
The product code was CC-2511, the batch number,IF 1618 and the tissue acquisition 
number, 8560. 
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Cells were donated by a 31 year old female Caucasian and were supplied in 1.0 ml 
frozen cryovials which always contained between 500,000 and 525， ООО cells. 
The stated viabil ity, as determined by Trypan Blue exclusion, was always in excess o f 
80%. 
3.1.2 Cell culture and cell handling equipment 
Incubator 
A LEEC controlled temperature mammalian culture cabinet was used for both the 
incubation o f N H D F and reagent equilibration. 
Flow cabinet 
A Microf low Class п laminar flow cabinet was used for the sub-culturing o f cells and 
preparation o f cell culture media and reagents. 
Centr i fuge 
Centrifนgation was carried out using a Phil l ip Harris Scientific Centrifuge (Sigma 
Laboratories). 
3.1.3 Cell culture media and reagents 
Fetal Bovine รemm (ras). Fibroblast Basal Media (FBM), Gentamycin / 
Amphotericin в (1000 units). Trypsin, Trypsin Neutralising Solution (TNS) and 
Hanks Balanced Salt Solution (HBSS) were purchased from Biowhittaker U K Ltd, 
Woking, England 
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Hydrogen peroxide (5 M , зо % wt / wt). Trypan Blue (0.4 %) and Iron (П) sulphate 
were purchased from Sigma Aldrich 
3.1.4 Cell proliferation and ELISA kits 
3.1.4.1 MTS assay kit 
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)֊2H-
tetrazolium, inner salt)] ՝MTS cell titre one solution' assay kits were purchased from 
Promega UK, Southampton, England. 
3.1.4.2 PICP assay 
Enzyme Linked Immunosorbent Assay (ELISA) kits for quantification o f procollagen 
type I carboxy peptide (PICP) were purchased from Takara, Tokyo, Japan by way o f 
Biowhittaker U K Ltd, พotóng, England. 
3.1.4.3 KGF assay 
Enzyme Linked Immunosorbent Assay (ELISA) kits for quantitation o f Keratinocyte 
Growth Factor (KGF) were purchased from R and D Systems, Oxford, England. 
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3.1.5 Glassware and plastiware 
3.1.5.1 Glassware 
An improved Neubauer haemocytometer and 20 ml stoppered tubes were purchased 
from Fisher Scientific, Leicestershire, England. 
3.1.5.2 Plastiware 
25 cm сиішге flasks, 10.0 ml sterile pipettes, 35 mm culture plates, 96-well flat-
bottomed microtitre plates and 15.0 ml conical centrifuge tubes were purchased from 
Fisher Scientific, Leicestershire, England 
3.1.6 Liquid handling 
Single charnel pipettes, ranging from from 1-1000 [iL and a Fisherbrand eight 
chamei multipipette (20-300 pL) was purchased from Fisher Scientific, 
Leicestershire, England. 
3.1.7 Measurement o f optical densities 
Absorbance changes o f biological reagents were determined using a Dynex M R X 
automated plate reader. 
For proliferation / cytotoxicity assays, plates were read at 490 nm. 
For quantification o f procollagen type-I carboxypeptide (PICP) and keratinocyte 
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growth factor ( KGF ), plates were read at 430 nm. 
3.1.8 Plant Material 
Samples o f Cissus rotundifolia leaves, Zanthoxylum chalybeum bark and leaves and 
Cassia Abbreviata bark were provided by Dr Philip Cheung o f the Department of 
Health, University o f Durham, Durham, England. 
3.2 Methods 
3.2.1 Sub-culturing o f N H D F 
A l l reagents were allowed to equilibrate in the incubator prior to use with the cells. 
A l l handling o f N H D F occurred in a Class п laminar flow cabinet. 
NHDF were grown to approximately 80 % confluence. 
Media was aspirated from the flask and the cells rinsed wi th 5 ml HBSS. 
2 ml o f Trypsin / EDTA was added and NHDF monitored microscopically for 3 min. 
After the majority o f cells had been detached from the flask by Trypsin / EDTA 
solution, 4 ml o f Trypsin Neutralising Solution was added and the resulting cell 
suspension transferred to a 15 ml conical centrifuge tube. The flask was rinsed wi th a 
further 2 ml of HBSS to collect residual cells and this was added to the tube. The cell 
suspension was centrifuged at 100 g for 5 min and the resulting pellet was re-
suspended in 4 ml o f fibroblast basal media I 10 % FBS by slow pipetting using a 10 
ml pipette. Depending on requirements, re-suspended NHDF were either distributed 
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equally into four 25cm^ flasks containing 10 ml fibroblast growth media / 10 % FBS 
or counted using a haemocytometer, diluted and known quantities dispensed (seeded) 
into culture vessels for experiments. 
Cells from between the third and fifth passages were used in all experiments. 
3.2.2 Cell counting using a haemocytometer 
3.2.2.1 Background 
A haemocytometer consists of a thickened glass slide into which a small, perfectly 
square counting chamber has been cut. The volume of the square is 0.1 mm^ (10՜^ ml). 
The floor o f the chamber is divided into nine sections and the type o f cell determines 
which sections are used for counting. 
3.2.2.2 Counting o f NHDF 
50 μ L of cell suspension is mixed with an equal amount o f Trypan Blue (0.4 %) and 
9 μLof the mixture was pipetted into the haemocytometer. 
In the case o f NHDF, only the four outer squares were used for counting. The mean 
cell number, ' C a v ' , was used to determine the cell number per m l , ' C m l ' as shown in 
the fol lowing equation ： 
C n j = 2 C a v x l O ' (5 .1 ) 
The factor o f lo4 was necessary to express the volume (counted in 10 ml) in tenns o f 
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1.0 ml and a factor o f 2 was іпсофогаЇЄ(1 to account for the dilution in Trypan Blue. 
3.2.3 Aqueous extraction of plant material ： experimental rationale 
3.2.3.1 Nature of extractant 
The extraction o f plant material is the first step in the scientific investigation o f herbal 
medicines. A fundamental of the screening strategy employed when bioprospecting 
for new medicines is the isolation o f a single chemical entity which is believed to be 
responsible for a particular effect. To this end, a variety o f solvents and techniques 
are used to extract specific chemical groups from raw plant material. However, the 
extraction and isolation of a single chemical entity has no merit unless sole 
responsibility for an attributed effect can be demonstrated; there is a school o f thought 
which contends that the efficacy o f medicinal plants is a consequence o f the 
interaction between the many chemical components present and that isolating 
particular components reduces the overall effect. 
It is intended in the current รณdy to determine the degree o f interaction between herbs 
in combination, as opposed to isolating and identifying active herbal ingredients 
believed to be responsible for effects. Therefore, in terms o f the extraction o f plant 
material, the premise is that traditional application o f the whole plant can be best 
represented in vitro by aqueous extraction. Although admittedly, this fraction w i l l not 
reproduce exactly the proportions found in undisturbed plant materials, it w i l l , by 
virtue of water being the universal solvent, contain a significant number o f chemicals 
present. 
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3.2.3.2 Aqueous extraction o f plant material ： method 
Leaves from Cissus Rotundifol iaandZanthoxylum Chalybeum ( 5 g ) were chopped 
into small pieces o f about 1 mm^. 
Herbal medicine Br ie f description of aqueous solution 
Cissus rotundifolia leaf extract 
( C rotundifolia{L)) 
Pale yellow solution required filtering 
twice 
Zanthoxylum chalybeum bark extract 
(Z chalybeum(B)) 
Light brown solution required fi ltering 
four times. 
Zanthoxylum chalybeum leaf extract. 
(Z chalybeum{L)) 
Pale yellow solution required fi ltering 
three times 
Cassia abbreviata bark extract 
c. abbreviata(B)) 
Light brown solution required filtering 
three times. 
Table 5.1. Description and abbreviation o f aqueous herbal extract solutions. 
Bark from Xanthoxylum chalybeum and Cassia abbreviata (5 g) was sawn into 
small pieces o f about 2 mm 2 . 
A l l plant materials were heated separately at 80°c in 500 ml o f distilled water for 1 
hour and descriptions o f the resulting herbal solutions are given in Table 5.1. 
The solutions were freeze dried and kept in the dark at 4°С until required for use. 
3.2.4 Assessment o f NHDF proliferation ： experimental rationale 
3.2.4.1 Representation of the wound microenvironment 
NHDF growth media consists o f a basal media (which maintains cells in a healthy but 
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qmescent state) to which can be added a source o f growth factors in varying 
proportions. A common form o f such an additive is Fetal Bovine Serum (FBS), which 
is replete wi th the growth factors listed in Table 2.1. 
The use o f basal media supplemented with 10 % FBS is a recunent factor in the 
normal maintenance o f NHDF cell lines*^' and construction o f in vitro models o f the 
skin.'^* Additionally, it has been shown to be necessary for the healing o f whole skin 
organ c u l t u r e . A d j u s t m e n t of the proportion o f growth factors in culture medium 
presents an elegant means by which the microenvironment o f wound-related 
processes may be simulated at the cell culture level. Depleted levels of growth factors 
such as those found in chronic wound fluid are generally represented by greatly 
reduced amounts o f FBS (usually 0.5 %) or even serum free media. Conversely, the 
addition to growth media o f factors known to promote excessive proliferation 
facilitates the modelling o f fíbrotic disorders in vitro. 
It is conceivable that the use of even small amounts (0.5 %) o f FBS could produce 
artefacts by interacting wi th herbal constituents in a growth enhancing manner and, 
therefore, the use o f a media devoid of growth factors has the advantage o f 
establishing unequivocally the contribution of herbal components to cell proliferation. 
Even allowing for the growth factor reduction discussed previously caused by 
excessive matrix metalloproteinase activity, chronic wounds present a physiological 
mil ieu in which herbal drugs w i l l , to some degree, come into contact wi th various 
mitogens. Given the assertion that the wound healing microenvironment can be 
modelled by varying the proportion o f FBS, an attempt was made to represent this 
inevitability. 
In the study of the proliferative effects of an aqueous extract from c. odorata, the 
activity o f the extract in basal media supplemented with 0.5 % FBS was compared 
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with that in basal media supplemented with 2 % FBS . " Although a rationale for the 
selection o f the latter FBS percentage was not given, it has been demonstrated that 2 
% is the minimum serum supplementation which maintains the cell viabil ity o f 
cultured whole skin but results in an overall impairment o f wound healing.'^''**" 
The use o f basal media supplemented wi th 2 % FBS is thus appropriate in the model­
l ing of a physiological environment in which growth factors are reduced but not 
absent. 
Large amounts o f IGF-1 are present in the dermis o f keloids and hypertrophic scar;*^* 
although other growth factors, notably members o f the TGF-ß family have been 
implicated in the aetiology of fibrotic disoTdeTS,^'*^՝^'*'*՝^'*^ IGF-1 has been shown to 
influence the expression o f at least one TGF-ß i so fo rm. " ' Consequently this growth 
factor has been used in conjunction wi th NHDF to construct a representative model o f 
these disorders to study the anti-fíbrogenic effects o f drugs/* ' I t was felt that such a 
model was appropriate for similar in vitro assessment o f the herbal extracts. 
3.2.4.2 Incubation period o f N H D F wi th herbal extracts 
Several cell culture-based รณdies o f the proliferative effects o f herbal extracts on 
NHDF determine cell numbers at various points after the application o f herbal 
extracts, as opposed to a single measurement, շ՚՚՚՚՚շ՛՛**.՛»^ ,162,163 
Enumeration o f NHDF at several points after herbal extract addition has the 
advantage o f establishing a time course for effects; also, insight is given as to the 
length o f time taken for effects to be manifest. Realistically, 24 hours after addition o f 
extracts is the earliest point at which such determination can, and should, be made. 
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The performance of assays or cell counts at multiple time points requires that one 96 一 
well batch o f cells be used for each point; however, assessment o f the separate and 
combined effects of several herbal extracts on a variety o f wound healing processes 
necessitates some economy o f time and resources. 
A graphical depiction o f how the effect o f the most potent dose, determined after one 
incubation period, varies wi th time, presents a means to іпсофогаїе a temporally-
based assessment while minimising overuse o f reagents and biological material. 
Regarding the length o f the incubation period, a choice was made based on 
physiological reasoning, rather than arbitrarily; it has been shown in whole skin organ 
сиІШге, that dennal fibroblasts proliferate for a period o f էԽշշ days prior to migration 
into the wound site on the fourth day post -wounding/'"* 
Prolonged inflammation and its deleterious effect via free radicals and proteases 
would therefore reduce the growth rate of NHDF during this period. A three day 
incubation period o f NHDF with herbal extracts prior to enumeration, wi th cells 
grown in both types o f reduced media, would best represent such a situation. 
In the absence o f data pertaining to time periods for which fibroblasts are most active 
during fibrotic disorders, the same three day period may be used to assess the effects 
of herbal extracts on an NHDF-based model. Thus a symmetry is maintained in the 
assessment o f proliferative and antiproliferative effects. 
Once the extracts are added, the desired result o f a controlled, self contained model o f 
wound healing does not reconcile wi th the invasive nature of media changes and it 
was thus felt that effects should be judged on a single application basis. 
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3.2.4.3 Methods o f NHDF enumeration 
Direct counting o f cells is the only unequivocal means o f determining changes in cell 
number and hence the extent o f proliferation. 
However, when a range o f concentrations of several potentially stimulatory or 
inhibitory agents are being investigated, counting microscopically wi th a 
haemocytometer is time consuming and would reduce the breadth and scope o f a 
study such as the current one. Relatively inexpensive assays which lend themselves to 
repeated assessment o f large samples are an advantage in terms o f both time and 
resource conservation. 
The application o f these assays to the current study is that changes in NHDF 
proliferation may be assessed quantitatively by changes in the absorbance signals o f 
cells exposed to herbal extract. The simplest way o f expressing the extent o f such 
changes is by indexing the absorbances o f NHDF treated with herbal extracts to those 
o f untreated controls.The majority o f studies involving the effects upon NHDF 
proliferation o f herbal extracts have employed the M T T ՕՏՏՅ)՛;^^՛՛*՛՛*՛՛"^՛^*^ others have 
used the neutral red ՅՏՏՅ)՛.՛*^ ՛՛*՛ 
M T T [3-( 4， 5-Dimethylthiazol-2-yl )-2, ร-Diphenyltetrazol ium Bromide ] assay 
First described in 1983, the M T T reagent is a pale yellow dye and may be added 
directly to the media in which cells are cultured. ՚^ ՛* 
The M T T assay is based on the reduction by l iv ing cells o f the dye; specifically, the 
tetrazolium ring o f the dye is reduced to formazan by the succinate-tetrazolium-
reductøse system, which is active only in viable cells, to produce a purple formazan 
product. 165 The reaction is believed to occur in mitochondria and is directly 
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proportional to viable cell number The formazan product is insoluble in culture 
media, precipitating as crystals and must be extracted into an organic solvent such as 
acidified sodium dodecyl sulphate. The optical density o f the resฬting organic 
formazan solution is determined at 570 n m . i 6 6 
Neutra l red assay 
The neutral red assay is a dye inclusion method for the determination o f cell viability. 
The cationic neutral red dye diffuses through the cell membrane, accumulating in the 
cytoplasm, where it is іпсофогаїесі into, and bound by, the lysosomes o f viable cells 
in a manner which is directly proportional to cell number." ' Media must be removed 
prior to addition of the neutral red solution. After incubation, the neutral red solution 
is discarded, the cells washed and a solution such as acetic acid in ethanol is used to 
elute any neutral red which has been taken up by the cells. The absorbance o f the 
neutral red solution is measured at 540 n m / ' * 
In any cell culture-based assay, disturbance o f cells prior to measurement must be 
mimmised. The major difference between the two assays is that, after іпсофогаїіоп 
into cells, neutral red is chemically unchanged, merely residing in lysosomes. It 
follows that any neutral red solution on the exterior o f cells w i l l be eluted when the 
organic extractant is added and, i f not removed, contribute to absorbance readings; 
this necessitates several invasive washing steps which often remove cells and also 
reduce assay sensitivity. 
In the case o f the M T T assay, the only measurable product is produced by, and 
retained within, cells, thus abrogating the need for washing. 
Furthermore, the metabolic activity o f NHDF, as measured by the M T T assay, has 
been used as a means o f demonstrating the efficacy o f tissue engineered skin products 
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in several clinical studies. ՚™՛^^^՛*՛^ This assay, therefore, is able to reflect metabolic 
changes o f NHDF which may occur even in the absence o f proliferation, an insight 
which would not be prodded by the neutral red assay. 
It was decided to use a modified form o f the M T T assay, namely, the MTS [3-(4, 5一 
dimethylthiazol֊2֊yl)֊5֊(3֊-carboxymethoxyphenyl)֊2֊<4֊sulphophenyl)֊2H֊ 
tetrazolium, inner salt]. 
Bio-reduction o f MTS reagent yields a formazan product which is soluble in culture 
media, thus eliminating the potentially error-prone extraction step. The solution can 
be applied without prior or subsequent cell culture invasion and exhibits more rapid 
colour development than M T T . ' " ' " ' * 
Tetrazolium-based assays such as M T T and MTS develop optical densities via cell the 
metabolism; hence, drugs affecting the metabolic rate at which the tetrazolium ring is 
reduced to formazan w i l l produce artefacts."^ Indirect assays of cell growth, reliant 
on measurements o f cellular processes, must in some way be correlated wi th cell 
number. 
The construction o f a time course has been discussed and graphical depictions o f 
absorbance versus time were proposed for the most effective herbal extract 
concentrations. Data from such considerations would comprise half o f the criteria for 
MTS assay correlations wi th cell number and it would simply remain to perform 
manual counts upon parallel sets of plates. 
The data obtained would enable cell number versus time and absorbance versus cell 
number to be plotted. A linear correlation in the latter case denotes that changes in 
absorbance are depicting changes in cell number; depending on the extent, deviation 
from linearity would be indicative of either absorbance changes being completely due 
to metabolic effects or a combination o f metabolic and proliferative effects. 
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3.2.5 Effects o f herbal extracts on NHDF proliferation ： method 
3.2.5.1 Preliminary work and general information 
M T S assay. 
For colourimetric determinations, 20 μL MTS reagent was added to each well and the 
plate incubated for 2 hours prior to optical density measurement at 490 nm. 
Determination of Igf -1 concentration for N H D F fíbrotic model 
IGF-1 solutions of 10, 20, 30, 40 50, 60, 70, 80， 90 and 100 μg I ml were prepared 
from frozen stock in basal media / 1 0 % FBS. Upon preparation, solutions were drawn 
through a 0.2 μιη filter for sterilisation; all culture media contained Gentamycin / 
Amphotericin в (1000 units) 
NHDF (3 X lO 3 ) were seeded into replicate wells o f a 96 well plate in lOOļļL basal 
media / 10 % FBS and allowed to attach for 24 hours. The media was aspirated and 
replaced with basal media 110% FBS containing the specified concentrations o f IGF-
1. A set of cells grown in basal media / 1 0 % FBS was used as a normal control. 
The plate was incubated for 3 days and the MTS assay performed. 
The dose response curve for this experiment, płotted on logarithmic axes, is shown in 
Figure 3.1 
The maximum effect of 52% above controls corresponded to a IGF-1 concentration o f 
70 μ§ I ml and this concentration was selected for use in the NHDF fíbrotic model. 
Solutions of herbal extracts 
Herbal extract solutions o f lO—3' lO 2 , 1๙， 1.0, 10, 100 and 1000 уเԳI ml were 
57 
(ซ 50 
Q ЗО 
ร 20 
О 1 շ 
Logio IGF-1 dose (microgrammeร/ทาเ) 
Figure 3 .1. Dose response relationship between NHDF grown in basal media / 10% 
FBS + IGF-1 
prepared in 15 ml tubes by serial dilution of refrigerated stock on the day o f the 
experiment. Extract solutions were created in basal media, basal med ia /2 % FBS and 
basal media / 10 % FBS containing 70pg / ml IGF-1. Upon preparation, all solutions 
were drawn through a 0.2 μ ιη filter to remove microorganisms; all culture media 
contained Gentamycin / Amphotericin в (1000 units). 
Assessment of herbal extract interference w i th M T S reagent. 
The possibility existed that the herbal extracts alone may interact wi th the MTS 
reagent and alter the optical densities o f different groups. To establish the extent o f 
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any interference, herbal extract solutions Լ100μL o f ІОООцд / ml) , diluted in the 
different media types, were incubated with շՕրԼ o f MTS reagent for 2 hours. 
Controls consisted o f the corresponding media type without herbal extracts. 
There was no statistically significant difference between the control groups and those 
which included herbal extract solutions and it was concluded that the extracts did not 
interfere wi th the MTS assay. 
Assessment of the optical densities of herbal extract solutions. 
The herbal extract solutions may themselves contribute to optical densities in a dose 
dependent fashion, thus distorting the trae nature of herbal effects on proliferation. 
To investigate this, herbal extract solutions (100[iL o f lOOOpg I ml) , diluted in the 
different media types, were incubated for 2 hours, after which absorbances were 
measured at 490 nm, reference wavelength 630 nm. Controls consisted o f the 
corresponding media type without herbal extracts. 
There was no statistically significant difference between the control groups and those 
which included herbal extract solutions and it was concluded that the extracts alone 
did not contribute to optical densities in at 490 nm. 
3.2.5.2 Assessment of herbal extracts in simulated cfeonic wound environment 
NHDF (3 X 1๙) were seeded into 96-well plates in ЮОцЬ basal media / 10 % FBS 
and allowed to attach for 24 hours. The media was aspirated and replaced with basal 
media or basal media 12 % FBS. 
NHDF were allowed to equilibrate for 24 h, the media was aspirated and the herbal 
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extract solutions, diluted in either basal media or basal media 12 % FBS, were added 
in the specified concentrations. Controls consisted of NHDF grown in basal media 
and basal media / 2 % FBS. Additionally, a set of cells grown in basal media / 1 0 % 
FBS was used as a positive control. 
The cells were incubated with the extracts for a 3 day period and the MTS assay was 
performed. 
3.2.5.3 Assessment o f herbal extracts in a simulated fibrotic environment 
NHDF (3 X 1๙) were seeded into 96-well plates in ЮОцЬ basal media 110 % FBS 
and allowed to attach for 24 hours. Media was aspirated and replaced wi th 
basal media 110% FBS supplemented with 70 I ml IGF-1. 
NHDF were allowed to equilibrate for 24 h, the media was aspirated and the herbal 
extract solutions, diluted in basal media I 10 % FBS supplemented with 70 μ§ I ml 
IGF-1, were added in the specified concentrations. Controls consisted of a set o f cells 
grown in basal media I 10 % FBS. The cells were incubated with the extracts for a 3 
day period, after which the MTS assay was performed. 
3.2.5.4 Assessment o f cytotoxicity 
In all experiments, ten wells were allocated as a reference for cytotoxicity assessment. 
Upon seeding o f NHDF into wells, the cells were allowed to equilibrate for one hour, 
after which time the MTS assay was performed. 
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The 0ՕՄ6Տթօո(սո§ absorbances o f these cells were taken as a baseline and herbal 
extract concentrations which produced absorbances o f less than this minimum level 
were assumed to be toxic. 
3.2.5.5 Correlation o f cell number with optical density 
Although dose response curves were constructed for herbal extracts which produced 
changes in optical density measurements, their effect upon proliferation was yet to be 
concretely established. To this end, the herbal extract concentrations which gave the 
greatest change in optical density were selected for correlation. 
NHDF (3 X 1๙) were seeded into 35 mm culture plates in 1.0 ml basal media / 1 0 % 
FBS and allowed to attach for 24 hours. The media was aspirated and replaced with 
basal media basal media / 2 % FBS or basal media / 1 0 % FBS supplemented wi th 70 
ц § / т 1 IGF-1 
NHDF were allowed to equilibrate for 24 һ and the media was aspirated. The herbal 
extract solutions, diluted in either basal media, basal media 12 % FBS or basal media 
/ 10 % FBS supplemented wi th 70 μ§ / ml IGF-1, were added in the specified 
concentrations. Depending on the wound related effect being examined, controls 
consisted of basal media, basal media I 2 % FBS or basal media / 10 % FBS 
supplemented with 70 μ§ I m l IGF-1. 
For each herbal extract concentration, one set o f plates was used for the MTS assay 
and another (parallel) set was used for direct haemocytometer cell counts. The MTS 
assay and the parallel cell counts were performed 1, 3, 5, 7 and 9 days after addition 
o f herbal extracts to provide both a time course and correlation of changes in MTS 
response and cellular growth. 
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3.2.6 Antioxidant effects of herbal extracts ： experimental rationale 
3.2.6.1 Protective and scavenging effects 
In all studies o f this nature, NHDF were exposed to predetermined concentrations of 
oxidants and effects were gauged in the context o f being protective or scavenging. 
Protective effects 
The assessment of protective effects was based on the extent to which incubation with 
herbal extracts prior to oxidant exposure reduced subsequent damage. 
Scavenging effects 
Scavenging effects involved a determination of the degree to which herbal extracts 
reduce toxic effects by interacting directly wi th oxidants in the extra-cellular 
environment. 
The incubation period for which cells are cu l toed wi th herbal extracts prior to 
exposure to oxidants is a potentially confounding factor. Assuming an extract has an 
effect upon cell growth, the number o f viable cells w i l l be increased or decreased 
during the incubation period, which in tum w i l l conceal the true nature of extract 
effects on NHDF or oxidants. This problem can be obviated by selecting a period 
which precedes the point at which growth is induced by a particular herbal extract. 
3.2.6.2 Representation o f oxidant environment 
A l l studies o f this nature involving NHDF exposure to an inflammatory environment 
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employed hypoxanthine-xanthine oxidase and / or hydrogen peroxide as a means o f 
generating oxygen free radicals. ՚^՛՛*՛*՛՛**՛՛**՛^՛* 
The antioxidant studies which applied hydrogen peroxide most l ikely generated the 
hydroxy! radical by the Fenton reaction. The harmful effects o f the superoxide radical, 
generated from xanthine / hypoxanthine oxidase are believed to be indirect, resulting 
from its conversion to hydroxyl radical. 
The Fenton reaction and the Haber-Weiss reaction, discussed in are interdependent 
and a consideration o f the relative amounts of Fe2+, Fe3+ and H2O2 required in each 
has given insight into the molar ratios required for maximum cytotoxicity. 
The continuation o f the Fenton reaction is dependent upon the generation o f sufficient 
Fe2+ from the Haber-Weiss reaction and it has been shown that cytotoxicity is 
maximal when Fe2+ and Fe3+ are in equal ratio,*™'*'''**" a condition which is satisfied 
when Fe^"^and H2O2 are inal: 1 ratio/*^ 
Preliminary work to establish a suitable oxidant environment consists of NHDF 
exposure to various amounts o f H2O2 and Fe2+ in a fixed ratio of 1 : 2 and iron п 
รฟphate ( FeS04 ) is to be used as the source of Fe^ "^ . 
3.2.6.3 Culture media in which hydrogen peroxide and herbal extracts are diluted 
For protective experiments, NHDF were cultured in basal media supplemented with 
10 % FBS and herbal extracts were added to cells in this media. 
Oxidants were diluted in HBSS prior to addition to NHDF. 
For scavenging effects, NHDF were cultured in 10 % FBS prior to the addition o f 
either oxidants diluted in HBSS (controls) or oxidants and various concentrations o f 
herbal extracts diluted in HBSS (treatment groups). 
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The species used for the риф08Є8 o f replicating the effects o f prolonged inflammation 
are, in physiological conditions, powerful oxidants. The obverse o f this is that they are 
easily reduced. Were the oxidants to be diluted in basal media, they would be rapidly 
reduced by the carbohydrates, lipids and amino acids necessary to support growth at 
the basal level. Addit ion of oxidants to media containing any proportion o f FBS 
would simply compound this problem. To an extent, such components would act as 
scavengers for oxidants and greatly ameliorate their effects, thus masking any ability 
of herbal extracts to protect or scavenge oxidants. 
HBSS does not contain iron salts, w i l l not disrupt the equilibrium o f the proposed 
Fenton reaction-based model and hence provides a temporary сиІШге medium in 
which oxidant environments may be represented. 
3.2.6.4 Method of cell viabil ity determination 
The merits o f the MTS assay have been previously discussed and this assay was 
selected for cell viabil ity determination. 
3.2.7 Antioxidant effects of herbal extracts ： methods 
3.2.7.1 Preliminary work and general information 
Solutions of herbal extracts and H2O2 / FeCh 
H2O2 solutions o f 10՜^, 10՜^ ІОЛ \0-\ 10•^ 1 ๙ and 1.0 M were prepared in 15 m l 
centrifuge tubes from refrigerated stock; HBSS was the diluent. FeS04 was 
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immediately added and the tubes lightly vortexed. The overall ratio of FeS04 ： №0շ 
was 2 : 1 for each solution. Unless stated otherwise, all H2O21 FeS04 solutions shall 
hereafter be referred to as oxidants or oxidant solutions. 
Herbal extract solutions o f 1 ๙ ' 10'^, 10՜', 1.0, 10, 100 and 1000 це I ml were 
prepared in 15 ml centrifuge tubes by serial dilution o f refrigerated stock on the day 
of the experiment. 
For assessment o f protective effects, herbal extract solutions were prepared in basal 
media / 1 0 % FBS. 
For assessment o f scavenging effects, herbal extracts were added to HBSS which 
contained oxidants in such a way that the resulting solutions were comprised of herbal 
extracts in the specified concentrations together with the required FeS04 ： YhOi 
molarity ratio o f 2 ： 1; these solutions were prepared immediately prior to their use 
wi th cell cultures. 
M T S assay 
Generally, for colourimetric determinations, 20 μ L MTS reagent was added to each 
wel l and the plate incubated for 2 hours prior to optical density measurement at 490 
nm， reference wavelength 630 nm 
Determination of oxidant concentration 
NHDF ( 3 x 1 0 ^ ) were seeded into wells o f a 96-well microplate in basal media / 10 
% FBS. Cells were allowed 24 hours for attachment after which the media was 
aspirated and the cells washed twice wi th physiologically buffered saline ( PBS ). 
Concentrations of oxidants, diluted in HBSS, in the specified concentration range and 
molarity ratio, were added and the plate incubated for 1 hour. Controls consisted o f 
cells incubated in HBSS only. At the end o f the incubation period, the oxidant 
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solutions were aspirated, replaced with basal media / 10 % FBS and the MTS assay 
was performed. 
A n oxidant concentration consisting o f lO—2 M H2O2 / 2 X 10՜^ FeS04, which reduced 
viable cell numbers to 32 % o f untreated controls, was felt to adequately reduce the 
number o f viable NHDF whilst allowing a sufficient potential recovery, as shown in 
Figure 3.2. 
-3 -2 -1 0 
Log 10 hydrogen peroxide dose in oxidant 
Figure 3.2. Dose response relationship between percentage NHDF viabil ity and 
oxidant dose 
Determination of 'protect ive' incubation period of N H D F w i th herbal extracts 
NHDF (3 X 1๙) were seeded into 96-well microplates in basal media / 10 % FBS. 
Cells were allowed 24 hours for attachment after which the media was aspirated and 
the herbal extract solutions, diluted in basal media / 10 % FBS, were added in the 
specified concentrations. The plate was incubated for a period of 12 hours and the 
MTS assay was performed. 
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There were no effects upon NHDF proliferation o f any herbal extract during this 
period and a 12 hour incubation was selected for the assessment o f protective effects. 
3.2.7.2 Protective effects o f herbal extracts 
NHDF (3 X 10^) were seeded into 96-well microplates in ІООцЬ basal media 110 % 
FBS. Cells were allowed 24 hours for attachment after which the media was aspirated 
and the herbal extract solutions, diluted in basal media / 1 0 % FBS, were added in the 
specified concentrations. 
NHDF were incubated with the extracts for a period o f 12 hours, after which the 
media was aspirated and the cells washed twice wi th PBS. 
Oxidant solutions (10՜^ M H2O2 / 2 X 10—2 FeCh), diluted in HBSS, were added and the 
plates incubated for 1 hour. After incubation, oxidant solutions were aspirated, 
replaced with basal media / 1 0 % FBS and the MTS assay was performed. 
3.2.7.3 Scavenging effects of herbal extracts 
NHDF (3 X 1๙) were seeded into 96-well microplates in ЮОцЬ basal media / 10 % 
FBS and allowed to attach for 24 hours, after which the media was aspirated and cells 
were washed twice wi th PBS. 
Solutions consisting o f 10՜2 M H2O2 / 2 X 10՜^ FeS04 and the specified herbal extract 
concentrations were added and the plates incubated for 1 hour. After incubation, 
oxidant solutions were aspirated, replaced with basal media / 1 0 % FBS and the MTS 
assay was performed. 
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3.2.8 Effects o f herbal extracts on collagen production: experimental rationale 
3.2.8.1 Collagen quantification 
Radioimmunoassay-based measurement of collagen production 
A common method o f collagen determination is based on the measurement o f the 
amount of hydroxyproline, which accounts for approximately ten percent o f the 
collagen molecule. Quantification may be performed by radioimmunoassay, the 
principle o f which is the uptake by NHDF o f radioactively labelled proline, which in 
turn is incorporated into hydroxyproline prior to collagen synthesis.**^ This method 
has been used to measure collagen-producing effects o f extracts o f Ginkjo biloba^^ 
and Centella asiatica *^՝*^ A problem wi th the direct quantification o f collagen, as 
attempted in the radioisotope assay, is that it is generally insoluble in aqueous 
solutions such as culture media. This necessitates the several digestion, extraction, 
separation and purification Տէ6թտ՛*՛՛**՛՛*^ and a major criticism for such treatment is loss 
of analyte due to the number o f times the original collagen source is processed. 
Procollagen type-I carboxy peptide (PICP) assay 
Type I collagen is one o f several collagen types which are synthesized as precursor 
molecules. These collagens are first synthesized in the form o f procollagen α-chains, 
each o f which has a carboxy-terminal extension peptide that aids in triple-helix 
formation during the assembly o f the procollagen molecule.**^ 
Soluble procollagen molecules are released into the extracellular space, and thereafter 
mature into insoluble collagen fibres by removal o f the soluble carboxy-terminal 
extension peptide outside the fibroblasts/^՚* 
68 
Thus, levels o f procollagen type I carboxy-peptide (PICP) in cell culture supematants 
may be used to reflect ongoing collagen synthesis/*^ 
The earliest example o f collagen determination by quantification o f PICP was based 
on radioimmunoassay. However, the advent of self contained enzyme linked 
immunosorbent assay (ELISA) kits based on cell culture in microtitre plates has 
resulted in PICP quantitation by virtue of colourimetric measurement. 
The principle o f such measurement, as described by the manufacturers,**' is as 
follows ： 
The system is based on a sandwich-type enzyme linked immunoassay (ELISA), which 
utilizes two monoclonal antibodies, each recognising a different epitope on the PICP 
molecule. The assay ki t comprises a 96-wel l microtitre plate which has been 
precoated with one clone and an antibody-peroxidase conjugate solution (POD-
conjugate). 
In the presence o f both the pre֊֊coated and POD-conjugated forms o f the antibody, 
PICP samples or standards are bound to each at the respective epitope. 
The addition to the microtitre plate o f a buffered solution comprising hydrogen per -
oxide and tetramethyl benzidrine initiates a reaction between this reagent and POD. 
The resulting colour intensity is proportional to the amount o f PICP present in 
samples or standards and can be measured spectrophotomerically. Furthermore, accu­
rate sample concentrations can be determined by reference to a standard curve. 
The assay procedure requires several washing steps to remove potentially 
confounding species such as unbound PICP which remains in the cell culture 
supernatant and, regarding potential loss o f analyte, is ostensibly open to the same 
criticisms as the radioimmunoassay. The major difference, however, is that the 
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analyte remains bound to the microtitre plate and is not subjected to further chemical 
treatment once the reaction has been stopped. 
The relative self containment o f the assay is primarily due to the fact that PICP is 
merely a polypeptide sequence having primary, but not secondary or tertiary structure. 
Consequently, it is non-fibrillar, readily soluble in aqueous solution and hence culture 
media. 
It was decided that the virtue o f measuring collagen directly in the radioisotope assay 
is offset by the potential analyte losses; additionally, the variety o f different chemical 
treatments to which the collagen source is subjected, make it a lengthy procedure. 
The PICP assay lends itself readily to the expedient screening of several drags for 
their effects on collagen production by cultured NHDF and was, therefore, selected 
for this риф08Є. 
3.2.8.2 Culture media in which herbal extracts were applied 
In previous studies o f herbal extracts, cells were seeded in basal media I 10 % FBS 
and allowed to attach to the plate prior to replacement wi th serum-free media 
supplemented with ascorbic acid (50 цд/ші).^*''*^'''^ 
For the рифозез o f assessing collagen production in a simulated chronic wound 
environment, the virtues of changing to seram-free media are as follows ： 
1. Avoidance of cross reaction 
Animal-derived serum can contribute artefacts to collagen quantification, particularly 
in the case o f the PICP assay, where the antibodies in the ELISA kit cross react with 
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animal derived PICP 187 
2. Effects on collagen production are at t r ibuted to herbal extracts only 
The only way o f emphatically attributing effects upon NHDF collagen production to 
herbal extracts is to expose the cells to herbal extracts in the absence o f growth factors 
present in FBS. It is conceivable that extracts may act synergistically wi th growth 
factors and hence distort their true contribution. 
Although the stimulatory effect o f ascorbic acid on collagen production has been 
demonstrated,'**'^*' รณdies o f the effects of dnigs or chemicals have been made in its 
absence. ^ ՚ " ՛ "^ I t was felt that ascorbic acid was a potentially confounding factor in 
exactly the same way as FBS and the substance was omitted from culture media. 
3.2.9 Effects o f herbal extracts on collagen production ： methods 
3.2.9.1 Preliminary work and general information 
M T S assay. 
For colourimetric determinations, 20 μ L MTS reagent was added to each well and the 
Plate incubated for 2 hours prior to optical density measurement at 490 nm, reference 
wavelength 630 nm. 
Procollagen type- I carboxy peptide (PICP) assay 
Upon completion o f a 3 day incubation period, cell culture supematants were 
collected by aspiration and the PICP assay was performed in the fol lowing steps ： 
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1. 100μL· antibody-POD conjugate was added to each well o f the pre-coated 
microtitre plate. 
2. Cell culture supematants and standard PICP solutions (20цЬ) were added 
immediately after step 1. 
3. The plate was covered and incubated at 37° с for 3 hours 
4. The contents of each well was aspirated and discarded. 
5. Wells were washed four times each wi th 100 μ L o f physiologically buffered 
saline (PBS). 
6. 100 Buffered solution (hydrogen peroxide / tetramethyl benzi drine) is 
added to each well and the plate incubated at room temperature for 15 min. 
7. ІООцЬ of 1 N H2SO4 is added to stop the reaction and the absorbances were 
recorded at 430 nm. 
Solutions of herbal extracts 
Herbal extract solutions o f 10՜^· 10 ^  10 ՛ , 1.0, 10, 100 and 1000 μg I ml were prepar­
ed in 15 ml tubes by serial dilution o f refrigerated stock on the day o f the 
experiments. Extract solutions were created in basal media and basal media / 10 % 
FBS supplemented with 70 μ§ / ml IGF-1 and drawn through a 0.2μηι filter for 
sterilisation; all culture media contained Gentamycin / Amphoterecin в (1000 units). 
3.2.9.2 Assessment o f herbal extract effects on PICP production by NHDF grown in 
basal media 
3 X 1๙ NHDF were seeded into 96 well plates in ІООцЬ basal media / 1 0 % FBS and 
allowed to attach for 24 hours. The media was aspirated and replaced with basal 
media. 
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NHDF were allowed to equilibrate for 24 h, the media was aspirated and the herbal 
extract solutions, diluted in basal media, were added in the specified concentrations. 
Controls consisted o f NHDF grown in basal media. 
The cells were incubated with the extracts for a 3 day period and the PICP assay was 
performed. 
To assess the extent to which altered NHDF coUagen production was due to changes 
in proliferation, the MTS assay was used; aspirated supematants were replaced with 
basal media and the MTS assay was performed, as a means o f distinguishing from 
genuinely affected collagen production or production due to altered cell numbers. 
3.2.9.3 Assessment o f herbal extracts on PICP production by NHDF-based fibrotic 
model 
NHDF (3 X 1๙) were seeded into 96-well plates in 100μL basal media I 10 % FBS 
and allowed to attach for 24 hours. Media was aspirated and replaced wi th 
basal media / 1 0 % FBS supplemented with 70 / ml IGF-1. 
NHDF were allowed to equilibrate for 24 h, the media was aspirated and the herbal 
extract solutions, diluted in basal media I 10 % FBS supplemented wi th 70 μ£ / ml 
IGF-1, were added in the specified concentrations. Controls consisted o f a set o f cells 
grown in basal media / 10 % FBS. The cells were incubated wi th the extracts for a 3 
day period, after which the PICP assay was performed. 
Herbal extract concentrations which appeared to inhibit PICP production coincided 
with concentrations having similar effects on the proliferation o f the NHDF-based 
fibrotic model. In these cases, aspirated supematants were replaced wi th basal media 
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and the MTS assay was performed, as a means o f distinguisMng from genmnely 
affected collagen production or production due to altered cell numbers. 
3.2.9.4 Assessment o f cytotoxicity 
In all experiments, ten wells were allocated for cytotoxicity assessment. Upon seeding 
o f NHDF into wells, the cells were allowed to equilibrate for one hour, after which 
time the MTS assay was performed. The coffesponding absorbances o f these cells 
were taken as a baseline and herbal extract concentrations which produced 
absorbances less than this minimum level were assumed to be toxic. 
3.2.10 Effect o f herbal extracts on KGF production ： experimental rationale 
3.2.10.1 Reasons for selecting KGF for รณdy 
Most of the growth factors produced by NHDF affect the proliferation of a wide 
variety o f cellular targets, stimulating the proliferation o f cells derived from 
mesodermal, ectodermal and endodermal tissue; additionally, they can act as 
neurotrophic and angiogenic factors in v /vo/ '^ 
Clearly, these growth factors have a very broad mitogenic spectrum. As a result o f 
this ambiguity, an emphatic casual relationship between the effects o f drugs, herbal or 
otherwise, on the production o f such growth factors and enhancement o f wound 
healing cannot be established. 
The existence o f keratinocyte growth factor (KGF), in the cell culture supernatant o f a 
human lung fibroblast cell line, was first reported in 1989.*' ' In contrast to most o f 
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the other NHDF growth factors, KGF was thought to be a higMy specific mitogen for 
different types of epithelial cells and was named as a result of observed predominant 
activity on keratinocytes/'''^''* 
More recent studies have reinforced the specific nature of this cytokine; in studies of 
whole skin organ сฟture, expression of KGF has been detected only in the dermis*'^ 
and the receptor for KGF is expressed by epithelial cells only.*'* This growth factor is 
thus doubly specific, in terms of the cellular source and target cells. 
Biopsies of incisions from patients undergoing plastic surgery were found to contain 
KGF levels which were three fold that of uninjured sk in" ' and the growth factor has 
been shown to protect cultured epidermal keratinocytes from reactive oxygen 
species/'* 
The current study is restricted to the investigation of the effects of herbal extracts on 
dermal cells; however, an investigation into the effects of herbal extracts on the 
production of keratinocyte growth factor by NHDF may give an insight into how the 
extracts may influence, albeit indirectly, epidermal cells such as keratinocytes. 
3.2.10.2 KGF measurement by enzyme linked immunosorbent assay (ELISA) 
There has been very little work pertaining to the production of KGF by cultured 
NHDF; only three articles were found in which the production by these cells of the 
growth factor was quantified, none of which involved herbal extracts. Two studies 
compared KFG production by human oral and dermal fíbroblasts'"*^"" whereas the 
other investigated the effects of hyaluronic acid on production. 
A l l studies employed enzyme linked immunosorbent assay (ELISA) kits for KGF 
quantitation. »"'^ »"'^ "^ 
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The principles behind the determination of KGF in this way are similar to those for 
PICP but there are procedural differences.^"^ In the case of the PICP assay, the 
antibody POD-conjugate is added to the microplate prior to addition of samples or 
standards; whereas in the KGF assay, the order of addition is reversed; binding of 
KGF to the antibody coated onto the plate occurs first, which in turn necessitates extra 
washing steps prior to the addition of the conjugated version of the antibody. 
This was the procedure for the original ELISA kit for the PICP assay/^^ prior to an 
overall improvement. The ELISA kit described for KGF quantification has, thus far, 
not been similarly upgraded. 
The resulting colour intensity is proportional to the amount of PICP present in 
samples or standards and can be measured spectrophotomerically. Furthermore, 
accurate sample concentrations can be determined by reference to a standard curve. 
3.2.10.3 Culture media in which herbal extract solutions were created 
Regarding the studies which compared oral and dermal fibroblasts, one assessed KGF 
production in basal media / 10 % FBS,^"" the other employed seram-free media. 
When fibroblasts of different origin are being compared, as opposed to an 
investigation of the effects of a test substance and a control, it could be argued that 
theinclusion in culture media ofFBS is reasonable because the two cell types can be 
assessed in terms of an optimal growth environment. 
The serum free assessment was felt to be superior, however; commercially available 
serum undoubtedly contains significant amounts of KGF and, even allowing for the 
fact that one group of cells may exhibit measurably different production than another, 
the true amount secreted into culture medium is impossible to gauge. 
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Regarding the assessment of hyaluronic acid,^*" there was no virtue in the addition to 
NHDF of the biopolymer in anything other than serum free media. As is the case in 
studies which involve proliferation and collagen producing effects, only the test 
substance should be present, to achieve an unequivocal determination of its 
contribution in isolation. Given the myriad of growth factors which comprise FBS, 
KGF production due solely to interaction between hyaluronic acid and FBS compone­
nts, cannot be discounted; such an occurrence would still result in a level of KGF 
production greater than that for controls. 
It was thus decided to apply herbal extracts to NHDF in basal media only. 
3.2.11 Assessment of herbal extract effects on KGF production ： methods 
3.2.11.1 Preliminary work and general information 
MTS assay 
For colourimetric determinations, 20μL MTS reagent was added to each well and the 
plate incubated for 2 hours prior to optical density measurement at 490 腿, reference 
wavelength 630 nm. 
Keratinocyte growth factor (KGF) assay 
Upon completion of a 3 day incubation period, cell culture supematants are collected 
by aspiration and the KGF assay is performed in the following steps ： 
】. 100 ゆ samples and standards were added to the wells. 
2. The plate was covered and incubated at 37° с for 3 h. 
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3. The contents of each well were aspirated and the wells washed four times each 
with 100 μL of physiologically buffered saline (PBS). 
4. 200 antibody-POD conjugate was added to each well of the pre-coated 
microtitre plate. 
5. The plate was covered and incubated for 1.75 h. 
6. The contents of each well were aspirated and washed four times each with 100 
|iL of physiologically buffered saline (PBS). 
7. 200 μL buffered reagent solution (hydrogen peroxide I tetramethyl benzidrine) 
was added to each well. 
8. The plate is covered and incubated for 30 min. 
9. 50 of 2 N H2SO4 was added to stop the reaction and the absorbances are 
recorded at 490 腿. 
Solutions of herbal extracts 
Herbal extract solutions of lO—3' 10 ^  10՜', 1.0, 10, 100 and 1000 μ§ I ml were prepar­
ed in 15 ml tubes by serial dilution of refrigerated stock on the day of the 
experiments. Extract solutions were created in basal media and drawn through a 
0.2μηι filter for sterilisation; all culture media contained Gentamycin / Amphoterecin 
В (1000 units). 
3.2.11.2 Determination of the effects of herbal extracts on KGF production 
NHDF (3 X 1๙) were seeded into 96 well plates in ЮОцЬ basal media /10 % FBS 
and allowed to attach for 24 hours, after which time the media was aspirated and 
replaced with basal media. 
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NHDF were allowed to equilibrate for 24 hours, the media was aspirated and the 
herbal extract solutions, diluted in basal media, were added in the specified 
concentrations. 
Controls consisted of NHDF grown in basal media. 
The cells were incubated with the extracts for a 3 day period and the KGF assay was 
performed. 
To asses the extent to which altered KGF production by NHDF was due to changes in 
proliferation, the MTS assay was used; aspirated supematants were replaced with 
basal media and the MTS assay was performed, as a means of distinguishing from 
genuinely affected collagen production or production due to altered cell numbers. 
3.2.11.3 Assessment of cytotoxicity 
In all experiments, ten wells were allocated for cytotoxicity assessment. Upon seeding 
of NHDF into wells, the cells were allowed to equilibrate for one hour, after which 
time the MTS assay was performed. The corresponding absorbances of these cells 
were taken as a baseline and herbal extract concentrations which produced 
absorbances less than this minimum level were assumed to be toxic. 
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3.3 Pharmacological assessment of herbal extract performance 
3.3.1 General pharmacological principles 
3.3.1.1 Dose response relationships 
Analysis of the effects of drugs, whether the drags are herbal or otherwise, ultimately 
relates effect with concentration. In the case of studies involving several drugs having 
similar effects, a standard means of representation and comparison is required. 
Physiological responses are due to the activation of corresponding receptors and the 
agents which are capable of binding to these receptors (and producing effects) are 
known as agonists; since there are a finite number of receptors, the pharmacological 
behaviour of a drug tends toward the attainment of some maximum effect. 
Studies of dmg-receptor interactions (on the basis of the drug being a single chemical 
entity) often result in the generation of concentration-effect curves and the behaviour 
of particular drugs may be compared; an example is given in Figure З.За "^^  The 
geometry of the curves corresponds to a rectangular hyperbola and the general 
equation describing the relationship is ： 
E = Emax*c (3.1) 
C+EC50 
Where 'E ' is the effect resulting from a particular dose, 'C ' , 'Emax' is the maximum 
possible effect (attained when receptors are fully occupied by agonists) and 'EC50' is 
the dose at which half the maximum effect is produced (0ՕՄ6տթօո(սո§ to half maximal 
receptor-agonist binding). 
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It is common pharmacological practice to plot dose-response relationships on 
logarithmic axes, as a means of determining the dose regime over which changes of 
effect are linear, as shown in Figure 3.3b. 
The rectangular hyperbola is transformed into a sigmoid and is useful for drug 
comparisons, as shown in Figure 3.4a; the linear parts of the curve are in tum plotted 
logarithmically so a comparison can be made of two (or more) drugs over their most 
effective doses (Figure 3.4b). 
The potency of a drug may be defined as the amount required to produce a given 
effect; potency varies inversely with the magniณde of the dose required to produce 
the effect and is a means by which the behaviour of different drugs may be 
compared. ^ "՚* 
3.3.1.2 Detection and measurement of drug interactions 
Two drugs having overtly similar pharmacological properties may be combined for 
the purpose of investigating whether or not the effects of the combination differ from 
the sum of individual effects. There are four ways in which drag combination 
behaviour may be categorised: 
1. Additive behaviour 
The sum of the effects of a specified ratio of separate components is equal to the 
effect produced by the same ratio in combination. The implications of this type of 
behaviour are that the mechanisms of action are independent, drug behaviour in 
combinations being consistent with individual dose response curves.^"* 
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Figure 3.3 Two common methods of representing the dose response relationship, 
а/ Rectangular hyperbola resulting from effects being plotted on a linear dose scale 
b/ Sigmoid resulting from effects being plotted on a logarithmic dose scale 
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Figure 3.4 Use of logarithmic scales for the рифозе of drug comparison; lesser 
potency drug (blue curve), greater potency drug (black curve). 
a/ Sigmoidal plots for all effects 
b/ Regression plots of the linear portion of the sigmoid. 
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շ. Super-additive behaviour (synergy) 
When combined, drugs may interact chemically or physically; as a result the sum of 
the effects of a specified ratio of separate components is less than the effect produced 
by the same ratio in combination. Alternatively, for a given effect, a lesser quantity of 
the combined dose is required in comparison to the sum of individual doses; 
pharmacological drug interaction results in an enhanced overall effect. 
3. Sub-additive behaviour 
Drugs may exert their effects by the same mechanism, binding to the same receptor; 
in this case, there is competition between them for the binding site and the drug 
having the more compatible structure is preferentially bomid. 
In combinations, the less compatible drugs will produce inferior effects in comparison 
to their individual application.^"^ 
4. Antagonistic behaviour 
Drugs may or may not act on the same receptor but nevertheless interact or influence 
one another in such a way that the ability to produce a given effect is reduced for one 
or all of them; pharmacological drug interaction results in a reduced overall effect.'** 
Dose response curves may be added to produce a theoretical additive curve; 
comparison of the pharmacological behaviour of acณal combinations with this model 
have been used to asses the nature and degree of drug interactions (Figure 3.3).^"*'^"' 
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Figure 3.3. Visual comparison of the pharmacological; behaviour of drug 
combinations in terms of theoretical additivity (black curve), super-additivity (blue 
curve) and less than additivity (red curve) 
3.3.1.3 Analysis of herbal extract interactions: rationale 
Preliminary experiments revealed that upon the attainment of a maximum, the effects 
of several of the herbal extracts declined steadily with increased dose; this deviates 
from classical pharmacological behaviour. Herbal extracts contain several chemical 
components (as opposed to the single entity represented in Figure 3.1); it was 
therefore felt that comparison of herbal extract combinations with theoretical additive 
curves would be best effected in terms of the complete dose response data, rather than 
being restricted to the linear portion of the logarithmic plot. 
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For two herbal extracts demonstrating particular effects, a theoretical additive model 
was derived from individual dose response data; the model was based on the addition 
of a fixed quantity of one extract to another and the added drug was of lesser potency. 
Figure 3.4a shows the hypothetical dose response curve of Drag 1; 10 μ§ of Drag 2 
(corresponding to a pharmacological effect of 10 units) are added to 2, 5, 10 and 20 
μ§ of Drag 1. Only the more potent drug (Drug 1) is shown on the dose axis, enabling 
the proportion of Drug 1 in the combination to be readily apparent. The original dose 
response curve undergoes an upward translation of 10 units due to the effects of the 
added drag. 
Figure 3.4b illustrates a hypothetical comparison between the theoretical additive 
curve from Figure 3.4a and the effects of actual combinations. 10 μg of Drug 2 are 
added to 2, 5, 10 
and 20 μ§ of Drag 1 to give Drug 2 proportions of 5:1, 2:1, 1:1 and 1:2. For the 
additive curve, as the proportion of Drag 2 is reduced from 1:1 to 1:2 , there is a slight 
decline in effects; the curve for super-additive behaviour, in addition to demonstrating 
a greater effect, continues to ascend whereas the curve corresponding to less than 
additive behaviour exhibits a decline which is more pronounced than for the additive 
curve. 
In addition to demonstrating differences in the magnitude of effects between additive 
and combination curves, there is the potential for these diagrams to give insight into 
differences between the pharmacological profiles of actual and theoretical behaviour. 
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а/ 
b/ 
Dose of greater potency herbal extract 
Dose of more potent drug 
Figure 3.4. Hypothetical derivation and application of theoretical additive curves for 
the รณdy of drug interactions when 10 μg of Drug 1 is added to 2, 5, 10 and 20 μ§ of 
Drug 2 
a/ Derivation of theoretical additive curve (unbroken line) from original dose 
response curve (broken line) 
b/ Use of the theoretical additive curve for the demonstration of additive (black), 
super-additive (blue) and less than additive behaviour(red) 
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3.3.1.4 Analyses of herbal extract interactions：methodology 
Dose response relationships 
Dose response relationships and values ofEC50, IC50 and Emax were generated with 
with the use of SPSS for Windows (version 11.0) 
Upon demonstration of herbal extract effects in terms of NHDF proliferation, 
response to oxidants, and production of PICP or KGF, the relative absorbances of 
treatment groups and control groups were used to obtain effects by the following 
general equation: 
Effects = Absorbance of group treated with herbal extract X 100 - 100 (3.2) 
Absorbance of control group 
Effects were thus expressed in terms of a percentage above or below control values. 
Herbal extract dose response curves were constructed and plotted on logarithmic axes. 
The ascending portion of the dose response curves were fitted to hyperboUc models 
using curve fitting software. 
Analysis of herbal extract combinations 
Combinations of two effective herbs were made by adding the less potent herbal 
extract in the following proportions ： 5:1,2:1, 1:1 and 1:2. 
Combinations of one effective herb and one ineffective herb were made by adding the 
ineffective herbal extract in the following proportions ： 5:1,2:1, 1:1 and 1:2. 
Combinations of two non-effective herbs were made by adding herbal extracts in the 
following proportions ： 5:1,2:1, 1:1 and 1:2 and 1:5. 
In all cases, the effects of combinations were derived from Equation 3.2 and 
compared with the sum of effects from individual dose response data. 
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Rather than being inferred from the original dose response relationship, the additive 
data were generated in tandem with combination experiments, as a means of effecting 
direct comparisons. 
Bio-molecule production indexed to growth 
In the case of single herbal extracts which affected NHDF growth and appeared to 
influence bio-molecule production, the use of Equation 3.2 was not sufficient to 
demonstrate an intrinsic effect; the possibility existed that changes in the production 
of bio-molecules such as PICP and KGF were solely attributed to changes in cell 
number as opposed to bio-molecule-producing characteristics. 
For this reason, for a given dose, apparent effects on bio-molecule production were 
compared with established effects upon growth; only statistically significant 
differences between the groups were considered to genuinely reflect effects on bio-
molecule production. 
Similar comparisons were made in the case of combinations of growth-affecting 
herbal extracts which appeared to affect NHDF production of biomolecules. 
3.4 Statistical analyses 
Al l statistical operations were performed with the use of SPSS for Windows (version 
11.0). Generally, differences at the 1% level were considered to be significant. 
3.4.1 Dose response relationships 
For the dose response relationship for single herbs, replicates of ten wells of a 96-well 
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plate were used to represent each herbal extract concentration. 
Analysis of variance (ANOVA) was performed to determine the significance of 
differences between the absorbances of groups treated with herbal extracts and control 
groups. 
To assess the effects of herbal extracts on NHDF production of biomolecules (PICP 
and KGF), an independent samples t-test was performed to determine differences 
between apparent effects and growth-related effects. 
3.4.2 Correlation of absorbance with NHDF number 
For the assessment of the variation of absorbances with NHDF number, replicates of 
five plates were used Correlations between absorbances and cell number were 
established using linear regression. 
3.4.3 NHDF number vs time for growth-affecting herbal extracts 
For the assessment of differences in NHDF growth under the influence of herbal 
extracts, replicates of five plates were used. 
An independent samples t-test was used to determine the significance of growth 
related differences between herbal extracts and controls and also differences between 
two or more herbal extracts. 
3.4.4 Comparisons of Combination and additive behaviour 
Replicates of ten wells of a 96-well plate were used to represent the concentration of 
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each addi t ive and combina t ion herbal extracts A n independent samples t-test was 
per formed to establ ish the signi f icance o f di f ferences between the effects o f 
combinat ions and theoret ical addit ives. 
I n the case o f herbal extracts w h i c h af fected N H D F g rowth , apparent effects o f 
combinat ions on b iomolecu le product ion were compared w i t h the effects o f the same 
combinat ions on g row th by an independent samples t-test. 
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Chapter 4-Effects of herbal extracts on NHDF proliferation 
4.1 E f fec ts o f h e r b a l ex t rac ts on N H D F c u l t u r e d i n basal med ia 
4.1.1 Summary o f ef fects 
4.1.1.1 Single herbal extracts 
Z chalybeum(B) demonstrated no effects up to a dose o f 200 μ§/ηι1, whereupon 
tox i c i t y was evident (Append ix 1.1). 
Ζ chalybeumÇL), when appl ied at a dose range o f 0.001-1000 μ§/Ώύ, demonstrated 
no effects upon N H D F g row th ; increased dosages produced no effects and tox ic i t y 
was eventual ly observed at a dose o f 1100 μ§/πι1 (Append i x 1.1) 
c. rotundifolia(L), when appl ied at a dose range o f 0.001-1000 μ§/ηι1, demonstrated 
an enhancing ef fect on the g row th o f N H D F and tox i c i t y was eventual ly observed at a 
dose o f 1 1 0 0 μ g / m l . 
c. abbreviata(B), when appl ied at a dose range o f 0.001-1000 ņg/m\, demonstrated an 
enhancing ef fect on the g row th o f N H D F and t ox i c i t y was eventual ly demonstrated at 
a dose o f 1300 μ^/ηύ. 
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4.1.1.2 Comb ined herbal extracts 
The ef fect upon N H D F g row th was assessed for the f o l l o w i n g s ix paired herbal 
extract combinat ions: 
Combinat ions o f z chalybeum{B) I z. chalybeum{L) conta in ing z. chalybeum(B) 
proport ions o f 5 : 1 , 2 : 1 , 1:1, 1:2 and 1:5 produced no effects upon N H D F growth . 
A d d i t i o n o f Z chalybeumÇB) to с. rotundifoliaÇL) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 d i d not a f fect the N H D F g r o w t h enhancing ab i l i t y o f c. rotundifolia(Ľ). 
A d d i t i o n o f Z chalybeumÇL) to с. rotundifoÎia(L) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 d i d not a f fect the N H D F g row th enhancing ab i l i t y o f c. rotund։folia{L). 
A d d i t i o n o f z. chaIybeumÇB) to c. abbreviataÇB) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 d i d not a f fect the N H D F g row th enhancing ab i l i t y o f c. abbreviatale). 
A d d i t i o n o f z. chalybeumÇL) to c. abbreviata(B) i n propor t ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 d i d not af fect the N H D F g row th enhancing ab i l i t y o f c. abbreviaia(B). 
Combinat ions o f c. rotundifolia{L) I c. abbreviata{B) conta in ing c. rotundifoli(L) 
proport ions o f 5 : 1 , 2 : 1 , 1:1 and 1:2 produced effects w h i c h were super-addit ive and 
sub-addit ive. 
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4.1.2 Dose response relat ionships fo r с. rotundifolia(L) and c. abbreviata(B) 
For c. rotundifoliaÇL), stat ist ical ly s ign i f icant ef fects, up to a m a x i m u m , were 
observed over the dose range \-80μgίm\ ( p<0 .001 ; ¥{12, 1 1 7 ) = 7334.0) . 
For c. abbreviata(B), stat ist ical ly s igni f icant ef fects, up to a m a x i m u m , were 
observed over the dose range 1-40цв/т1 ( p<0 .001 ; F ( 1 2 , 1 1 7 ) = 2763.0) . 
Percentage N H D F g row th above controls, p lo t ted on a logar i thmic scale, is shown in 
Figure 4.1a. I n the case o f c. rotundifolia(L), between the f i rst and second dose 
appl icat ion, there is a re lat ive ly smal l increase i n effects. App l i ca t i on o f subsequent 
doses, up to the m a x i m u m effect , resulted i n greater increases i n effects on a l inear 
basis; i n contrast, a l though the p ro f i l e o f c. abbreviata{B) was l inear fo r the first three 
doses, the increase in effects due to the appl icat ion o f the four th dose wass less than 
l inear. 
For bo th herbal extracts, there was a steady decl ine o f effects w i t h dose once a 
m a x i m u m was at ta ined; this decl ine was more pronounced i n the case o f c. 
abbreviata{B). 
c. abbreviata(B) was the more potent herbal extract and also attained a h igher 
m a x i m u m ef fect (64 .25% compared w i t h 60 .84%) ; 
The ascending por t ion o f the dose response curves were also p lo t ted on a l inear dose 
scale and fitted to hyperbol ic models w h i c h are b r ie f l y descr ibed be low. These plots 
are shown i n Figure 4. l b . 
For c. rotundifolia(L), the value o f E m a x (74.5%) and E C 5 0 (24.3 pg /m l ) were 
reasonable approx imat ions o f the actual m a x i m u m ef fect (60 .84%) and the dose 
w h i c h resฟts i n h a l f the actual m a x i m u m (20.0 \ i į j m \ ) respectively. 
94 
а/ 
.9 1.2 1.5 1.8 2.1 2.4 2.7 3.0 
Log 10 herbal extract dose 
b/ 
с 20 
40 60 80 
Herbal extract dose (microgrammes/ml) 
F i g u r e 4.1 N H D F g rowth versus dose for c. rotundifolia lea f extract (b lue curves) 
and c. Abbreviata bark extract(b lack curves). 
a/ ef fects versus dose p lo t ted on a logar i thmic scale 
Ы ef fects versus dose (up to m a x i m u m ef fect ) p lo t ted on a l inear scale and fitted to 
a hyperbol ic mode l . 
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The value o f was 0.98, w h i c h demonstrated a good corre la t ion o f effects w i t h dose 
for the mode l , up to the m a x i m u m . 
For c. abbreviata(L), the value o f E m a x (67 .1%) was a good approx imat ion o f the 
асШа І m a x i m u m ef fect (64 .25%) whereas the E C 5 0 (2.5 μg /m l ) d i d not approx imate 
w e l l to the dose w h i c h results i n h a l f the actual m a x i m u m (6.0 μ§/ιη1). 
The value o f ŕ was 0 . 9 1 , w h i c h demonstrated a good corre la t ion o f effects w i t h dose 
for the mode l , up to the m a x i m u m 
4.1.3 Corre la t ion o f absorbance w i t h N H D F number when cells were cu l tured i n the 
presence o f the most e f fect ive herbal extract doses 
L inear regression was per fo rmed for absorbance (490nm) and cel l number for N H D F 
g r o w n in the presence o f herbal extracts. 
Corre la t ion coef f ic ients per ta in ing to treatment o f cel ls w i t h 80 μ§/ιη1 o f c. 
rotundifolia(L) and 40 I m l o f c. abbreviata{B) were 0.92 and 0.91 respective!y 
and the corre lat ion i n each case was taken to be l inear; a ฬรนal representat ion o f the 
relat ionship fo r the app l ica t ion o f each herbal extract is shown i n Figure 4.2. 
4.1.4 T i m e course for N H D F cu l tu red i n the presence o f the most ef fect ive herbal 
extract dose 
I n F igure 4.3, g rowth rates o f N H D F cul tured i n the presence o f 80 μ§ I m l o f c. 
rotundifoliaÇL) and 40 ЩI m l o f c. abbreviata(B) were compared. 
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F i g u r e 4.2 Cor re la t ion o f absorbance w i t h N H D F nvimber for c. ro tund i fo l i a (L ) and 
c, abbreviata{B) U p o n add i t ion o f a single dose o f herbal extract, cel ls were cu l tured 
over a per iod o f 9 days in 35 m m cul ture plates; ce l l counts and absorbance readings 
were per fo rmed at 1, 3, 5, 7 and 9 days after herbal extract appl icat ion. 
a/ Corre la t ion fo r N H D F treated w i t h 80 pg /m l o f c. rotundifoliaÇL) 
b/ Corre la t ion for N H D F treated w i t h 40 μg/ml o f c. abbreviataÇB) 
(F ive repl icate plates were used fo r measurement o f absorbance and cel l number) . 
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F i g u r e 4.3 N H D F number versus t ime for N H D F cu l tured i n basal med ia on ly (b lack 
curve) , basal med ia + 80 μ§/ιη1 o f с. r о tund if о ι ia l ea f extract (red curve) and basal 
med ia + 40 μ§/ηι1 с. abbreviata bark extract (b lue curve). 
U p o n addi t ion o f a single dose o f herbal extract, cel ls were с ฝ t u r e d over a per iod o f 9 
days i n 35 m m cul ture plates; ce l l counts were per fo rmed at 1, 3, 5, 7 and 9 days after 
appl icat ion o f 80 μξ/ΐϊύ o f c. rotundifoliaiX) and 40 pg /m l o f с . abbreviata(B). 
(Results are the mean and standard dev ia t ion o f five repl icate plates). 
Contro ls consisted o f cel ls cu l tured i n basal media only. 
General ly, d i f ferences between cont ro l and N H D F treated w i t h herbal extracts on ly 
became s igni f icant on day 3. 
Ce l l numbers fo r N H D F g rown i n the presence o f c. rotundifolia(L) were superior t o 
that o f cont ro l cel ls on day 3 ( t = 5.8, p<0.001) , 5 ( է = 11.5, p<0 .001) , 7 ( t = 15.0, 
p<0.001) and 9 ( t = 16.0, ţxO.OOl) . 
98 
I n the case o f N H D F g rown i n the presence o f c. abbrev։ata(B), ce l l numbers were 
superior to controls at days 3 ( t = 14.4, p<0.001) , 5(t = 20.9, p<0.001) , 7(t = 20.2, 
p<0.001) and 9( t = 18.2, p<0.001). 
I n terms o f herbal extract compar isons, ce l l numbers i n the group c u l t o e d i n the 
presence o f С . abbreviata{B) were superior to those o f the group treated w i t h c. 
rotundifolia(L); comparisons were made at days 3, 5 and 7 (day 3:t = 11.0, p < 0 . 0 0 1 ; 
day 5: է = 8.2, p<0.001 and day 7: է = 5.2, p<0.01) . 
The respective g row th rate at corresponding t ime periods fo r N H D F cul tured i n basal 
med ia on ly and i n the presence o f herbal extracts is shown i n Table 4.1 
N a t u r e o f g r o w t h 
med ia Basal m e d i u m c. rotundifolia(L) c. abbreviata(B) 
G r o w t h ra te 
(ce l ls /day f o r days 1-3) 3000 7000 13000 
G r o w t h ra te 
(ce l ls /day f o r days 3-5) 500 7500 4500 
G r o w t h ra te 
(ce l ls /day f o r days 5-7) -500 2500 500 
G r o w t h ra te 
(ce l ls /day f o r days 7-9) -1000 -500 -1500 
T a b l e 4.1 G r o w t h rates for N H D F g r o w n i n basal media and basal med ia conta in ing 
c. rotundifolia l ea f extract and c. abbreviata bark extract. 
For N H D F cu l tured i n the presence o f c. rotundifoliaÇL), the g rowth rate between 
days 3 and 5 was superior to that be tween days 1 and 3; between days 5 and 7, the 
g row th rate decreased marked ly , a l though N H D F пшпЬегร were s t i l l increased over 
this per iod ; between days 7 and 9, the g rowth rate was unchanged. 
For N H D F cu lmred i n the presence o f c. abbreviataÇB), the in i t i a l g rowth rate, 
between days 1 and 3, was the greatest; between days 3 and 9, g row th rates were pro-
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gressively reduced and actual ly became negative between days 7 and 9. 
O n day 9, there were no s igmf icant di f ferences between N H D F numbers between 
groups treated w i t h herbal extracts. 
4.1.4 Behav iour o f combinat ions o f c. rotundifolia(L) and c. abbreviataÇQ) 
4.1.4.1 Compar ison plots fo r addi t ive and combina t ion effects 
Figure 4.4a shows the ef fect o f add ing 10 pg /m l o f c. rotundifoliaÇh) to 2 , 5 and 10 
and 20 f ig /ml o f c. abbreviata{B). Be tween c. rotundifolia(L) proport ions o f 5:1 and 
1:1, the behaviour o f combinat ions was characterised by a roughly l inear re lat ionship 
between effects and c. abbreviata(B) dose whereas fo r addi t ive behaviour, increases 
i n effects were less pronounced. ; between c. rotmdifoliaÇL) proport ions o f 1:1 and 
1:2, the increase i n effects occurred to an equal degree fo r addi t ive and combina t ion 
behaviour. A t c. rotundifolia(L) proport ions o f 5:1 and 2 : 1 , the effects o f 
combinat ions were sub-addit ive ( t = 12.0, p<0.001) and ( t = 19.8, p<0.001) 
respect ively; reduct ion to proport ions o f 1:1 and 1:2 produced super-addit ive 
behaviour (t = 17.5, fKO.OOl) and ( t = 17 .1 , p<0.001) respectively. Th is t rend was 
also observed w h e n a dose o f 20 pg /m l o f c. rotundifoliaÇu) was added to c. 
abbreviata{B) i n s imi la r fixed mass ratios (data not shown) . 
The add i t ion o f 30 pg /m l o f c. rotundifolia(L) to 6, 15, 30 and 60 μ§/ιη1 o f c. 
abbreviata(B) is shown i n Figure 4.4b. A rough ly l inear dose-effect ге1а110П8Ыр was 
again evident between c. rotundifolia(L) proport ions o f 5:1 and 1:1 fo r combinat ions, 
in contrast to addi t ive behaviour, where the increases i n effects became less 
pronounced. The effects o f combinat ions were sub-addi t ive at c. rotundifolia(L) 
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F i g u r e 4.4 A d d i t i v e behaviour (b lack curve) compared w i t h combina t ion behaviour 
( red curve) fo r X . chalybeum bark extract I c. rotundifolia l ea f extract combinat ion , 
a/ Add i t i ve and combina t ion behaviour when a dose o f 10 pg /m l o f c. rotundifolia 
l ea f extract is added to the indicated doses o f c. abbreviata bark extract, 
b/ Add i t i ve and combina t ion behaviour when a dose o f 30 pg /m l c. rotundifolia lea f 
extract is added to the indicated doses o f c. abbreviata bark extract. 
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proport ions o f 5:1 and 2:1 ( t = 38.9, p<0.001) and ( t = 26.6 , ρΚΟ.ΟΟΙ) respectively but 
super-addit ive when the propor t ion decreased to 1:1 and 1:2 ( t = 35.3, p<0.001) and ( t 
= 36.3, ρく0.001) respectively. 
Between c. rotundifoliaÇL) proport ions o f 1:1 and 1:2, there was a fur ther dispari ty 
between the prof i les i n that the effects o f combinat ions cont inued to increase as 
opposed to the sl ight decrease exh ib i ted i n the case o f addi t ive behaviour. Th i s t rend 
was also observed when doses o f 40 , 50, 60 and 70 μ§/ηι1 с. rotundifolia(L) were 
added to c. abbreviata{B) i n s imi la r fixed mass proport ions (data not shown). 
Figure 4.5a depicts the add i t ion o f 80 pg /m l c. rotundifoliaÇL) to 16, 40 , 80 and 160 
pg /m l o f c. abbreviataÇS). A s c. rotundifolia{L) proport ions are reduced to 1:1, 
comb ina t ion behaviour was characterised by an increase i n effects whereas addi t ive 
effects reach a m a x i m u m at a c. rotundifoliaÇL) p ropor t ion o f 2 : 1 . B o t h addi t ive and 
combina t ion effects were reduced as the c. rotundifolia(L) p ropor t ion decreased to 
1:2. A t c. rotundifoliaÇL) proport ions o f 5:1 and 2 : 1 , the effects o f combinat ions were 
sub-addit ive (t = 47.0 , ρく0.001) and (է = 34.2, p<0.001) respect ively whereas 
proport ions o f 1:1 and 1:2 produce super-addit ive behaviour ( t = 11.4, p<0.001) i n 
bo th cases. Th is t rend was also evident for the add i t ion to c. abbreviataÇB) o f 100 
pg /m l (s imi la r f i xed mass proport ions) . 
U p o n add i t ion o f 200 μ§/ηι1, a l though a s imi la r t rend was observed, the increase i n 
the effects o f combinat ions (as c. rotundifoliaÇL) proport ions are reduced to 1:1) 
was less pronounced, (data not shown). The effects produced by the add i t ion o f 400 
pg /m l o f c. rotundifoliaÇL) are shown i n Figure 4.5b. A t c. rotundifoliaÇL) 
proport ions o f 5:1 and 2 : 1 , the effects o f combinat ions were sub-addit ive ( t = 97.3, 
p<0.001) and (t = 17.4, p<0.001) respect ively w h e r e a s l : ! and 1:2 produced 
superaddit ive behaviour (t = 11.7, p<0.001) and ( t = 15.3， p<0.001) respectively. 
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F i g u r e 4.5 Add i t i ve behaviour (b lack curve) compared w i t h comb ina t ion behaviour 
( red curve) f o r c. abbreviata bark extract I c. rotundifolia l ea f extract combinat ion , 
a/ Add i t i ve and combina t ion behaviour when a dose o f 80 μ§/ηι1 o f c. rotundifolia 
l ea f extract is added to the ind icated doses o f c. abbreviata bark extract, 
b/ Add i t i ve and combina t ion behaviour when a dose o f 400 μg /m l c. rotundifolia l ea f 
extract is added to the indicated doses o f c. abbreviata bark extract. 
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Add i t i ve effects reach a m a x i m u m at a c. rotundifolia{L) p ropor t ion o f 5:1 and 
decreased upon reduct ion o f the propor t ion to 2 : 1 , whereas comb ina t ion effects 
cont inue to increase, at ta in ing a m a x i m u m at a c. rotundifolia(L) p ropor t ion o f 1:1; a 
fur ther reduct ion o f c. rotundifoliaQS) p ropor t ion to 1:2 produced a negl ig ib le 
decrease i n the effects o f combinat ions ; the decrease in addi t ive ef fects, however , 
progressed i n a steady fashion. 
Th is t rend was also evident when 600, 800 and 1000 Yiįjmi o f с. rotundifolia(L) were 
added to c. abbreviata(B) i n s imi la r fixed mass proport ions (data not shown). 
The combinat ions attained a m a x i m u m ef fect ( 133 .5% N H D F g row th above contro ls) 
when 20 μξ/τηΐ o f c. rotundifolia(L) was added to 40 μ§/ηι1 o f c. abbreviata(B). 
4.1.5 Discussion 
4.1.5.1 Ind iv idua l dose response relat ionships 
B o t h herbal extracts exh ib i ted c o m m o n behaviour whereby, upon produc ing a 
part icular m a x i m u m ef fect , fur ther increases i n dosage produced sub-max imal effects 
w h i c h decreased steadi ly (Figure 4.1a). Th is behaviour deviates f r o m classic 
pharmacolog ica l behaviour, where, as effects approach a m a x i m u m leve l , fur ther 
increases in dosage produce negl ig ib le changes i n effect. 
One explanat ion fo r this d i f ference is the fact that herbal drags conta in several 
chemica l components w h i c h may, i n su f f ic ient quant i t ies, displace bound act ive 
ingredients f r o m g row th receptors. 
104 
The curve fitting parameters for the hyperbol ic plots o f effects versus dose were 
most ly reasonable approx imat ions o f m a x i m u m ef fect values and the doses w h i c h 
produced effects o f h a l f the m a x i m u m . Di f fe rences between software-ascr ibed and 
actual values o f E m a x and E C 5 0 are due the sof tware t reat ing the data as sections o f 
larger hyperbolas and hence extrapolat ing and іпЇеф0ІаІіп£ the effects. 
I t is appropr iate, however , to apply the mode l as a dose response re lat ionship up to the 
m a x i m u m . 
4.1.5.2 Corre la t ion o f absorbance w i t h N H D F number 
The M T S assay is an ind i rect means o f de te rmin ing changes i n ce l l number on the 
basis o f the measurement o f ce l l metabo l i sm; however , some pharmacolog ica l agents 
may af fect metabol ic end po in t o f the assay and hence give false indicat ions regarding 
the extent o f g row th and a corre lat ion between absorbance and cel l number is 
required. 
The good conela t ions established between absorbance and N H D F number when c. 
rotundifoliaÇL) and с abbrev։ata{B) were appl ied i n unsupplemented med ia prov ided 
va l ida t ion for the pharmacolog ica l behaviour o f i nd iv idua l and comb ined herbal 
extracts. 
4.1.5.3 T i m e course for N H D F g rown i n the presence o f c. rotundifoliaÇL) and 
c. abbreviata(ร)) 
Between days 1 and 3, the g rowth rate o f N H D F treated w i t h c. abbreviata{B) was 
approx imate ly 2.5 t imes that for cel ls treated w i t h c. rotundifoliaÇL). Th is represents 
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the on ly per iod dur ing w h i c h the g rowth rate o f N H D F treated w i t h c. abbreviata(B) 
is superior. Thus this in i t ia l marked increase i n cel l numbers appears to be the ma jo r 
reason for the di f ferences i n the g row th prof i les. Possibly, c. abbreviata(B) is more 
rap id ly assimi lated, bound to receptors and hence able to exert more pronounced 
effects at an early t ime po in t ; o n the other hand, c. rotundifolia(L) may be less readi ly 
assimi lated, increasing its e f fect over a longer per iod. 
A l l med ia types were appl ied on the basis o f a single dose and the eventual deplet ion 
o f nutr ients is the most l i ke l y cause o f the decl ine i n the numbers o f c. abbreviata(B) 
treated cel ls. 
4.1.5.4 Ef fec ts due to combinat ions o f c. rotundifoliaÇL) and c. abbreviata(B) 
General ly , the effects o f combinat ions were sub-addit ive when c. rotmdifolia(L) was 
present i n proport ions greater than 1:1, namely 2:1 and 5 : 1 ; as the c. rotundifoliaÇL) 
propor t ion was reduced to 1:1 and 1:2, comb ina t ion effects were super-addit ive. 
The observed less than addi t ive behaviour may be due to one o f the f o l l ow ing : 
1. The t w o herbal extracts may exert thei r g rowth enhancing effects by the same 
mechan ism, b ind ing to a s imi la r N H D F receptor; i n th is case, herbal extracts compete 
fo r the b ind ing site and the more structural ly compat ib le act ive ingredient is bound. I n 
such a scenario, the less compat ib le herba! extract w i l l produce an in fer io r e f fect i n 
compar ison to its behaviour ind iv idua l l y . 
2. The t w o herbal extracts may or may not act on the same receptor but nevertheless 
interact or in f luence one another i n a way w h i c h disrupts the g rowth enhancing 
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activity o f one or both of them (antagonism). Given the mฟtimde o f components 
present in herbal extracts, it is possible that such interference may be between 
components other than the active ingredients. 
The super-additivity is the result o f increasing the proportion of c. abbreviatale) 
from 1:5 to 1:1. Regardless of the means by which sub-additivity is produced, the 
proportion o f 1:1 would appear to herald the positive interaction o f the two extracts. 
Super-additivity was also evident when post-maximal effects were declining, which 
suggests that the eventual displacement o f the active ingredient(ร) f rom receptors may 
be offset when the herbal extracts are combined. 
4.2 Effects of herbal extracts applied in basal media / 2 % FBS 
4.2.1 Summary o f effects 
4.2.1.1 Single herbal extracts 
Z chalybeumÇB) demonstrated no effects up to a dose of 600 μg/ml, whereupon 
toxicity was evident (Appendix 1.1) 
Z chalybeum{V), when applied at a dose range o f 0.001-1000 μ§/ηύ, demonstrated 
no effects upon NHDF growth; increased dosages produced no effects and toxicity 
was eventually observed at a dose o f 1300 μg/ml (Appendix 1.1) 
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с. rotundifolia{L), when applied at a dose range o f 30 -1000 pg/ml, demonstrated an 
enhancing effect on the growth o f NHDF and toxicity was eventually observed at a 
dose o f 1500 μg/ml. 
c. abbreviata(B), when applied at a dose range o f 20 -1000 μg/ml, demonstrated an 
enhancing effect on the growth o f NHDF and toxicity was eventually demonstrated at 
a dose of 1600 μ§/ηι1. The nature o f this dose response relationship is described in 
more detail in section 4.2.2 
4.2.1.2 Combined herbal extracts. 
The effect upon NHDF growth was assessed for the fol lowing six paired herbal 
extract combinations 
Combinations o f z. cha/ybeumÇB) I z. cMlybeum(L) containing ζ chalybeumiB) 
proportions o f 5:1,2:1,1:1,1:2 and 1:5 produced no effects upon NHDF growth. 
Combinations o f ζ chalybeum(ß) I с. rotundifoliaĢJ) containing ζ chalybeนm(JB>) 
proportions o f 5:1, 2 :1 , 1:1, 1:2 did not affect the ability of c. rotundifolia(L) to 
enhance NHDF growth 
Combinations o f z. chaiybeumÇL) I c. rotund։folia(L) containing ζ chalybeum(B) 
proportions o f 5:1, 2 :1 , 1:1, 1:2 did not affect the ability o f c. rotundifolia{L) to 
enhance NHDF growth. 
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Combinations o f z. chalybeumÇB) I с. abbreviata{B) containing z chalybeum(B) 
proportions o f 5:1, 2 :1 , 1:1, 1:2 did not affect the ability of c. abbreviata(B) to 
enhance NHDF growth 
Combinations o f z. chalybeum{L) I c. abbreviata{B) containing z. chalybeum(E) 
proportions o f 5:1, 2 :1 , 1:1, 1:2 did not affect the ability o f c. abbreviata(B) to 
enhance NHDF growth 
Combinations o f c. rotundifolia(L) I c. abbreviataÇQ) containing c. rotundifoliaÇL) 
proportions o f 5:1, 2 :1 , 1:1 and 1:2 produced effects which were superior to the 
theoretical additive model. 
4.2.2 Dose response relationships for с rotundifolia(L) and c. abbreviata(B) 
For c. rotmdifolia(L), statistically significant effects, up to a maximum, were 
observed over the dose range 30-120μΒ/ηι1 (p<0.001; F(15,144 ) = 1276.8). 
For c. abbreviaia(B), statistically significant effects, up to a maximum, were 
observed over the dose range 20-70μ§/ιη1 (ρκΟ.001; Ғ(12, 1 1 7 ) = 1709.8). 
Percentage NHDF growth above controls, plotted on a logarithmic scale, is shown in 
Figure 4.6a. In the case o f both herbal extracts, there is a less than linear increase o f 
NHDF growth wi th herbal extract dose and, up to their respective maximum effects, 
the behaviour o f c. rotundifolia{L) and c. abbreviata(B) is described by a similar 
profile. For both herbal extracts, the maximum effect was maintained for three 
subsequent dose applications, after which increased dosages produced sub-maximal 
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Effects. For both herbal extracts, there was a steady decline o f effects once a 
maximum was attained. 
c. abbreviataÇB) was the more potent herbal extract and also attained a higher 
maximum effect (27.6% compared wi th 20.9%); additionally the decrease in effects 
wi th dosage for this herbal extract, once the maximum had been attained, was less 
pronounced. 
The ascending portion o f the dose response curves were also plotted on a linear dose 
scale and fitted to hyperbolic models which are briefly described below. These plots 
are shown in Figure 4.6b. 
For c. rotundifoliaÇL), the values o fEmax (42.0%) and EC50 (90.7 \iįjm\) were not 
good approximations of the actual т а х і т ш п effect (20.9%) or the dose which results 
in half the actual maximum (30.0 ц§/т1); however, the value o f ŕ was 0.94, which 
demonstrated a good correlation of effects wi th dose, up to the maximum. 
For c, abbreviata(L), the value o f Emax (35.6%) was a more reasonable 
approximation o f the actual maximum effect (27.6%); it was not possible to establish 
from Figure 4.7b the dose which results in half the actual maximum; the value o f โ^ 
was 0.92, which demonstrated a good correlation of effects wi th dose for the model, 
up to the maximum 
4.2.3 Correlation o f absorbance wi th NHDF number 
Correlation coefficients pertaining to treatment o f cells wi th 90 I m l o f c. 
rotundifoliaQS) and 70 μ§ / ml of c. abbreviataiß) were 0.95 and 0.97 respectively 
and a visual representation is shown in Figure 4.7. 
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Figure 4.6 NHDF growth versus dose for c. r о tund if о і ia leaf extract (blue curves) 
and c. Abbreviata bark extract(black curves). 
a/ effects versus dose plotted on a logarithmic scale 
b/ effects versus dose (up to maximum effect) plotted on a linear scale and fitted to 
a hyperbolic model. 
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4.2.4 Time course for NHDF cultured in the presence o f the most effective herbal 
extract dose 
The growth rate o f NHDF cultured in the presence o f 90 μg I m l o f c. rotundifolia{L) 
and 70 \yg I m l o f c. abbreviata(b) were compared wi th the growth o f cells cultured 
in basal media I 2% FBS; the results o f these experiments are shown in Figure 4.8 
Generally, differences between control and NHDF treated wi th herbal extracts only 
became significant on day 3. 
Cell numbers for NHDF grown in the presence o f c. rotundifolia(L) were superior to 
those o f control cells on day 3 (t = 5.8, p<0.001), 5 ( t = 5.8, p<0.001) and 7 (t = 4.0, 
p<0.001); however, the relative increase in NHDF пшпЬегร at each time point was 
rougMy the same for both groups, resulting in similar growth profiles. Between days 7 
and 9, there was a decrease in cell numbers which was more pronounced in the case 
o f NHDF grown in the presence o f c'. rotundifolia(L) and there was no significant 
difference between cell numbers o f each group on day 9. 
In the case o f NHDF grown in the presence o f c. abbreviataÇQ), cell numbers were 
superior to controls at days 3 (t = 20.9, p<0.001), 5(t = 14.5, p<0.001), 7(t = 8.5, 
p<0.001)and 9 ( t = 11.0, p<0.001). 
Cell numbers in this group were also superior to those o f the group treated wi th c. 
rotundifolia{L) when compared at the same time points (day 3:t = 14.5, p<0.001; day 
5: է = 8.2, p<0.001; day 7: է = 5.2, p<0.001; day 9: է = 8.6, p<0.001). 
The respective growth rates and corresponding time periods for NHDF grown in basal 
media 12% FBS and basal media 12% FBS plus herbal extract are shown in Table 4.2 
When compared wi th NHDF grown in control media or media contøining с. 
rotundifolia{L), NHDF growth under the influence o f c. abbreviataiß) did not 
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resemble the profile o f either o f the other groups; growth was very rapid and far 
superior over the period between 1 and 3 days whereas between days 3 and 7, the 
growth rate was inferior to both the other groups, actually remaining stationary 
between days 5 and 7. Between days 7 and 9, NHDF numbers declined at a rate which 
was less pronounced than for the group treated with c. rotundifolia(L) and similar to 
the control group. 
Nature of g rowth 
media Basal medium 
+ 2% FBS 
c. rotund։folia{L) c. abbreviata{B) 
Growth rate 
(ceUs/day for days 1-3) 3500 7500 17500 
Growth rate 
(cells/day for days 3-5) 10000 10000 5000 
Growth rate 
(cells/day for days 5-7) 3500 2500 500 
Growth rate 
(cells/day for days 7-9) -3500 -5500 -2500 
Table 4.1 Growth rate comparison for cells grown in basal media / 2% FBS and basal 
media I 2% FBS containing c. rotundifolia leaf extract and c. abbreviata bark 
extract. 
4.2.4 Behaviour o f combinations o f c. rotundifoliaÇL) and c. abbreviata(B) 
4.2.4.1 Comparison plots for additive and combination effects 
Figure 4.9a shows the effect of adding 40 μ§Λη1 o f c. rotmdifol։a(L) to 20, 40 and 
80 \iįjm\ o f c. abbreviataÇB). A t all proportions o f c. rotundifoliaÇL), 2 :1, 1:1 and 
1:2 the effects o f combinations were greater than additive (t = 30.8, p<0.001; է = 55.0, 
p<0.001; է = 54.6, p<0.001 respectively), and the shape o f the curves for both types 
of behaviour was similar. 
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Figure 4.7 Correlation o f absorbance with NHDF number for c. rotundifolia(L) and 
c. abbreviata(B) upon addition o f a single dose o f herbal extract, cells were cultured 
over a period o f 9 days in 35 mm culture plates; cell counts and absorbance readings 
were performed at 1, 3, 5, 7 and 9 days after herbal extract application. 
a/ Correlation for NHDF treated wi th 90 μ§/ιη1 of с. rotundifolia(L) 
Ы Correlation for NHDF treated wi th 70 pg/ml o f c. abbrev։ata(B) 
(Five replicate plates were used for measurement o f absorbance and cell number). 
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Figure 4.8 NHDF number versus time for NHDF cultured in media containing 2% 
FBS only (black curve), 2% FBS + 90 μ§/ηΐ1 o f с. rotundifołia leaf extract (red curve) 
and 70 pg/ml c. abbreviata bark extract (blue curve). 
Upon addition o f a single dose o f herbal extract, cells were сฟtured over a period o f 9 
days in 35 mm culture plates; cell counts were performed at 1, 3, 5, 7 and 9 days after 
application of 80 pg/ml of c. rotundifołia and 40 μ§/ηι1 o f с. abbreviata. 
(Results are the mean and standard deviation o f five replicate plates). 
The divergence o f combination behaviour from additivity appeared to increase wi th 
an increasing proportion o f c. abbreviataci); in particular, between proportions o f 1:1 
and 1:2, the effects o f combinations continued to increase 
whereas those for additivity remained unchanged. Similar behaviour was 
demonstrated when a dose of 50 ц§/т1 o f c. rotundifoliaQJ) applied in the same fixed 
mass ratios (data not shown). 
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Figure 4.9 Additive behaviour (black curve) compared with combination behaviour 
(red curve) for c. rotundifolia bark extract I c. rotundifolia leaf extract combination, 
a/ Additive and combination behaviour when a dose o f 40 pg/ml o f c. rotundifolia 
leaf extract is added to the indicated doses o f c. abbreviata bark extract, 
b/ Additive and combination behaviour when a dose o f 60 μ§/ηι1 с. rotundifolia leaf 
extract is added to the indicated doses of c. abbreviata bark extract. 
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The addition o f 60 μ§/ιη1 o f c. rotundifolia(L) to 30, 60 and 120 μ^/ταΐ o f c. 
abbreviataÇB) is shown in Figure 4.9b. Effects o f combinations are greater than 
additive for all proportions o f c. rotundifoliaÇL), 2:1, 1:1 and 1:2 (t = 44.0, p<0.001; է 
= 45.9, p<0.001; է = 46.6, p<0.001 respectively). The most pronounced divergence 
occurs when the c. rotund։folia(L) proportion is reduced from 2:1 to 1:1. Due to the 
higher doses combined, percentage NHDF growth reached a maximum value beyond 
which effects began to decline; effects were reduced by similar relative amounts for 
both curves between c. rotundifolia{L) proportions o f 1:1 and 1:2. Similar behaviour 
was demonstrated by the addition o f 70, 80 and 90 μξ/πύ с. rotundifolia(L) in the 
same fixed mass ratios (data not shown) 
The addition o f 100 μ§/ηι1 o f с. rotundifoliaÇL) to 20, 50, 100 and 200 цд/ші o f c. 
abbreviataÇB) is shown in Figure 4.10a. The effects o f combinations were greater 
than additive for all c. rotundifolia(L) proportions, 5:1, 2 :1 , 1:1 and 1:2 (t = 27.3, 
p<0.001; է = 60.2, ρく0.001; է = 57.1, ρく0.001; է =59.6, ρκΟ.ΟΟΙ respectively). The 
divergence between additive and combination behaviour became more pronounced 
when the c. rotundifoliaÇL) proportion was reduced from 5:1 to 2:1. 
Between c. rotundifolia(L) proportions of 2:1 and 1:1, the effects o f combinations 
remain at the maximum level, whereas those for the additive model begin to decline. 
As the c. rotundifoÎiaÇu) proportion is further decreased to 1:2, both the additive and 
combination effects decrease by the same relative amount. 
When c. rotundifolia(L) was added in doses o f 200,400, 600 and 800 pg/ml, 
common behaviour was exhibited by the combinations, as shown for the latter dose in 
Figure 4.10b; in this case, 800 цв/т1 was added to 160, 400 and 800 μ£/πι1 o f c. 
abbreviata(B). A t all proportions o f c. rotundifoliaÇL), 5:1, 2:1 and 1:1, effects for 
combinations were greater than additive (t = 40.6 , ρく0.001), (է = 43.8 , ρ<0.001) and 
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Figure 4.10 Additive behaviour (black curve) compared wi th combination behaviour 
(red curve) for X. chalybeum bark extract / c. rotundifołia leaf extract combination, 
a/ Addit ive and combination behaviour when a dose o f 100 \iįjm\ o f c. rotundifołia 
leaf extract is added to the indicated doses o f c. abbreviata bark extract, 
b/ Addit ive and combination behaviour when a dose o f 800 μ§/ηι1 с. rotundifołia leaf 
extract is added to the indicated doses of c. abbreviata bark extract 
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(է = 35.4 ,ρκΟ.001) respectively); additionally, the decline in effects declined to a 
similar degree as the c. rotundifolia(L) proportion was reduced from 5:1 to 1:1. 
The combinations attained a maximum effect (66.04% NHDF growth above controls) 
when 70 μΒ/ιηΙ of c. rotundifolia{L) was added to 70 พλ o f с. abbreviata(B). 
4.2.4 Discussion 
4.2.4.1 Individual dose response relationships 
Both herbal extracts exhibited common behaviour whereby, upon producing a 
particular maximum effect, further increases in dosage produce only sub-maximal 
effects which decreased steadily (Figure 4.7a). This behaviour deviates from classic 
pharmacological behaviour, where, as effects approach a maximum level, further 
increases in dosage produce negligible changes in effect. 
One explanation for this difference is the fact that herbal drugs contain several 
components which may, in sufficient quantities, displace bound active ingredients 
from growth receptors. 
Interestingly, in the case o f experiments performed in media supplemented wi th FBS, 
c. abbreviata(B) exhibited a lesser decline in effects once the maximum had been 
attained; the opposite was the case in experiments performed in basal media (Figure 
4. la) . Thus, the use o f FBS appears to alter the dynamics o f herbal extract dose 
response profiles. 
The curve fitting parameters for the hyperbolic plots o f effects versus dose were not 
good approximations o f maximum effect values and the doses which produced effects 
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of half the maximum. Differences between software-ascribed and асШаІ values o f 
Emax and EC50 are due the software treating the data as sections of larger hyperbolas 
and hence extrapolating and interpolating the effects. 
It is appropriate, however, to apply the model as a dose response relationship up to 
the maximum. 
4.2.4.2 Correlation o f absorbance with NHDF number 
The MTS assay is an indirect means of deteraiimng changes in cell number on the 
basis of the measurement o f cell metabolism; however, some pharmacological agents 
may affect metabolic end point o f the assay and hence give false indications regarding 
the extent o f growth and a correlation between absorbance and cell number is 
required. 
Although such a correlation had already been established when herbal extracts were 
applied in basal media, it was felt the possibility existed that the extracts could 
combine with 2% FBS to produce effects that were predominantly metabolic. 
The good correlations established between absorbance and NHDF number when c. 
rotundifoliaÇL) and c. abbreviataiß) were applied in basal media 12% FBS provided 
validation for the pharmacological behaviour of individual and combined herbal 
extracts. 
4.2.4.3 Time course for NHDF grown in the presence o f c. rotundifoliaÇL) and 
c. abbreviata{B) 
The greater cell densities o f NHDF cultured in 70 μ§/ηι1 с. abbreviata{B) were by 
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virtue o f the superior rate o f growth between days 1 and 3; over this period, the 
growth rate under the action of c. abbreviataÇB) is approximately three times that for 
c. rotundifolia(L) over this period. Between days 3, 5 and 7, the growth rate for 
NHDF cultured in media containing c. abbreviata(B) was inferior to that for cells 
cultured in control media and media containing c. rotundifol։a(L). Differences o f this 
nature were also evident in experiments involving basal media; possibly c. 
abbreviata{B) is more rapidly assimilated, bound to receptors and hence able to exert 
almost maximum effects at an early time point; on the other hand, c. rotundifolia(L) 
may be less readily assimilated and attains its т а х і т ш п effect over a longer period. 
In the case o f NHDF grown in control media and also media containing herbal 
extracts, cell numbers begin to decline after day 7; o f the two herbal extracts, the 
decline was more pronounced in the case o f media containing c. rotundifol։a(L), 
which was the opposite o f finding resulting from basal media experiments; all media 
types were applied on the basis o f a single dose and the eventual depletion o f nutrients 
is the most l ikely cause o f the decline. 
4.2.4.4 Effects due to combinations o f c. rotundifolia{L) and c. abbreviata(B) 
Overall, combinations o f the two herbal extracts, when applied in media containing 
2% FBS consistently produced super-additive effects at all experimental proportions; 
this is in contrast to their behaviour in basal media, where effects were sub-additive 
when c. abbreviata{B) was present in less than equal proportions and super-additive 
at equal and greater than equal proportions. It therefore seems reasonable to conclude 
that 2% FBS enhances the interaction o f the herbal extracts which was demonstrated 
for basal media; additionally, in the case o f effective and non-effective herbal 
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extracts, doses at which NHDF toxicity was observed were elevated in comparison to 
experiments in basal media, indicative o f enhanced tolerance. 
Super-additivity was also cedent when post-maximal effects were declining, which 
suggests that the eventual displacement o f the active ingredient(ร) from receptors is 
offset due to combining the herbal extracts. 
4.3 Effect of herbal extracts on growth of the fíbrotic model 
Dist inction between growth inhibi t ion and toxicity due to herbal extracts 
In proliferation assessments o f the type discussed here, a decrease in viable cell 
number relative to controls may be due to inhibit ion o f growth, cell death / damage or 
some combination o f the two. 
Thus, at the outset, it is important to establish a baseline measurement o f healthy non-
growing cells. This value may be expressed as a percentage below that o f growing 
cells and, on a dose response curve, w i l l be represented by a horizontal line; since this 
value corresponds to the initial number o f seeded cells, all effects below this line 
signify cell damage and the curve is effectively partitioned into areas of reduced 
growth and cell toxicity. 
4.3.1 Summary of effects 
4.3.1.1 Single herbal extracts 
c. rotundifoliaÇL), when applied at a dose range o f 0.001-1000 μ§/ηι1, demonstrated 
no effect on the growth of the fibrotic model; increased dosages produced no effects 
and toxicity was eventually observed at a dose o f 1700 μ§/ηι1 (Appendix 1.2) 
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с. abbreviataÇS), when appl ied at a dose range o f 0.001-1000 pg /m l , demonstrated no 
ef fect on the g row th o f the f ib ro t i c mode l ; increased dosages produced no effects and 
tox ic i ty was eventual ly demonstrated at a dose o f 1800 μ§/ηι1 (Append ix 1.2). 
Ζ chalybeum(L), w h e n appl ied at a dose range o f 0.001-1000 μ g / m l , demonstrated no 
effect on the g row th o f the f ib ro t i c mode l ; increased dosages produced no effects and 
tox ic i t y was eventual ly observed at a dose o f 1800 μ§/ηι1 (Append ix 1.2). 
z. chalybeum(B), when app l ied at a dose range o f 0.001-1000 g g / m l demonstrated 
inh ib i to ry effects up to a dose o f 1600 μ§/ ιη1, whereupon tox i c i t y was evident 
4.3.1.2 Comb ined herbal extracts 
The ef fect upon the g rowth o f the f i b ro t i c m o d e l was assessed fo r the f o l l o w i n g s ix 
paired herbal extract combinat ions 
Combinat ions o f z. chalybeum(B) w i t h z. chalybeum(L) i n z. chalybeumÇL) 
proport ions o f 5 : 1 , 2 :1 ,1 :1 and 1:2 d i d not a f fec t the ab i l i t y o f z. chalybeum{B) to 
inh ib i t the g row th o f the fibrotic model . 
Combinat ions o f z. chalybeumÇL) I c. rotundifoliaÇL) conta in ing z. chalybeum ( B ) 
proport ions o f 5 : 1 , 2:1， 1:1, 1:2 and 1:5 produced no effects upon the g row th o f the 
fibrotic model . 
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Combinat ions o f z chalybeumÇL) I с. abbreviata(B) conta in ing z chalybeumÇB) 
proport ions o f 5 : 1 , 2 : 1 , 1:1, 1:2 and 1:5 produced no effects upon the g rowth o f the 
fibrotic mode l . 
Combinat ions o f c. rotundifoliaĢS) I c. abbreviaíaÇB) conta in ing c. rotundifoliaÇL) 
proport ions o f 5 : 1 , 2:1， 1:1, 1:2 and 1:5 produced no effects upon the g row th o f the 
fibrotic model . 
Combinat ions o f z сһа1уЬеит(ВУ с. abbreviata(B) conta in ing с. abbreviata(B) 
proport ions o f 5 : 1 , 2 : 1 , 1:1,1:2 d i d not af fect the ab i l i t y o f z. chalybeum(ร) to inh ib i t 
the g row th o f the f i b ro t i c mode l . 
Combinat ions o f z. chalybeum(B) I c. rotundifoliaÇL) conta in ing c. rotundifolia{L) 
proport ions o f 5 : 1 , 2 : 1 , 1:1, 1:2 reduced the ab i l i t y o f z. chalybeum(B) to inh ib i t the 
g row th o f the fibrotic mode i . 
4.3.2 Dose response relat ionships for z. chalybeum(B). 
For the aqueous extract o f the bark o f X . chalybeum, s igni f icant effects were observed 
over a dose range o f 30 - 1000 \ i į j m \ ( ркО.001 , Ғ (14 , 135) = 9681.8). 
Percentage g row th be low contro ls versus log 10 herbal extract dose is shown i n Figure 
4.11a. I n contrast to the logar i thmic plots o f c. rotundifolia{L) and c. abbreviata(B), 
i n bo th unsupplemented and supplemented media , the m a x i m 腿 effect is main ta ined 
and the p lot for the z. chalybeum(B) data most closely resembled a s igmo id ; 
The ascending por t ion o f the dose response curve was p lo t ted on a l inear scale and 
f i t ted to a hyperbol ic mode l , as shovra in Figure 4.1 l b . 
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а/ 
b/ 
๐ χ 
.2 
I 
О) 
В 
І 
Φ CL 
1.6 1.8 2.0 2.2 2.4 2.6 2.8 3.0 3.2 
Logio dose of z. chalybeum bark extract 
40 50 60 70 80 90 100 
Zanthoxylem chalybeum bark extract (ทาicrogrammeร/ทาI) 
F i g u r e 4.11 Dose response relat ionships fo r z chalybeum bark extract 
a / Percentage g row th b e l o w contro ls versus dose p lo t ted on a logar i thmic scale 
b/ Percentage g row th be low contro ls (up to the m a x i m u m ef fec t ) versus dose p lo t ted 
on a l inear scale and fitted to a hyperbol ic mode l . 
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For Z. chalybeum{B), the value o f E m a x (109.0%) and IC50 (171.8 μ§/ηύ) d i d not 
approximate we l l to the actual m a x i m u m (38 .8%) and dose w h i c h produced h a l f the 
actual m a x i m u m (40.0 μ§/ηι1) respectively. 
The va lue o f was 0.97, w h i c h demonstrated a good οοπβ ίαΰοη o f effects w i t h dose 
for the mode l , up to the m a x i m u m . 
4.3.3 Cor re la t ion o f absorbance w i t h N H D F number 
L inear regression was per fo rmed for absorbance (490nm) and cel l number for N H D F 
g rown i n the presence o f 100 μ§ / m l o f z. chalybeum(B). 
The corre la t ion coef f ic ient was 0.97 and the re lat ionship was taken to be l inear; a 
visual representat ion o f the relat ionships is shown i n Figure 4.12. 
4.3.4 T i m e course for N H D F cul tured i n the presence o f the most ef fect ive herbal 
extract dose 
General ly , di f ferences between the groups were s igni f icant from day 3 onward. 
Ce l l numbers for N H D F g r o w n i n cont ro l med ia were superior to those g rown i n the 
presence o f cont ro l cells on day 3 ( t = 8.5, p<0.01) , 5 ( t = 10.6, p<0 .001 ) , 7 ( t = 10.6, 
p<0.001) and 9 ( t = 10.6, p<0.001) . 
The g row th rates o f N H D F g rown i n cont ro l and herbal extract med ia are shown i n 
table 4.3. 
From day 3 onward , there was a clear reduct ion in g rowth due to the act ion o f this 
dose o f z. chalybeum(B). There was also a dispari ty between the g rowth p ro f i l es ; f i om 
days 1 to 7, the g row th rate o f cont ro l cel ls decreases w i t h t ime over th is per iod 
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whereas the rate for N H D F treated w i t h z. chalybeum(B) was l inear. Thus, a l though 
the herbal extract reduced the N H D F number , ce l l g row th proceeds at a fixed rate 
between days 1 and 7. Be tween days 7 and 9, there is a decl ine i n ce l l numbers for the 
cont ro l group (due to a negative g row th rate) whereas fo r the treatment group, there 
was a sl ight increase i n N H D F numbers. 
N a t u r e o f g r o w t h 
med ia Basal m e d i m n / 1 0 % 
FBS + IGF֊1 
z. chalybeumÇB) 
G r o w t h ra te 
(ce l ls /day f o r days 1-3) 15000 5500 
G r o w t h ra te 
(ce l ls /day f o r days 3-5) 8000 5500 
G r o w t h ra te 
(ce l ls /day f o r days 5-7) 5000 5000 
G r o w t h ra te 
(ce l ls /day f o r days 7-9) -3000 -1500 
T a b l e 4.3. g rowth rates o f N H D F cu l tured i n basal med ia 110% FBS and 
Basal med ia 110% FBS + 70 Hg/ml I G F - 1 . 
4.3.3 E f fec t o f combinat ions o f z chalybeumÇS) and с. rotundifolia(L) o n N H D F 
fibrotic mode l 
The addi t ion o f 60 μ§ I m l o f c. rotundifolia(L) to 30, 60 and 120 μ§ / m l o f z. 
chalybeum(B) is shown i n Figure 4.13a. The addi t ive curve demonstrated l inear 
change o f ef fects w i t h dose as the ζ chalybeum(B) p ropor t ion was increased to 1:1. 
Between propor t ions o f 1:1 and 1:2, the change o f effects w i t h dose was less 
pronounced, ( t = 20.2, p<0.001) ; as the p ropor t ion is reduced to 1:1, and 1:2, addi t ive 
behaviour is exh ib i ted ; the less than addi t ive behaviour was responsible for the 
d i f ference i n p ro f i le o f the t w o curves. 
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а/ 
NHDF number (х 10000) 
b/ 
る 
Days after eadd№oท ot Հ. chalybeum bark extract 
F i g u r e 4.12. Cor re la t ion o f N H D F number w i t h absorbance and t ime course for z. 
chalybeum(B) U p o n add i t ion o f a single dose o f herbal extract, cel ls were cu l tured 
over a per iod o f 9 days i n 35 m m cul ture plates; ce l l counts and absorbance readings 
were per fo rmed at 1 , 3, 5, 7 and 9 days after herbal extract appl icat ion. 
a/ Corre la t ion w i t h absorbance for NHDF treated w i t h 100 Hg/ml o f z. chalybeum(B) 
Ы T i m e course for N H D F treated w i t h 100 μg/m\ o f z. chalybeumÇB). 
(results are the means and standard dev ia t ion o f five repl icate plates). 
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а/ 
b/ 
Dose ๙ Z. chalybeum bark extract (microgrammes/ml) 
Dose of z. chalybeum bark extract 
F i g u r e 4.13. Compar ison o f addi t ive (b lack curve) and comb ina t ion ( red curve) 
behaviour fo r combinat ions o f c. rotundifoliaÇL) and z chalybeum{B) 
a/ A d d i t i v e and comb ina t ion behaviour when 60μ§/ηι1 o f c. rotundifolia l ea f extract 
is comb ined w i t h 30 , 60 and 120 pg /m l o f z. chalybeum bark extract 
b/ Add i t i ve and combina t ion behaviour when 4 0 0 ц £ / т 1 o f c. rotundifolia lea f extract 
is comb ined w i t h 80, 200, 400 and 800 це/ті o f z chalybeum bark ex t rac tAt c. 
rotundifolia(L) p ropor t ion o f 2 : 1 , the effects o f the combina t ion are less than addi t ive 
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This t rend was also observed upon add i t ion o f 70, 80， 90 and 100 μg I m l o f c. 
rotundifoliaÇL) to z. chalybeum(B) i n s imi lar fixed mass proport ions (data not 
shown). 
Figure 4.13b shows the result o f add ing 400 μ§ / m l o f c. rotundifolia(L) to 80, 200, 
400 and 800 μ§ I m l o f z. chalybeumÇQ). the addi t ive effects at tained a m a x i m u m 
value at a c. rotundifoliaÇL) p ropor t ion o f 2 : 1 ; at proport ions o f 1:1 and 1:2 effects 
remained unchanged. 
A t c. rotundifol։a{L) p ropor t ion o f 5:1 and 2 : 1 , the effects o f the comb ina t ion were 
less than addi t ive ( t = 2 4 . 1 , p<0.001) and ( t =12.8， p<0.001) respect ively). A s the 
p ropor t ion is reduced to 1:1, and 1:2, addi t ive behaviour is restored. 
Th is t rend was observed when doses o f 2 0 0 , 6 0 0 , 800 and 1000 μ§ I m l o f 
c. rotundifol։a(L) were added i n s im i la r fixed mass proport ions (data not shown) 
4.3.4 Discuss ion 
4.3.4.1 Dose response relat ionships 
N o effects were observed at doses b e l o w 30 p g / m l ; this may ref lect that the act ive 
ingredient(ร) , due to inh ib i t i on by surrounding components, are on ly able to mani fest 
once a part icu lar concentrat ion has been reached, whereupon effects increase w i t h 
dose fa i r l y steadily. 
The act ive ingredient(ร) o f ζ chalybeum(B) extract most probably exerts effects by 
in ter fer ing physica l ly or chemica l ly w i t h g row th receptor func t ion ; this interference 
reaches a m a x i m u m at 100 րջ/աԼ beyond w h i c h fur ther i nh ib i t i on o f 
g row th is not possible, presumably because the sites at w h i c h in teract ion occurs are 
saturated. 
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Dose response cmves for с. rotundifolia(L) and с. abbreviata(B), discussed 
prev iously , were characterised by ef fects decreasing steadi ly once a m a x i m u m had 
been attained, w h i c h is i n contrast to z. chalybeum(B). 
One reason proposed fo r such decreases was that other components o f the herbal 
extracts displaced the act ive ingredient(ร) from receptors as the herbal extract 
concentrat ion increased; a possible explanat ion fo r the effects remain ing at the 
m a x i m u m level i n the case o f z. chalybeum(B) is that there are lesser amount o f these 
disrupt ive components. 
The reason for the dispar i ty between the curve fitting parameters (Emax and IC50) 
and the actual values recorded are due the sof tware t reat ing the data as sections o f 
larger hyperbolas and hence ext rapolat ing and i n t e φ o l a t i n g the effects. 
I t is appropriate, however , to apply the mode l as a dose response re lat ionship up to the 
m a x i m u m . 
4.3.4.2 Cor re la t ion o f N H D F number w i t h absorbance 
The assay for ce l l g rowth is based on changes in the metabo l ism o f N H D F . The 
importance o f demonstrat ing that ce l l number and absorbance are closely correlated is 
that i t removes the possib i l i ty that absorbance reduct ions are due to metabol ic 
suppression by z. chalybeum(B). 
The good corre la t ion ゲ = 0.97) established enables not on ly single, bu t combined 
extracts to be assessed unambiguously. 
H a d there been no such corre la t ion between the M T S assay and N H D F number, the 
neutral red assay w o ฟ d have been selected fo r use. 
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4.3.4.3 Grow th rate p ro f i l e o f N H D F cul tured i n med ia conta in ing 100 μ§/ιη1 o f 
z. chalybeum bark extract 
The greatest d i f ference between the g row th rates o f cel ls treated w i t h ζ 
chalybeum{B) and contro ls occurred between days 1 and 3, where the rate o f cont ro l 
cells was approx imate ly t feee fo ld that o f the t reatment group. 
The g rowth rate o f extract-treated cel ls cont inued to increase w i t h each subsequent 
t ime po in t and N H D F numbers in the cont ro l group eventual ly began to fa l l (most 
l i ke ly due to deplet ion o f nutr ients as a result o f much larger ce l l numbers) ; 
nevertheless, the early reduct ion o f cel l g row th i n the t reatment group was the ma jo r 
determinant o f the overa l ! d i f ference i n N H D F numbers. 
4.3.4.4 Ef fects o f combinat ions o f z chalybeumÇB) and с. rotundifolia(L) 
Interest ingly, despite thei r ab i l i t y to enhance the g rowth o f N H D F i n bo th 
unsupplemented and supplemented media , c. rotundifolia{L) and c. abbreviata(B) 
demonstrated no effects on the g rowth o f N H D F i n the fibrotic mode l . One reason fo r 
this may be that the amount o f g row th factors already present i n the mode l ( 1 0 % 
FBS+IGF-1) produced a m a x i m u m amount o f g row th w h i c h ftirther add i t ion o f 
mi togens was unable to in f luence. 
W h e n evaluat ing the effects o f combinat ions o f z. chalybeนm{B) and c. 
rotundifoliaQJ), i t must be real ised that due to c. rotund ifolia(L) hav ing no over t 
ef fects, the addi t ive curve was s imp ly the dose response curve fo r z. chalybeum(B). 
W h e n combined w i t h z. chalybeum{B), c. rotundifolia(L) reduced the extent to w h i c h 
cel l g rowth was inh ib i ted ; because the t w o extracts are not compet ing fo r s imi la r 
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growth receptors, a negative in teract ion between them, as opposed to sub-addi t iv i ty , is 
be l ieved to be the phenomenon by w h i c h effects are reduced. 
I t seems ш і і к е ї у that combina t ion w i t h an ant i -pro l i ferat ive herbal extract i n some 
way enabled c. rotundifolia(L) to enhance ce l l g rowth . Th is , i n part , is supported by 
the observat ion that c. abbreviata(B), another g rowth enhancing extract ( i n basal 
med ia and basal med ia I 2 % F B X ) had no ef fect on the per formance o f z. 
chalybeum(B). M o r e l i ke ly is the premise that c. rotundifoli(L), i n proport ions greater 
than 1:1, disrapts the inh ib i to ry act ion o f z. chaiybeum(B) o n g row th receptors. 
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Chapter 5 一 Effects of herbal extracts on N H D F production of PICP 
and K G F 
5.1 E f fec ts o f h e r b a l ex t rac ts on N H D F p r o d u c t i o n o f P I C P a n d K G F 
5.1.1 Summary o f effects 
5.1.1.1 Single herbal extracts 
z. chalybeum(L), when appl ied at a dose range o f 0.001-1000 p g / m l , demonstrated no 
effects on the product ion by N H D F o f PICP and K G F ; increased dosage produced no 
effects up to a dose o f 1100, whereupon tox i c i t y was evident. 
Z chalybeum{ร), when appl ied at a dose range o f 0.001-1000 p g / m l , demonstrated an 
apparent ly inh ib i to ry ef fect on the product ion by ' f i b ro t i c ' N H D F o f PICP and K G F ; 
however , w h e n these effects were indexed to N H D F g rowth , i t was found that there 
were no int r ins ic effects on PICP or K G F product ion. T o x i c i t y was eventual ly 
observed at a dose o f 1600 ц £ / т 1 
С. rotundifolia{L), w h e n appl ied at a dose range o f 0.001-1000 \iįjm\, demonstrated 
an apparent ly enhancing ef fect on the product ion by N H D F o f P ICP and K G F ; 
however , when these effects were indexed to N H D F g rowth , i t was found that there 
were no int r ins ic effects on PICP or K G F product ion. T o x i c i t y was eventual ly 
observed at a dose o f 1100 μ§/Γη1. 
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с. abbreviata(B), when appl ied at a dose range o f 0.001-1000 μ§/ηι1, demonstrated an 
apparent ly enhancing ef fect o n the p roduc t ion by N H D F o f P ICP and K G F ; however , 
when these effects were stat ist ical ly compared to N H D F g rowth , i t was found that 
there were no in t r ins ic effects on PICP or K G F . T o x i c i t y was eventual ly observed at a 
dose o f 1300 цв/т1. 
5.1.1.2 Comb ined herbal extracts 
The ef fect upon N H D F product ion o f PICP and K G F was assessed fo r the f o l l o w i n g 
six paired herbal extract combinat ions: 
Combinat ions o f z. chalybeum{B) I z. chalybeumÇL) conta in ing z. chalybeum{B) 
proport ions o f 5 : 1 , 2 : 1 , 1:1, 1:2 and 1:5 produced no effects. 
A d d i t i o n o f Ζ chalybeumÇS) to с. rotur։difolia(L) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 produced effects w h i c h were apparent ly less than addi t ive when c. 
rotundifoliQJ) was present i n propor t ions greater than 1:1; however, when these 
combina t ion effects were compared stat ist ical ly to the effects o f the same 
comb ina t ion o n growth-re lated ef fects o f the N H D F f ib ro t i c mode l , i t was found that 
there were no s igni f icant di f ferences between the t w o groups. 
A d d i t i o n o f Ζ chalybeum(L) to c. rotundifol։a{L) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 had no ef fect upon b iomolecu le product ion. 
A d d i t i o n o f z. chalybeumÇB) to c. abbreviata(B) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
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and 1:2 had no ef fect upon b iomolecu le product ion. 
A d d i t i o n o f z. chalybeum{V) to c. abbreviata(B) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 had no ef fect upon b iomolecu le product ion. 
Combinat ions o f c. rotundifoliaÇL) I c. abbreviaíaÇB) conta in ing c. rotundifoli{L) 
proport ions o f 5 : 1 , 2 : 1 , 1:1 and 1:2 produced effects w h i c h were apparent ly less than 
addi t ive when c. rotundifoliaĢJ) was present i n proport ions greater than 1:1 and 
super-addit ive when i n proport ions o f 1:1 or less; however , when these combina t ion 
efFects were compared stat ist ical ly to the effects o f the same combina t ion on N H D F 
g rowth , i t was found that there were no s igni f icant di f ferences between the t w o 
groups. 
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Chapter-6 Effects of herbal extracts upon NHDF exposed to oxidants 
6.1 P ro tec t i ve ef fects o f h e r b a l ex t rac ts 
6.1.1 Summary o f results 
6.1.1.1 Single herbal extracts 
z. chaIybeum(B) demonstrated no effects f r o m a dose o f 0.001 p g / m l up t o 800 ц § / т 1 , 
whereupon tox ic i t y was evident. 
z. chalybeumQS), when appl ied at a dose range o f 0.001-1000 μξ/χηΐ, demonstrated no 
protect ive ef fects; increased dosages produced no effects and tox ic i t y was eventual ly 
observed at a dose o f 1600 μg /m l . 
c. rotundifolia(L), w h e n app l ied at a dose range o f 0.001-1000 ц д / т 1 , demonstrated 
no protect ive ef fects; increased dosages produced no effects and tox ic i t y was 
eventual ly observed at a dose o f 1400 μξ/ΐπΐ. 
С. abbreviata(B), w h e n appl ied at a dose range o f 0.001-1000 p g / m l , demonstrated no 
protect ive ef fects; increased dosages produced no effects and tox i c i t y was eventual ly 
observed at a dose o f 1600 μg /m l . 
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6.1.1.2 Comb ined herbal extracts. 
The protect ive ef fect upon N H D F was assessed fo r the f o l l o w i n g six pai red herbal 
extract combinat ions: 
Combinat ions o f z chalybeum(B) I z. chalybeumÇL) conta in ing z. chalybeum{B) 
proport ions o f 5 : 1 , 2 : 1 , 1:1, 1:2 and 1:5 produced no protect ive effects. 
Combinat ions o f z. chalybeum{B) I c. rotundifolia(L) conta in ing z. chalybeum(B) 
proport ions o f 5 : 1 , 2 : 1 , 1:1,1:2 produced no protect ive effects. 
Combinat ions o f z. chalybeumÇL) I c. rotund։folia{L) conta in ing z. chalybeum(B) 
proport ions o f 5 : 1 , 2 : 1 , 1 : 1 , 1:2 produced no protect ive effects. 
Combinat ions o f z. chalybeumÇB) I c. abbreviata(B) conta in ing z chalybeumÇB) 
proport ions o f 5 : 1 , 2 : 1 , 1:1,1:2 produced no protect ive effects. 
Combinat ions o f z chalybeumÇL) I с. abbreviata^) conta in ing z. chalybeumÇB) 
proport ions o f 5 : 1 , 2 : 1 , 1 : 1 , 1 : 2 produced no protect ive effects 
Combinat ions o f c. rotundifolia(L) I c. abbreviata{B) conta in ing c. rotundifolia 
( L ) proport ions o f 5 : 1 , 2 : 1 , 1:1 and 1:2 produced no protect ive effects. 
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6.2 Scaveng ing ef fects o f h e r b a l ex t rac ts 
6.2.1 Summary o f resฟts 
6.2.1.1 Single herbal extracts 
c. abbreviata(B), when appl ied at a dose range o f 0.001 一 1000 μg/m\ produced no 
scavenging ef fects; increased dosages produced no effects and tox i c i t y was eventual ly 
observed at a dose o f 1300 μ£/ηι1 (Append ix 1.3) 
c. rotundifolia(L), when appl ied at a dose range o f 0.1-1000 μ§/ϋύ, demonstrated an 
ox idant scavenging ef fect and tox i c i t y was eventual ly observed at a dose o f 1900 
Hg/ml. 
Ζ chalybeum{V), when appl ied at a dose range o f 1.0 -1000 p g / m l , demonstrated an 
ox idant scavenging ef fect and tox ic i t y was еуепШа І Іу observed at a dose o f 2100 
Ζ. chalybeum{B), when appl ied at a dose range o f 10 -1000 μ§/ ιη1, demonstrated an 
ox idant scavenging ef fect and tox i c i t y was eventual ly observed at a dose o f 2000 
Hg/ml. 
6.2.1.2 Comb ined herbal extracts 
A d d i t i o n o f non-scavenging c. abbreviata{B) to c. rotundifoliaQS), z. chalybeum(L) 
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and Z. chalybeum(B) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 and 1:2 d i d not af fect the ox idant 
scavenging ab i l i t y o f the latter three herbal extracts. 
A d d i t i o n o f z. chalybeum(B) to c. rotundifolia(L) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 produced pure ly addi t ive effects. 
A d d i t i o n o f z. chalybeumQS) to c. rotundifoliaÇL) i n proport ions o f 5 : 1 , 2 : 1 , 1:1 
and 1:2 produced effects w h i c h were addi t ive and greater than addi t ive. 
Combinat ions o f z chalybeum{B) I z. chalybeum(L) conta in ing z. chalybeum(B) 
proport ions o f 5 :1 ,2 :1 ,1 :1 and 1:2 produced effects w h i c h were sub-addit ive. 
6.2.3 Dose response relat ionships for c. rotundifolia l ea f extract, z chalybeum bark 
extract and z chalybeum l ea f extract. 
For c. rotundifolia, stat ist ical ly s igni f icant ef fects, up to a m a x i m u m , were observed 
over the dose range 0.1-30цв/т1 (p<0.001; F(12, 117)= 1945.5). 
For Z chalybeum bark extract, stat ist ical ly s ign i f icant ef fects, up to a m a x i m u m , were 
observed over the dose range 10-70μ§/ηι1 ( p < 0 . 0 0 1 ; F ( 1 3 , 1 2 6 ) = 1329.3). 
For Ζ chalybeum l ea f extract, stat ist ical ly s ign i f icant effects were observed over the 
dose range 1.0-40цв/т1 ( p < 0 . 0 0 1 ; F ( l 1,108) = 1149.4 
Percentage N H D F protect ion above contro ls , p lo t ted on a logar i thmic scale, is shown 
in Figure 6.1a. I n the case o f c. rotundifolia(L), there was an in i t ia l l inear dose 
response re lat ionship fo r the first four dose appl icat ions; at subsequent dose 
appl icat ions, up to the m a x i m u m , effects deviate from l inear behaviour. Th is was not 
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the case for z. chalybeum{B), w h i c h , upon mani fes t ing an ef fect , ехШЬіЇ8 l inear 
behaviour up to the m a x i m u m . I n the case o f z. chalybeumÇL), there is a re lat ive ly 
smal ler rise i n effects between the appl icat ion o f the f i rs t and second dose, after w h i c h 
l inear i ty is exh ib i ted up to the m a x i m u m . 
General ly, a l l էԽշշ herbal extracts exh ib i t c o m m o n behaviour i n that, upon produc ing 
a part icular m a x i m u m ef fect , fur ther increases i n dosage produce only sub-max imal 
effects w h i c h decrease steadi ly; i n part icular, upon add i t ion o f the m a x i m u m dose 
(1000 gg /m l ) , Z chalybeum(L) and z. chalybeum(B) bo th produce effects s imi la r to 
their in i t ia l e f fect (Figure 6.1a). 
c. rotundifolia(L) is the more potent herbal extract and also attains a higher m a x i m u m 
ef fect (53 .74%) than either o f the other herbal extracts; add i t iona l ly the decrease i n 
effects once the m a x i m u m has been attained is less pronounced when compared w i t h 
the other extracts. 
Z chalybeumÇL) is more potent than z. сЫ1уЬеит^В), up to the m a x i m u m ef fect ; the 
m a x i m u m for bo th are comparable (47.65 and 4 5 . 3 8 % respect ively) and the eventual 
decrease i n effects is very s imi la r for bo th these herbal extracts. 
The ascending por t ion o f the dose response curves were also p lo t ted on a l inear dose 
scale and f i t ted to hyperbol ic models w h i c h are b r ie f l y described be low. These plots 
are shown i n Figure 6. l b . 
For c. rotundifoliaÇL), the value o f E m a x (60 .3%) compares favourably w i t h the 
actual m a x i m u m ef fect (53 .74%) and the EC50 (3.3 μg /m l ) appears to be a reasonable 
approx imat ion for the dose w h i c h results i n h a l f the actual m a x i m u m 
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а/ 
b/ 
p 
I 
8 
ш 
Զ I 
շ 
I 
1.5 2.0 2.5 3.0 
Logio herbal extract dose 
20 30 40 50 60 70 
Herbal extract dose (ทาicrogrammeร/ทาI) 
F i g u r e 6.1 Dose response relat ionships fo r c. rotundifolia l ea f extract (b lack curves), 
Z chalybeum lea f extract (b lue curves), z chalybeum bark extract ( red curves). 
a/ effects versus dose p lot ted on a logar i thmic scale. 
Ы ef fects versus dose (up to m a x i m u m ef fect ) p lo t ted on a l inear scale and fitted to 
hyperbol ic mode l . 
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For Z chalybeum ( L ) , the compar ison o f E m a x (57.0) w i t h the actual value (47 .65%) 
is less favourable; however , the EC50 (11.3μ§/πι1) appears to be a reasonable approx­
ima t ion o f the dose resul t ing i n ha l f the actual m a x i m u m . 
For z. сШІуЬеит ( В ) , the actual m a x i m u m ef fect (45 .38%) does not approx imate 
w e l l to the curve f i t t i ng parameter E m a x (87.1%) and the EC50 (53.2 μ§/ηι1) appears 
to be more than double that w h i c h produces h a l f the actual m a x i m u m . 
6.2.4 Ef fec ts due to paired combinat ions o f c. rotundifoliaÇL), ζ. chalybeum(B) 
and z. chalybeum(L) 
6.2.4.1 c. rotmd։folia(L) and ζ chalybeum(ร)) 
Figure 6.2a shows the ef fect o f adding 10 уเįjm\ o f z. chalybeum{B) to 2 , 5, 10 and 20 
pg /m l o f c. roiundifolia{L). A t a l l propor t ions o f z. chalybeum{B), there were no 
di f ferences i n addi t ive and combina t ion behaviour ; effects increased smooth ly w i t h 
doses o f bo th extracts. 
The add i t ion o f 20 μξ/ηύ o f z. chalybeum(B) to 4 , 10, 20 and 40 pg /m l o f c. 
rotundifolia(L) is shown i n Figure 6.2b. There was no d i f ference, between addi t ive 
and combina t ion behaviour ; however , i n contrast to Figure 6.2a, a m a x i m u m is 
produced at a 1:2 p ropor t ion o f z. chalybeum(B) and remains unchanged as z. 
chalybeumÇB) is added to larger amounts o f c. rotundifolia(Ľ). 
The behaviour shown i n Figure 6.2a cont inued un t i l the add i t ion o f a dose o f 70 μ§/ηι1 
o f Ζ. chalybeumÇB) to 14, 35 , 70 and 140 pg /m l o f c. rotundifoliaQ-), w h i c h is shown 
i n Figure 6.3a. Ef fec ts began to decl ine at z. chalybeum{B) proport ions o f 1:1 and 1:2 
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а/ 
b/ 
10 20 
Dose of С. rotundifolia leaf extract เท combin (microgrammes/ml) 
ซ 50 
У 40 
Dose of С. rotundifolia leaf extract in combination (กาicrogrammeร/ml) 
F i g u r e 6.2 A d d i t i v e behaviour (b lack curve) compared w i t h comb ina t ion behaviour 
(red curve) fo r z. chalybeum bark extract I c. rotundifolia lea f extract combina t ion , 
a/ A d d i t i v e and combina t ion behaviour when a dose o f 10 pg /m l o f z. chalybeum 
bark extract is added to the ind icated doses o f c. rotundifolia l ea f extract. 
Ы Add i t i ve and combina t ion behaviour when a dose o f 20 pg /m l o f z. chalybeum 
bark extract is added to the ind icated doses o f c. rotundifolia l ea f extract 
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а/ 
b/ 
I 
8 
I 
I 
Dose of c. rotนกdifolia leaf extract in combination (microgrammeร/ml) 
Dose of c. rotundifolia leaf extract in combination (microgrammeร/ml) 
F i g u r e 6.3 Add i t i ve behaviour (b lack curve) compared w i t h combina t ion behaviour 
(red curve) for X . chalybeum bark extract / c. rotundifolia lea f extract combina t ion , 
a/ A d d i t i v e and combina t ion behaviour when a dose o f 70 \ i į j m \ o f z. chalybeum 
bark extract is added to the indicated doses o f c. rotundifolia lea f extract 
b/ Add i t i ve and combina t ion behaviour w hen a dose o f 1000 μg /ml o f z chalybeum 
bark extract is added to the indicated doses o f c. rotundifolia lea f extract. 
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I n these combinat ions, there was no d i f ference between addi t ive and combina t ion 
behaviour at any re lat ive herbal extract propor t ion. 
D i f f e ren t behaviour was evidenced at addi t ions o f 100, 200, 300, 400, 600 and 800 
and 1000 μ§/ηι1 o f ζ chalybeumÇB), the latter o f w h i c h is shown i n figure 6.3b. U p o n 
at ta in ing a m a x i m u m ef fect at a z. chalybeum(B) p ropor t ion o f 5 : 1 , add i t ion o f X . 
chalybeumÇB) to larger amounts o f с rotundifoliaÇL} resulted i n a steady decl ine i n 
effects. There were no di f ferences between addi t ive and combina t ion behaviour fo r 
any o f the proport ions for this combinat ion . 
The at tainment o f the greatest m a x i m u m ef fect (100 .63% protect ion) corresponds to 
the add i t ion o f 60 μ§ /η ι Ι o f ζ chalybeum(B) to 30 μ§/ιη1 с. rotundifo¡ia(L). 
6.2.2 С. rotundifolia l ea f extract and ζ chalybeum lea f extract 
Compar ison plots fo r addi t ive and combina t ion effects. 
F igure 6.4a shows the add i t ion o f 10 μ§/ηι1 o f ζ chalybeum(L) extract to 2 , 5, 10 and 
20 pg /ml o f c. rotundifolia{L). There was no d i f ference between addi t ive and 
combina t ion behaviour un t i l the propor t ion o f ζ chalybeum{L) was reduced to 1:1, at 
w h i c h po in t the ef fects o f combinat ions exceeded addi t ive ef fects ( t = 22.7, p<0 .001) ; 
the divergence o f the curves increased when the propor t ion was fur ther reduced to 1:2 
( t = 20 .7 ,p<0 .001) . 
Th is behaviour was also evidenced due to the add i t ion o f 20 and 30 ц £ / т 1 ζ. 
chalybeumQS) i n s imi la r fixed proport ions to above (data not shown). 
A n add i t ion o f 40 p g / m l , t o c. rotundifolia{V) doses o f 8， 20. 40 and 80 p g / m l is 
shown i n F igure 6.4b. There was no d i f ference between addi t ive and combina t ion 
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а/ 
b/ 
Dose of С. rotundifolia leaf extract (microgrammes/ml) 
Dose ๙ c. rotundifol๒ leaf extract (microgrammeร/ทาI) 
F i g u r e 6.4 Add i t i ve behaviour (b lack curve) compared w i t h comb ina t ion behaviour 
( red curve) for z. chalybeum l ea f extract I c. rotundifolia l ea f extract combinat ion , 
a / A d d i t i v e and combina t ion behaviour when a dose o f 10 ц £ / т 1 o f z. chalybeum 
l ea f extract is added to the ind icated doses o f c. rotundifolia lea f extract, 
b/ Add i t i ve and combina t ion behaviour when a dose o f 40 μ§/ηι1 o f ζ. chalybeum 
l ea f extract is added to the indicated doses o f c. rotundifolia l ea f extract. 
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behaviour un t i l the propor t ion o f z. chalybeumÇu) was reduced to 1:1 and 1:2, at 
w h i c h po in t the effects o f combinat ions exceeded addi t ive ef fects ( t = 24.5 , p<0.001) 
and ( t = 73.8, p<0.001) respectively. I n the case o f addi t ive ef fects, at a z. 
chalybeum(L) p ropor t ion o f 2 : 1 , the effects reach a m a x i m u m ; subsequently, effects 
began to decl ine as the p ropor t ion o f z cholybeum(L) lessened. Th is was not the case 
for comb ina t ion behaviour, where at a z. chalybeum(L) p ropor t ion o f 1:1, effects 
reached a m a x i m u m w h i c h was main ta ined at the lesser p ropor t ion o f 1:2. Thus, when 
the p ropor t ion o f z. chalybeumÇL) decreased f r o m 1:1 to 1:2, there were di f ferences i n 
terms o f bo th the magni tude o f effects and the d i rec t ion i n w h i c h effects var ied w i t h 
dose fo r addi t ive and combina t ion behaviour. 
A n add i t ion o f 100 μg/m\ of z. chalybeumÇL) to 20 , 50, 100 and 200 μ§/ηι1 o f c. 
rotundifoltaÇL) is shown i n Figure 6.5a. D i f fe rence between addi t ive and combina t ion 
behav iour on ly became s ign i f icant when the p ropor t ion o f z. chalybeum{L) was 
reduced to 1:1 and 1:2 ( t = 24.5 , p<0.001) and ( t = 73.8, p<0.001) respect ively. The 
addi t ive curve reached a m a x i m u m at a ζ chalybeumÇL) p ropor t ion o f 5:1 and as the 
propor t ion decreased to 2 : 1 , the addi t ive and combina t ion behaviour was ident ica l . 
Be tween z. chalybeum(L) propor t ions o f 2:1 and 1:1, the comb ina t ion effects aitered 
d i rec t ion and increased to a level w h i c h dec l ined s l ight ly when the propor t ion was 
finally reduced to 1:2. i n contrast, the addi t ive curve cont inued to decrease i n a l inear 
fashion as z. chalybeumÇL) proport ions were reduced to 1:2. Th is t rend also resulted 
f r o m the add i t ion o f 200 and 400 μg /m l o f z. chalybeum{L) i n s imi lar fixed 
proport ions (data not shown). 
Commenc ing at an add i t ion o f 600 μ§/ηι1 o f z. chalybeumÇL), d i f ferences between 
combina t ion and addi t ive behaviour became less pronounced, a t rend w h i c h increased 
upon add i t ion o f 800 μ§/ηι1 (data not shown). 
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а/ 
Dose of С. rotundifolia leaf extract in combination (microgrammeร/ทาI) 
I I 50 
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Dose of с. rotundifolia in combination (microgrammes/ml) 
F i g u r e 6.5 A d d i t i v e behaviour (b lack curve) compared w i t h combina t ion behaviour 
(red curve) fo r Z chalybeum l ea f extract I c. rotundifolia l ea f extract comb ina t ion 
a/ A d d i t i v e and combina t ion behaviour when a dose o f 100 μ§/ηι1 o f z. chalybeum 
l ea f extract is added to the indicated doses o f c. rotundifolia lea f extract 
b/ Add i t i ve and combina t ion behaviour when a dose o f 1000 μ§/πι1 o f ζ chalybeum 
bark extract is added to the indicated doses o f c. rotundifolia l ea f extract. 
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The case o f an 1000 μg /m l add i t ion to 200, 500, and 1000 μξ/πύ of ζ. chalybeumÇu) 
is shown i n F igure 6.5b, where addi t ive and comb ina t ion behav iour was ident ical 
between z. chalybeumih) proport ions o f 5:1 and 2 : 1 ; as the propor t ion is reduced to 
1:1 and 1:2 there was a s l ight upward divergence o f comb ina t ion behaviour f r o m 
addi t ive behaviour ( t = 4.9, p<0.001) . 
The highest m a x i m u m va lue(114.6% N H D F protect ion above controls) was attained 
when 30 μg /m l o f z. chalybeum{L) was added to 30 pg /m l o f c. rotundifolia{V). 
6,2.3 z. chalybeum l ea f extract and z. chalybeum ba rk extract 
A n add i t ion o f 20 pg /m l o f z. chalybeumÇB) t o 4 , 10, 20 and 40 pg /m l z. 
chalybeumÇL) is depicted i n F igure 6.6a. A t a l l proport ions o f z. chalybeumÇB), 5 : 1 , 
2 : 1 , 1:1 and 1:2, the ef fects produced by the combinat ions were less than addi t ive ( t = 
21.4， p<0.001) , ( t = 20.2, p<0.001) , ( t = 18.0, p<0.001) and ( t = 12.4, p<0.001) 
respectively. Th i s was most pronounced at a z. chalybeumÇB) p ropor t ion o f 2 : 1 ; as 
the propor t ion was reduced to 1:1 and 1:2, there appeared to be a constant d i f ference 
between addi t ive and comb ina t ion effects. 
W h e n 30 pg /m l o f z. chalybeum(B) are added to 6, 15, 30 and 60 30 μg/ml o f ζ 
chalybeumÇu), shown i n F igure 6.6b, comb ina t ion ef fects were again less than 
addi t ive for a l l z. chalybeumÇB) proport ions o f 5 : 1 , 2 : 1 , 1:1 and 1:2 ( t = 18.8, 
p<0.001) , ( t = 22.6, p<0.001) , ( t = 19.7, p<0.001) and ( t = 7.0, p<0.001) respect ively 
B o t h curves rise steadi ly and at ta in m a x i m u m effects at a z. chalybeumÇB) p ropor t ion 
o f 1:1. F r o m this po in t , a s l ight dec l ine i n addi t ive ef fects coup led w i t h a steady 
increase i n comb ina t ion effects resฟts i n approx imate ly addi t ive behaviour by the 
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а/ 
b/ 
10 20 зо 41 
Dose of Z. chalybeum leaf extract (microgrammeร/ml) 
Dose of z. chalybeum leaf extract (microgrammes/ml) 
F i g u r e 6.6 Add i t i ve behaviour (b lack curve) compared w i t h combina t ion behaviour 
( red curve) for Z chalybeum bark extract I z. chalybeum lea f extract 
a / Compar ison o f addi t ive and combina t ion behaviour when a dose o f 20 ц § / т 1 o f X . 
chalybeum bark extract is added to the ind icated doses o f z. chalybeum l ea f extract, 
b/ Compar ison o f addi t ive and combina t ion behaviour when a dose o f 30 μ§/ηι1 o f X . 
chalybeum bark extract is added to the indicated doses o f z chalybeum l ea f extract. 
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comb ina t ion at a z. chalybeum{B) p ropor t ion o f 1:2. 
The add i t ion o f 40 , 50 and 60 pg /m l o f z. chalybeum(B) resulted i n a c o m m o n t rend 
and Figure 6.7a depicts the results o f add ing 60 μ§/ιη1 o f ζ chalybeum(B) to 12, 30, 
60 and 120 pg /m l o f z. chalybeumQS). A l l z. chalybeum(B) proport ions , 5 : 1 , 2 : 1 , 
1:1 and 1:2 resulted i n less than addi t ive effects ( t = , p<0.001) , ( t = , p<0.001) , ( t = , 
pKO.OOl) and (t =% pKO.OOl) respectively. B o t h curves attained a m a x i m u m at a z. 
chalybeumÇB) p ropor t ion o f 1:1; af ter this po in t , addi t ive effects began to decrease 
whereas combina t ion effects remained constant un t i l the propor t ion was decreased to 
1:2, at w h i c h po in t they also began to decl ine. 
Th is t rend cont inued upon addi t ion o f 70, 100 and 200 μ§/ηι1 o f z. chalybeum{B) i n 
s imi la r fixed mass ratios (data not shown). 
The add i t ion o f 400, 600 and 1000 μ^/πύ o f z. chalybeum(B) to z. chalybeum(L) i n 
s imi la r fixed mass ratios also resulted i n a c o m m o n t rend and the add i t ion o f the latter 
moun t is shown i n Figure 6.9b. A l l z. сЫ1уЬеит{Ъ) proport ions , 5 : 1 , 2:1 and 1:1 
resulted i n less than addi t ive effects ( t = 19.5, fXO.OOl) , ( t = 28.6, p<0.001) and ( t = 
18.0, p<0.001) respectively. 
B o t h the addi t ive and combina t ion curves attained a m a x i m u m at a z. chalybeum(B) 
propor t ion o f 5:1 after w h i c h po in t there is a steady decl ine i n effects for bo th types 
o f behaviour. 
The highest m a x i m u m va lue(67 .14% N H D F protect ion above contro ls) was attained 
when 40 pg /m l o f z. chalybeumÇB) was added to 40 μ§/ιη1 o f z. chalybeumÇL). 
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а/ 
b/ 
Dose of Z. chalybeum leaf extract (microgrammeร/ml) 
Dose of ՜Լ. chalybeum leaf extract (microgrammeร/ml) 
F i g u r e 6.9 Add i t i ve behaviour (b lack curve) compared w i t h combina t ion behaviour 
(red curve) for z. chalybeum bark extract I z. chalybeum lea f extract 
a/ A d d i t i v e and comb ina t ion behaviour when a dose o f 60 pg /m l o f z chalybeum 
bark extract is added to the indicated doses o f z. chalybeum l ea f extract. 
b/ Add i t i ve and comb ina t ion behaviour when a dose o f 1000 μ§/ηι1 o f z. chalybeum 
bark extract is added to the ind icated doses o f z. chalybeum l ea f extract. 
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6.3 Discuss ion 
6.3.1 Ind iv idua l dose response relat ionships for c. rotundifoliaih), z. chalybeum(B) 
and z. chalybeum{B) 
Str ic t ly speaking, the ab i l i ty o f drugs to 'scavenge' free radicals is not a phys io log ica l 
effect. A n y act ion o n the free radicals by the herbal extract components takes place 
extracel lu lar ly and is a pure ly chemica l phenomenon. However , the scavenging ab i l i t y 
o f herbal extracts is o f ten dependent on the b ind ing o f components to speci f ic sites on 
the free radical mo lecu le p r i o r to a chemica l react ion between t hem; th is s i tuat ion is 
analogous to drug-receptor b ind ing and the use o f a s imi la r means o f v isual 
representat ion is therefore appropriate. 
General ly , a l l three herbal extracts exh ib i ted c o m m o n behaviour i n that, upon 
p roduc ing a par t icu lar m a x i m u m ef fect , fur ther increases i n dosage produce on ly sub-
max ima l effects w h i c h decrease steadily (Figure 6.1a). Th is behaviour deviates f r o m 
classic pharmacolog ica l behaviour , where, as ef fects approach a m a x i m u m leve l , 
ftuther increases i n dosage produce negl ig ib le changes i n ef fect. One explanat ion fo r 
th is d i f ference is the fact that herbal drugs conta in several components w h i c h may , i n 
suf f ic ient quant i t ies, displace bound act ive ingredients f r o m receptors or, i n th is 
par t icu lar case, free radicals. 
I n the case o f z. chalybeumÇL) and z. chalybeum(ร), the m a x i m u m effects fo r bo th 
were comparable (47.65 and 4 5 . 3 8 % respect ively) and the decrease i n effects after 
at taiment o f the m a x i m u m fo l l owed a very s imi la r p ro f i l e for bo th these herbal 
extracts. These observations suggest that z. chalybeumQu) and z. chalybeum{B) may 
possibly exert the i r scavenging effects by s imi la r mechanisms. 
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I n contrast to С rotund։fol։a{L) and z chalybeum{B), fo r X . chalybeum(B), the actual 
m a x i m u m ef fect (45 .38%) does not approx imate w e l l to the curve f i t t i ng parameter 
(87 .1%) and the EC50 (53.2 μg /m l ) appears to be more than double that w h i c h 
produces h a l f the actual m a x i m u m (Figure 6.1b). The reason for th is discrepancy is 
that, i n the case o f z. chalybeum(ß) i n part icular, the data is treated as be ing a por t ion 
o f a larger curve and the h igher values o f E m a x and E C 5 0 are the result o f 
іп Їефо Іа Ї іоп. 
Nevertheless, i n a l l three cases, up to the m a x i m u m ef fect , the hyperboł ic models are 
good mathemat ica l descript ions o f the relat ionship between effects and dose. 
6.3.2 Ef fects o f pai red combinat ions o f herbal extracts. 
6.3.2.1 С rotundifoliaÇL) and z. chalybeum(B) 
Overa l l , there was no dev ia t ion f r o m addi t ive behaviour when the effects o f 
combinat ions o f these herbal extracts were compared w i t h theoret ical addi t ive ef fects; 
th is was the case when effects were increasing and dec l in ing (Figures 6.2 and 6.3) and 
suggests that the mechanisms o f free radical scavenging fo r c. rotundifoliaQJ) and z. 
chalybeum(B) are independent. E f fec ts produced by the herbal extracts are consistent 
w i t h the i r i nd iv idua l dose response curves and i t w o u l d appear that there was no 
restr ic t ion or interference between the act ive ingredient(ร) o f each. 
6.3.2.2 c. rotundifolia(L) and z. chalybeumÇL) 
General ly , when the propor t ion o f c. rotundifolia(L) is greater than or equal to 1:1, i t 
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appears that there is in teract ion between the t w o herbal extracts, resul t ing i n 
combina t ion behaviour w h i c h is greater than addi t ive. 
Cons ider ing the proport ions i n w h i c h the herbal extracts were comb ined , 1 ： 1 appears 
t o be the c r i t i ca l p ropor t ion at w h i c h an in teract ion becomes manifest. 
The existence o f addi t ive behaviour at proport ions less than 1:1 suggests that the 
herbal extracts scavenge free radicals v i a independent mechanisms un t i l the po in t at 
w h i c h c. rotundifolia(L) is present i n su f f ic ient quanti t ies to in i t ia te an interact ion. 
6.3.2.3 z. chalybeum(B) and z. chalybeum(L) 
Overa l l , the add i t ion o f z. chalybeum(B) to z. chalybeum i n any p ropor t ion 
consistently resulted i n combinat ions w h i c h produced less than addi t ive effects. There 
are t w o possible reasons for th is. 
1. The t w o herbal extracts may exert the i r scavenging effects by the same mechan ism, 
b ind ing to a s imi la r site on the free rad ica l ; i n this case, the herbal extracts compete 
for the b ind ing site and the act ive ingredient w i t h the more compat ib le structure i s 
preferent ia l ly bound. I n such a scenario, the less compat ib le herbal extract w i l l 
produce an in fer ior ef fect i n compar ison to when i t is appl ied alone. 
2. The t w o herbal extracts may or may not act on the same receptor bu t nevertheless 
interact o r in f luence one another i n a way w h i c h disrapts the scavenging act iv i ty o f 
one or bo th o f them (antagonism). G iven the mul t i tude o f components present in 
herbal extracts, i t is possible that such interference may be between components 
other than the act ive ingredients. 
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Chapter 7 一 General discussion and further work 
7.1 G e n e r a l d iscussion 
On ly i n one case were effects mani fest at a dose w h i c h was less than 1 μ§/ίΐύ (the free 
radical scavenging effects o f c. rotundifolia(L) became apparent at 0.1 μg /m l ) . 
Herba l extracts conta in a my r i ad o f chemica l components and, un l i ke the case o f 
pharmaceut icals based on single chemica l ent i t ies, there may be more than one act ive 
ingredient present; extending such rat ionale, the effects o f a g iven herbal drug may 
actual ly represent the resultant effects o f interact ions between the components and 
said in teract ion may on ly mani fest at a par t icu lar overa l l dose. 
W i t h the except ion o f the ant i -pro l i ferat ive effects o f z. chalybeum(B), a l l e f fec t ive 
herbal extracts f o l l o w e d the t rend o f a t ta in ing a m a x i m u m ef fect p r io r to a steady 
decl ine i n effects when the dose was ftirther increased. I t has been proposed that th is 
is due to displacement o f act ive ingredients f r o m receptors and is probably related to 
the l i ke l i hood o f physical in teract ion (due, i n tu rn , to the abundance o f chemica l 
components i n any herbal extract) . Previous w o r k o n w o u n d heal ing herbal medic ines 
also evidenced this decl ine i n post m a x i m a l e f fect bu t a reason was not proposed.^''"** 
A n ind ica t ion was g iven as to the d i f fe rent dynamics o f herbal extracts as they are 
in t roduced in to d i f f e r i ng w o u n d environments. I n the case o f c. rotmdifolia{L) and 
c. abbreviata(B), app l ied i n basal media , the aforement ioned decl ine i n post m a x i m a l 
ef fects was more pronounced i n the case o f the latter herb ; appl icat ion o f extracts i n 
basal med ia 12% FBS produced the opposite result. 
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A l t hough a causal re lat ionship may be c la imed between the app l ica t ion o f c. 
rotundifoIia(L), c. abbreviata{B) and z chalybeum{B) and al tered produc t ion o f 
PICP and K G F , i t is impor tant to establish whether effects are int r ins ic or g row th 
related; referencing apparent effects to g row th effects removes the possib i l i ty o f 
resources be ing designated to fur ther w o r k based on an ambiguous or false 
conclusion. 
Regard ing ant i -ox idant propert ies, i n N H D F , the hydroxy l radical is be l ieved to exert 
cy to tox ic effects by ox ida t ion o f proteins and D N A . ' * ' ' ' 
The herbal extracts, ei ther s ingly or i n comb ina t ion , when incubated w i t h cel ls pr ior 
to exposure to ox idants, were unable to a f fo rd pro tec t ion to N H D F ; this may ref lect 
either an inab i l i t y to interact i n any way w i t h sensit ive b iomolecules and I or 
organelles, or more fundamenta l ly , herbal extracts may be unable to prevent oxidants 
ftom permeat ing the ce l l membrane. 
F rom a b io-prospect ing perspective, the ph i losophy beh ind the general approach o f 
this study is emphat ica l ly targeted screening, whereby herbal medic ines are examined 
i n the context o f a speci f ic purported ef fect i n man. 
Str ic t ly speaking, the ce l l culture-based screening o f herbal medicines for the possible 
development o f new drags is an expedient, rud imentary procedure and w o u l d not 
inc lude herbal combinat ions ; indeed, none o f the herbal medic ines discussed i n the 
current w o r k are used i n comb ina t ion 
Th is w o r k has invest igated combina t ion behav iour (as compared to a theoret ical 
addi t ive mode l ) fo r the f o l l o w i n g reasons: 
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1 . For a g iven w o i m d heal ing ef fect , either i n the event o f one ef fect ive and one inert 
d rug or t w o inert drugs, thei r comb ina t ion presents the potent ia l to create an ent i re ly 
new pharmacolog ica l species 
2. Combinat ions consol idate the study o f e f fect ive single herbal extracts as a means 
o f assessing advantages due to combinat ion and ga in ing an ins ight in to mechanism. 
On l y one publ ished study exists per ta in ing to the invest igat ion o f interact ions between 
herbal medic ines; a l though, the study d i d not invo lve w o u n d heal ing, i t is fe l t that a 
b r i e f discussion o f methodo logy is o f mer i t . The ef fects o n cu l tu red PC 3 human 
prostate cancer cel ls o f PC SPES (an e ight-component herbal product marketed fo r 
the treatment o f prostate cancer) was invest igated; the manufacณrers o f PC SPES 
c la imed that synergy existed between the herbal components. The M T T assay was 
used to establish the relat ive cy to tox ic i ty o f added herbs and paired combinat ions, 
expressed i n the f o r m o f l inear dose response curves. 
The most cy to tox ic extract, Panax notoginseng, was deemed antagonist ic to the other 
seven herbal extracts, a l though no attempt was made to d is t ingmsh between 
antagonism and sub-addi t iv i ty . The authors conc luded that the methodology fo r the 
assessment o f pharmaceut ica l combinat ions may be app l ied to herbal combinat ions. 
F rom a pure ly pharmacolog ica l perspective, the use o f l inear dose response curves to 
determine interact ions is not in fer ior to the method emp loyed i n th is wo rk ; the 
m a x i m u m ef fect and hence op t ima l relat ive herbal extract doses may be determined i n 
either case. However , i t is fe l t that greater ins ight was gained f r o m a considerat ion o f 
a l l the data, i n terms o f trends and the extent to w h i c h increments altered addi t ive and 
combina t ion behaviour. 
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I n the case o f herbal extract combinat ions w h i c h af fected g rowth and ant iox idant 
propert ies,there were instances when either the combina t ion curve was ascending as 
addi t ive effects decl ined or v ice versa; such instances give a greater ind ica t ion o f the 
extent to w h i c h combina t ion and addi t ive behaviour d iverge, a perspective w h i c h 
w o u l d be lost were on ly the l inear port ions o f the dose response curves considered. 
W h e n effects are sub-max imal , superior effects o f combinat ions can be expla ined i n 
terms o f an interact ion p roduc ing a greater than addi t ive ef fect ; however, super-
add i t i v i t y i n the case o f dec l in ing effects is less easily accounted for. Clear ly , the 
combina t ion o f the herbal extracts reduced the extent to w h i c h post m a x i m a l effects 
decl ine. 
T w o reasons are proposed for th is : 
1 . There may be components i n the comb ined herbal extract inh ib i to ry t o the act ion 
o f species w h i c h displace agonists from receptors. 
2. The herbal extracts may contr ibute components w h i c h u l t imate ly combine to 
compr ise a complete ly new act ive ingredient w h i c h acts on a d i f fe rent receptor. 
W i t h o u t a detai led analysis o f receptors, and indeed, knowledge o f the nature o f the 
composi te components o f the herbal extracts, i t is general ly impossib le t o o f fe r more 
than speculat ion when discussing the nature o f receptor-agonist dynamics. However , 
t o some degree the addi t ive mode l is able to prov ide the basis f o r emphat ic 
determinat ions. For example, in the case o f the scavenging effects o f c. 
rotundifolia(L) I X . chalybeum(B) combinat ions, the observat ion that effects were not 
stat ist ical ly d i f fe rent f r o m the addi t ive mode l was strongly suggestive o f the extracts 
exer t ing thei r scavenging effects by independent means. 
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Interest ingly, i n cases where the behaviour o f combinat ions was both super-addit ive 
and less than addi t ive, super-addi t iv i ty was mani fest when the more potent ind iv idua l 
extract was present i n a propor t ion o f at least 1:1; thus, i n these cases, the propor t ion 
o f the more potent herbal drag determined the extent o f super-addi t iv i ty. 
I n the case o f c. rotundifolia(V) and c. abbreviata{B), the presence o f 2 % FBS 
comple te ly al tered the relat ive behaviour o f dose response prof i les o f herbal 
interact ion. W h e n extracts were appl ied i n basal media on ly , effects o f combinat ions 
were less than addi t ive when c. abbreviata{B) was present i n proport ions less than 
1:1; on the other hand, combinat ions appl ied i n supplemented med ia were super-
addi t ive at a l l c. abbreviataÇB) proport ions. The imp l i ca t i on is that 2 % FBS (a 
real ist ic representat ion o f the chronic w o u n d m i l i eu ) w o u l d be a favourable 
env i ronment i n w h i c h to introduce combinat ions o f these herbs. 
General ly , the s i tuat ion whereby t w o non-ef fec t ive herbal extracts are comb ined to 
produce effects was not evident i n any o f the invest igat ions; i t can on ly be conc luded 
that there were no physical or chemica l interact ions w h i c h produced a requi red 
agonist or antagonist to the corresponding receptor. 
The รณdy o f herbal extract combinat ions is fa i r l y s t ra ight forward on a ce l l cul ture 
basis, due to the fact that cel ls are phenotyp ica l ly ident ica l and large quanti t ies may 
be used w i t h good reproduc ib i l i ty . Such an under tak ing w o u l d present a serious 
chal lenge i f at tempted i n human studies. Sample numbers w o u l d be d i f f i cu l t to 
reproduce and the construct ion o f addi t ive curves w o u l d present prob lems due to the 
fact that there is greater var ia t ion between t w o human subjects than there is between 
t w o ident ica l fibroblasts. The behaviour o f one herbal extract i n a group o f subjects 
may d i f f e r s ign i f icant ly f r o m those o f another; hence, the summat ion o f the effects o f 
t w o d i f fe rent drugs may not have the same pharmacolog ica l or statist ical va l id i t y as 
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fo r the case o f d i f ferent groups o f cel ls. 
For these reasons, i t may be the case that ce l l cu l tore based studies o f d rug 
combinat ions are the on ly pract ical ind ica t ion o f the e f f i cacy o f drag combinat ions. 
7.2 F u r t h e r w o r k 
Each herbal extract exh ib i ted at least one ef fect on the w o u n d heal ing parameters 
considered and the results presented i n th is w o r k are a p la t fo rm for the fur ther study 
o f a l l the herbal extracts. 
A l t h o u g h N H D F have been shown to be cruc ia l to the onset o f w o u n d heal ing 
disorders, i t w o u l d be remiss not to t u rn at tent ion to the other ma in reparat ive cel ls, 
namely endothel ia l cel ls and kerat inocytes. 
b is ight w o u l d be gained f r o m the appl icat ion o f the extracts to more comp lex dermal 
and ep idermal models , used for the assessment o f d n i g effects on s imulated wounds; 
notable examples are dermal equivalents such as co l lagen gels to determine the effects 
o f drags on fibroblast contract ion and kerat inocyte monolayers fo r the s imu la t ion o f 
wounded epidermis and assessment o f the extent o f re-epidermal isat ion. 
T o a lesser extent, the use o f who le sk in organ cul ture has been used for the 
invest igat ion o f the in f luence o f drugs on several reparat ive cel ls s imultaneously, 
knowledge o f tox ic i ty . Th is may be extended i n human studies b y the analysis o f 
tissue samples (biopsies) and the al tered g row th o f the i r const i tuent cel ls due to the 
act ion o f a par t icu lar drug; such samples may be taken on a regular basis and hence 
prov ide a t ime course fo r par t icu lar in vivo ce l lu lar effects. 
The study o f w o u n d contract ion may also be extended to human studies; the reduct ion 
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o f w o u n d area is a c o m m o n means o f gauging the e f f icacy o f choigs and has been used 
in the c l in ica l study o f Chromolaena odorata. 
The study o f herbal extracts i n animals is not fe l t to be appropr iate, as the very nature 
o f such study involves the i n f l i c t i on o f wounds upon subjects. 
Overa l l , w i t h regard to a suitable paradigm for the comprehensive assessment o f the 
herbal extracts, a progression o f exper imenta l comp lex i t y is requi red; th is w o u l d be 
represented by cu l tured cel l monolayers, three d imens iona l sk in representations, 
measurement o f b iops ied cel ls and tissues to app l ica t ion i n l i v i n g human systems. 
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Appendix 1 一 Toxicity data 
A p p e n d i x 1.1 V i s u a l rep resen ta t i on o f t ox i c i t y f o r p r o l i f e r a t i o n expe r imen ts 
I n these cases, tox i c i t y is the m i n i m u m ef fect level deemed to be representative o f 
v iab le , non-pro l i fe ra t ing cel ls. Pro l i ferat ive effects due to herbal extracts have been 
expressed as percentage absorbance increases or decreases above or b e l o w untreated, 
g row ing cel ls ; the absorbance o f v iab le , non-grow ing cel ls may also be expressed i n 
these terms and when p lo t ted on dose response axes, g ive a hor izonta l l ine b e l o w 
w h i c h ef fect levels are representative o f non-v iable cel ls. 
Th is is exemp l i f i ed i n Figures A l . l , w h i c h shows the evenณal tox ic i t ies i n basal 
media for non-ef fect ive herbal extracts z. chalybeum{B) and z. chalybeumQu) and 
A l . 2 , w h i c h shows data for the same extracts i n basal m e d i a / 2 % FBS. 
A p p e n d i x 1.2 V i s u a l d i s t i nc t i on be tween g r o w t h i n h i b i t i o n a n d t o x i c i t y 
I n add i t ion to de termin ing l i m i t i n g cy to tox ic i ty fo r pro l i fe ra t ive herbal extracts, the 
pr inc ip les described i n A p p e n d i x 1.1 may be used to gauge the t ransi t ion between 
g rowth i nh ib i t i on and ce l l death / damage. 
Figure A1.3 shows the eventual tox ic i t y due to herbal extracts c. rotundifoliaÇL), с. 
abbreviata(B) and z. chalybeum(L) when these non-ef fect ive herbs were added to 
basal media / 1 0 % FBS + I G F - 1 . 
Figure A1 .4 i l lustrates h o w the l ine o f tox ic i t y acts as a par t i t ion between areas o f 
reduced g row th and reduced ce l l v iab i l i t y ( tox ic i ty ) . 
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а/ 
b/ 
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Herbal extract dose (microgrammes/ml) 
о 200 400 600 800 1000 1200 1400 
Herbal extract dose (microgrammes/ml) 
F i g u r e A l . l . Eventua l tox ic i t y o f non-ef fect ive herbal extracts z. cMlybeimi{b) (b lue 
crosses) and z. chalybeumQu) ( red crosses) i n p ro l i fe ra t ion exper iments 
a/ Herba l extracts appl ied i n basal med ia 
b/ Herba l extracts app l ied in basal med ia 12% FBS 
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Zanthoxylem chalybeuทา dose (microgrammes/ml) 
F i g u r e A 1 . 2 . Eventua l tox ic i t ies o f herbal extracts when appl ied i n basal med ia 110% 
FBS + 70цв/т1 I G F - 1 . 
а/ N o n ef fect ive herbal extracts c. rotundifoliaQJ) (b lack crosses), c. abbreviataiß) 
(b lue crosses) and z. chalybeumiL) ( red crosses) 
Ы An t i -p ro l i fe ra t i ve herbal extract z. chalybeumÇB) 
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A p p e n d i x 1.3 D i s t i n c t i o n be tween o x i d a n t cy to tox i c i t y and h e r b a l ex t r ac t -
i nduced t o x i c i t y 
This d is t inc t ion is more st ra ight forward than fo r the previous cases. For a l l 
experiments us ing ox idant solut ions, effects due to herbal extracts were def ined as the 
percentage absorbance above that o f oxidant- t reated cells. The zero l ine on the 
hor izontal axis thus represents the tox ic i t y due to ox idant a lone; ef fect levels be low 
this represent the addi t iona l tox ic i t y due to herbal extracts. 
Th is is i l lustrated i n Fig\ i re A 1 . 3 , w h i c h shows the eventual tox ic i t y o f the non ­
ef fect ive scavenging herbal extract c. abbreviata(B). 
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F i g u r e A 1 . 3 . Eventua l t ox i c i t y due to herbal extract c. abbreviatali) when appl ied i n 
ox idant scavenging exper iments 
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